data_1kde_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kde _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 121.07 0.462 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -134.22 -179.77 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.447 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.49 147.71 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.305 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.71 148.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.175 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.54 149.83 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -111.48 -23.1 10.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.32 178.44 8.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.974 0.416 . . . . 0.0 110.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.53 97.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.779 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.5 mt -89.79 118.48 69.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.78 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.39 147.68 16.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.522 1.481 . . . . 0.0 112.631 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.14 154.94 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.395 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 60.81 34.35 19.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -127.17 154.64 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.07 140.83 32.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.367 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.9 mt -82.53 167.13 18.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -143.92 -174.02 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.62 -31.9 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.36 -44.31 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.6 mtp -65.0 -29.11 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.728 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.46 149.08 23.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.345 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.06 179.35 8.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.84 135.81 51.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.381 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -178.0 141.92 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.7 121.85 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.247 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 167.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.457 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -125.73 138.97 33.01 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.315 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.59 137.17 42.01 Favored 'Cis proline' 0 N--CA 1.482 0.822 0 C-N-CA 124.075 -1.219 . . . . 0.0 112.481 0.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.26 106.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -112.62 2.78 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.91 139.46 85.59 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.41 172.69 13.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.525 1.483 . . . . 0.0 112.729 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.52 -0.13 32.03 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.784 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.99 19.79 5.38 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -140.14 29.95 2.01 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.429 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 20.7 mt -70.32 -46.85 20.31 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.147 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -76.66 -4.2 14.7 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.075 1.183 . . . . 0.0 113.263 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -96.87 -25.82 15.31 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -97.53 35.31 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.04 142.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 60.67 32.61 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.497 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.6 mmm -94.4 136.66 34.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.369 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -100.24 119.08 37.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -79.9 166.59 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.427 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -110.32 32.11 5.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.519 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -178.37 159.65 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.362 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.21 130.19 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -123.23 95.19 46.0 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.316 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.04 -174.96 2.47 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 121.675 1.583 . . . . 0.0 112.625 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.66 146.94 47.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.549 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.7 0.77 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 m -145.0 114.4 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 m -61.76 104.1 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -60.97 113.17 2.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.2 mtt -96.9 163.1 20.85 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.68 -26.34 3.18 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 121.861 1.707 . . . . 0.0 112.703 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.14 -32.81 61.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.468 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtm -71.66 -36.77 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -80.02 108.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -66.95 119.18 11.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.49 -31.91 7.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.45 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 52.3 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.158 0.504 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.139 0.495 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -144.56 -174.4 4.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.72 89.0 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.76 152.87 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.294 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.33 128.02 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -103.62 30.53 4.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.611 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -178.02 160.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.74 96.69 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.41 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -90.74 111.62 48.88 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.125 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.97 159.27 18.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.632 1.555 . . . . 0.0 112.607 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.08 154.28 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 60.63 33.29 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -133.07 144.06 49.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.43 152.12 36.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.09 168.25 12.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.364 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -148.66 169.38 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.3 -33.19 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.73 -30.08 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.708 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.0 mtm -100.13 31.18 3.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.8 mtm -150.13 144.5 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.457 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -160.05 175.87 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.427 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 t -104.24 128.61 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.419 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.92 145.5 8.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.96 127.92 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.333 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 m -154.16 162.8 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -123.91 140.06 33.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.08 140.12 52.29 Favored 'Cis proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.155 -1.185 . . . . 0.0 112.452 0.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.59 107.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.818 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.38 -106.65 1.81 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -82.07 139.46 45.91 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.32 165.78 18.57 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.523 1.482 . . . . 0.0 112.702 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.3 -3.76 38.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.68 1.7 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.718 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -128.31 27.74 5.56 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.862 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 22.6 mt -62.2 -47.41 90.15 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.214 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.5 Cg_endo -75.78 -20.19 15.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.09 1.193 . . . . 0.0 112.674 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -77.1 -28.01 54.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -97.9 35.57 1.69 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.755 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.29 142.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m 60.67 32.44 20.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.6 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.2 mmm -95.59 139.94 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.473 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -89.25 140.88 29.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.491 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.75 148.01 7.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.303 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -79.81 -21.69 43.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.6 -178.36 5.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.16 24.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.57 92.53 24.24 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.292 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.3 179.44 6.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.742 1.628 . . . . 0.0 112.66 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.06 151.61 34.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.96 40.26 93.41 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 m -129.53 118.97 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -62.31 109.74 1.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.44 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.15 114.91 5.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.389 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 mtt -95.91 158.88 33.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.364 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.9 -26.89 3.35 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 121.827 1.685 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.91 -32.97 70.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.1 mtp -73.81 -33.73 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.03 104.83 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -65.22 121.09 13.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.48 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.16 -31.2 7.87 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 40' ' ' LEU . 56.1 t80 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.061 0.458 . . . . 0.0 110.367 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.049 0.452 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -129.7 -174.73 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.362 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.92 144.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.9 t -144.93 155.81 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.258 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.52 122.95 28.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.328 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -102.47 32.51 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.41 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.96 164.92 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.169 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.1 tp -71.94 104.44 3.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.17 104.15 38.83 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.07 164.59 19.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.58 1.52 . . . . 0.0 112.678 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.45 147.93 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.84 51.75 4.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.432 0.634 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -144.97 124.06 12.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.413 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.64 148.44 46.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.423 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.94 166.67 13.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.7 p -150.25 -172.14 4.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.179 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.63 -31.43 63.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 21' ' ' MET . 9.7 p -75.3 -26.59 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.407 ' N ' HG11 ' A' ' 20' ' ' VAL . 33.1 mtp -96.98 27.32 4.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.968 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.8 mtm -150.41 148.98 29.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.079 0.466 . . . . 0.0 110.426 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -160.02 178.18 9.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.406 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 t -117.65 126.54 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -159.74 145.73 15.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.09 110.5 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.312 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.59 164.41 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -115.9 145.29 34.44 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.5 169.84 63.82 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 C-N-CA 124.097 -1.21 . . . . 0.0 112.592 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.76 112.16 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.81 -129.6 6.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.59 139.64 58.98 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.08 163.22 17.88 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.58 1.52 . . . . 0.0 112.882 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -14.58 63.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.401 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.96 -10.92 59.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.695 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.28 26.76 9.68 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.37 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 47.0 mt -66.74 -47.09 56.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.811 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.7 Cg_endo -76.5 -22.52 12.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.13 1.22 . . . . 0.0 112.639 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -76.78 -25.02 52.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 3.5 mt -97.72 31.6 2.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.94 141.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.195 0.522 . . . . 0.0 110.249 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.4 m 60.97 34.87 19.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.86 151.72 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -109.46 132.37 54.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.5 160.49 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -80.23 -33.96 37.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -131.63 -177.88 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.528 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 133.46 36.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.64 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -120.7 112.06 34.12 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.71 -176.13 3.02 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.533 1.489 . . . . 0.0 112.672 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.28 155.17 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.499 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 33.76 88.1 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -112.41 118.77 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.057 0.456 . . . . 0.0 110.306 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -61.82 104.74 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.28 115.27 3.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.362 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 21.7 mtt -96.67 160.74 28.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.542 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.98 -26.98 3.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.917 1.744 . . . . 0.0 112.727 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.35 -33.14 61.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtm -68.21 -38.45 81.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.454 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.3 t -79.98 108.32 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -65.14 121.17 14.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.05 -31.39 7.74 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 44.1 t80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -90.74 -173.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.17 92.3 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.398 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.76 151.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.77 126.07 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -102.67 31.42 4.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.66 168.26 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.2 tp -72.49 102.63 3.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.388 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 mt -105.76 101.24 31.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.45 162.1 22.28 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.579 1.52 . . . . 0.0 112.58 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.15 155.6 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.536 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.27 45.16 9.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.47 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 m -147.22 126.77 13.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.31 147.11 54.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.394 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.69 168.96 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.41 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -150.32 -179.84 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.382 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mt -68.79 -37.84 79.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.34 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 m -71.19 -26.48 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.784 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.0 mtp -96.55 27.97 3.59 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.9 mtm -150.25 144.31 25.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.05 0.452 . . . . 0.0 110.453 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -156.07 166.25 34.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.08 117.71 34.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -148.88 151.27 34.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.61 121.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.12 155.16 6.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.414 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -118.34 144.29 34.8 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.289 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.83 156.3 88.47 Favored 'Cis proline' 0 N--CA 1.481 0.77 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.463 0.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.97 112.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.505 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.75 -121.1 4.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -75.5 139.61 71.35 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.16 159.11 17.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.689 1.592 . . . . 0.0 112.926 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.33 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.03 -13.86 60.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.541 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -113.72 25.67 11.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.567 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.442 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.8 mt -64.37 -47.46 77.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.703 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -76.72 -13.48 17.93 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.174 1.25 . . . . 0.0 113.011 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.64 -27.69 28.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.904 0.383 . . . . 0.0 110.647 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 1.8 mp -96.37 41.87 1.1 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.166 0.507 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.2 t -90.1 135.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.395 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 60.3 37.5 20.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.611 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 95.8 mmm -91.5 140.24 29.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.22 143.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -110.47 160.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.386 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -113.43 31.93 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -178.59 172.43 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.6 142.33 37.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 92.06 7.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.4 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.33 -171.84 1.36 Allowed 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 121.743 1.629 . . . . 0.0 112.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.03 147.75 49.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.68 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.15 61.26 6.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -139.54 118.36 12.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 110.384 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -61.71 104.21 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.481 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.52 110.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.439 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtt -97.84 158.68 32.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.067 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.24 -18.51 11.07 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.734 1.623 . . . . 0.0 113.1 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -74.29 -40.26 62.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.954 0.407 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.2 ptp -68.77 -30.4 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.47 101.09 9.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.188 0.518 . . . . 0.0 110.11 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -64.47 126.96 29.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.27 -30.19 9.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 58.0 t80 . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 121.032 0.444 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 121.116 0.484 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -145.2 -177.15 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.479 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.56 92.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.98 145.7 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.221 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.12 120.73 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -102.32 30.93 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.35 158.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.939 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.7 tp -69.82 97.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.411 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -89.74 117.8 68.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.032 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.8 153.48 17.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.544 1.496 . . . . 0.0 112.635 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.58 149.98 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.449 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.56 37.02 19.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.558 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -136.18 140.6 43.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.9 153.0 43.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.443 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -88.47 172.66 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.387 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.28 165.4 33.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.343 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.1 -32.96 73.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.342 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 -30.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.374 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 mtm -98.84 32.32 2.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.22 144.26 26.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.307 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.07 158.02 32.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.406 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -94.19 104.31 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.508 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -141.04 142.68 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.42 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.56 129.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.422 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -155.52 161.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -119.57 144.18 36.28 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.2 160.47 85.76 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.524 0.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.35 96.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.48 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.19 -126.86 4.66 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.66 139.19 77.34 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.11 -179.88 5.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.574 1.516 . . . . 0.0 112.471 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.55 17.12 7.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.565 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -90.4 -29.54 17.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.012 0.434 . . . . 0.0 110.599 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.09 31.81 2.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.958 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 71.9 mt -64.17 -47.55 78.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.8 Cg_endo -76.04 -22.12 13.35 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.052 1.168 . . . . 0.0 112.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -77.59 -25.35 49.87 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 4.2 mt -98.06 31.14 2.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -86.47 137.06 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.365 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t 61.09 43.1 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.483 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 84.8 mmm -100.09 134.64 42.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.433 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.82 123.04 32.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.85 158.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.386 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -82.29 -31.84 29.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -132.36 -177.36 4.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.37 144.49 48.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.75 90.49 16.53 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.373 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.01 -178.21 4.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.714 1.609 . . . . 0.0 112.642 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.27 144.66 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.68 56.63 8.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -143.95 119.7 10.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 m -63.47 124.13 20.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 tp -81.15 119.59 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.301 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 21.3 mtt -96.49 155.56 37.77 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.95 -27.1 3.19 Favored 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 121.788 1.659 . . . . 0.0 112.699 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.27 -32.61 64.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.381 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -73.36 -35.0 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.447 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.1 t -79.81 112.63 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -71.48 120.67 17.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.392 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.65 7.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.44 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 53.1 t80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.097 0.475 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -101.33 -173.4 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.71 147.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -142.3 150.65 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.55 114.6 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.327 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.14 -27.21 65.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.62 -178.23 6.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -71.11 102.63 2.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.721 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -89.95 127.41 53.92 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.015 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.77 150.89 14.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.632 1.555 . . . . 0.0 112.753 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -67.61 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.329 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.16 35.14 21.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 m -129.8 148.29 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 136.53 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.388 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.46 170.34 15.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -150.27 168.41 24.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.0 -33.28 74.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.7 -28.59 34.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.435 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mtp -94.74 24.23 4.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.302 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 mtm -150.14 132.57 15.63 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 121.051 0.453 . . . . 0.0 110.218 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -143.8 172.45 12.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 t -105.53 126.02 51.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.269 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -161.43 146.22 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.65 125.66 38.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.83 168.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.475 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t -124.54 146.09 51.3 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.44 169.24 66.39 Favored 'Cis proline' 0 N--CA 1.482 0.818 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.665 0.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.73 99.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.54 -127.14 4.87 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.1 mt -78.14 139.37 60.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.35 163.84 17.06 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.673 1.582 . . . . 0.0 112.894 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.71 63.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.368 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -68.83 -10.89 59.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.656 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.52 30.61 7.11 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.36 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 43.5 mt -69.04 -47.36 29.85 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.795 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.2 Cg_endo -76.05 -24.37 11.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 120.992 1.128 . . . . 0.0 112.551 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -25.52 61.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.743 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 63' ' ' TYR . 1.6 mt -96.64 27.85 3.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.2 t -86.91 136.1 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t 61.04 32.69 19.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.437 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.2 mtp -94.33 134.48 36.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.244 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -86.18 145.31 27.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.545 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.66 -178.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.342 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.07 -22.39 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -137.52 -178.47 5.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.465 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.83 161.22 30.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.6 t -148.19 93.72 4.37 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.245 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.13 -176.01 3.0 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.683 1.589 . . . . 0.0 112.606 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.01 154.26 38.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.577 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.3 46.02 95.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.9 m -128.61 109.74 11.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 0.0 110.175 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -60.34 109.38 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.576 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.39 115.69 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.7 mtt -96.34 158.57 33.66 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.39 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.63 -26.39 3.88 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 121.826 1.684 . . . . 0.0 112.755 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.49 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 mtm -70.4 -38.56 74.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.492 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.31 110.32 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -70.15 123.43 21.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.372 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.01 -31.35 7.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' CD1' HD22 ' A' ' 40' ' ' LEU . 61.7 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.137 0.494 . . . . 0.0 110.292 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.154 0.502 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 m -134.02 -172.19 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.45 89.4 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.364 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.82 151.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.0 128.45 35.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.476 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -103.28 30.16 5.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.559 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.25 161.21 1.42 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.5 tp -71.75 94.83 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.92 111.98 49.53 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.137 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.26 157.17 19.8 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.457 1.438 . . . . 0.0 112.575 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.08 154.83 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 61.25 33.23 19.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.484 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -130.51 153.17 49.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.87 148.16 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.453 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.91 170.27 10.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.458 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -148.18 173.26 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.456 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.21 -32.4 73.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.48 -29.94 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.705 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.0 mtm -100.29 32.16 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.105 0.479 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.5 mtm -150.05 114.17 5.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.75 -178.04 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -109.63 113.36 26.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -137.82 142.31 40.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.46 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.98 82.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -114.53 146.12 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.41 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 t -111.25 141.97 25.44 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.306 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.86 132.05 23.7 Favored 'Cis proline' 0 N--CA 1.482 0.828 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.441 0.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.26 111.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.862 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.09 -94.19 1.09 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.01 139.73 27.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 167.05 16.29 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.677 1.585 . . . . 0.0 112.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -26.4 66.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.16 -18.1 56.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.4 35.73 3.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.407 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.8 mt -79.77 -46.84 1.49 Allowed Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.616 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.3 Cg_endo -77.13 -11.15 17.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.127 1.218 . . . . 0.0 113.084 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -85.68 -27.44 25.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.521 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 3.7 mt -94.16 46.64 1.17 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.16 133.89 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.309 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m 60.79 38.33 18.14 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.652 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 76.2 mmm -95.31 137.55 34.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.12 144.55 25.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.12 163.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.4 -33.6 20.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -126.95 -177.74 4.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.486 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.59 122.1 24.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.88 90.67 28.21 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.46 -172.86 1.64 Allowed 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 121.741 1.627 . . . . 0.0 112.662 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.0 152.83 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.71 39.02 90.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -130.79 118.06 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -61.9 108.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.73 114.95 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.265 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.3 mtt -93.22 150.03 38.43 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.19 -26.58 3.34 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.819 1.679 . . . . 0.0 112.635 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.46 -32.89 64.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mtm -74.27 -32.09 62.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 t -79.8 102.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.259 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -68.86 124.61 24.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.74 7.28 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.45 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 39.8 t80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -92.02 -171.51 2.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.391 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.72 90.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.56 154.79 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.38 131.61 35.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -107.99 31.91 5.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.65 158.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.08 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 tp -70.28 97.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.9 mt -89.75 112.14 50.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.079 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.35 157.49 19.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.507 1.471 . . . . 0.0 112.683 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.05 153.79 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.394 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 60.65 32.52 20.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -133.04 137.08 46.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.442 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.34 156.14 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.07 169.9 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.0 p -150.1 174.62 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.41 -36.14 81.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.02 -30.1 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.443 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 mtp -96.78 26.79 4.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.1 mtm -150.36 141.68 23.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.343 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.69 -178.11 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -115.56 129.45 56.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -158.63 139.45 12.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.361 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.76 121.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -152.83 161.34 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.444 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.18 145.61 35.36 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.42 175.69 41.15 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 C-N-CA 124.12 -1.2 . . . . 0.0 112.563 0.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.55 117.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.414 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.57 -134.28 5.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.7 mt -72.92 139.33 79.9 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.65 164.18 16.26 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.663 1.575 . . . . 0.0 112.868 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -25.04 66.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -58.98 -19.75 46.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.478 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -107.65 38.72 2.08 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.192 0.52 . . . . 0.0 111.483 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.3 mt -84.06 -46.94 0.74 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.576 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -78.35 -19.08 12.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.229 1.286 . . . . 0.0 112.853 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -83.73 -20.66 33.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 63' ' ' TYR . 9.0 mp -97.31 32.01 2.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.008 0.433 . . . . 0.0 110.935 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -79.5 140.08 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.037 0.446 . . . . 0.0 110.168 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p 56.68 41.43 28.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 92.3 mmm -97.43 133.12 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.307 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -92.43 144.02 25.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.626 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -110.91 157.89 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.165 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.94 -30.19 39.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -128.04 -177.42 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.534 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.75 35.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.528 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.92 98.06 49.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.94 177.77 7.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.628 1.552 . . . . 0.0 112.714 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.32 150.11 46.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.573 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.2 32.22 75.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -116.81 117.94 31.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -61.87 104.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.464 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.85 115.53 4.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.3 mtt -100.35 160.26 27.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.65 -26.85 3.58 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 121.81 1.673 . . . . 0.0 112.615 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.83 -39.13 83.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 41.1 mtm -69.98 -32.18 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.77 95.36 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.236 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -66.02 127.37 31.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.7 -31.09 8.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' CE1' ' CD1' ' A' ' 40' ' ' LEU . 33.1 t80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.266 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 121.09 0.471 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -149.87 -177.02 5.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.89 146.89 7.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -142.89 156.08 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.121 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.1 119.73 25.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -99.9 31.07 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.42 164.45 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.02 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.72 101.09 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 mt -96.5 108.93 45.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.269 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.73 -178.6 4.29 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.56 1.507 . . . . 0.0 112.589 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.04 154.66 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 60.62 33.98 20.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.526 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -130.42 131.47 45.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.2 157.1 36.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.525 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.18 165.55 13.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.484 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.3 p -150.08 171.14 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.336 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.26 -34.03 75.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -30.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.453 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.4 mtp -94.52 21.21 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.319 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.42 140.14 21.72 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.983 0.42 . . . . 0.0 110.425 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.13 176.37 11.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -103.05 142.81 33.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.372 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -170.88 140.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.467 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.67 96.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.19 172.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -131.46 145.72 58.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.5 167.33 71.16 Favored 'Cis proline' 0 N--CA 1.481 0.782 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.522 0.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.17 92.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.47 -126.61 2.31 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.88 139.66 76.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.18 163.69 15.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.661 1.574 . . . . 0.0 112.653 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.66 67.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.62 -22.42 45.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.9 37.98 2.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.149 0.499 . . . . 0.0 111.443 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 58.8 mt -81.31 -46.98 1.11 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.607 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -77.35 -22.35 11.02 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 121.164 1.243 . . . . 0.0 112.592 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -79.18 -22.56 44.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 63' ' ' TYR . 5.7 mp -96.83 28.78 3.31 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.29 145.21 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m 60.92 32.87 20.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 72.3 mmm -94.83 134.71 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.423 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.27 141.52 28.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.458 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 m -102.12 170.68 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.47 -31.4 15.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.614 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.74 167.91 21.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.0 120.36 13.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -105.89 114.29 62.89 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.123 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.2 -176.71 3.26 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 121.534 1.489 . . . . 0.0 112.604 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.58 157.16 38.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.416 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.41 31.93 82.41 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -113.33 118.71 35.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.065 0.459 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.9 m -61.81 105.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.27 115.5 3.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.484 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 35.4 mtt -101.46 155.65 36.11 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.38 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.1 -27.61 2.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.887 1.725 . . . . 0.0 112.629 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -64.84 -37.11 86.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.4 mtm -75.66 -34.8 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.404 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -79.94 111.2 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -82.82 129.75 35.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.85 -32.2 6.73 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CE1' HD13 ' A' ' 40' ' ' LEU . 1.7 t80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.14 0.495 . . . . 0.0 110.346 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -108.0 175.91 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.24 143.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.228 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.78 147.91 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.94 106.25 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.63 -28.69 67.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.8 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.79 -177.97 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.114 0.483 . . . . 0.0 110.364 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.81 103.56 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.627 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.2 mt -89.32 132.49 37.29 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.912 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.9 152.73 14.65 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.656 1.571 . . . . 0.0 112.744 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.2 tt -70.69 150.18 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 60.39 32.75 20.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.538 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -130.34 141.39 50.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.88 140.62 55.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -78.22 169.81 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.375 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -150.15 167.51 26.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.397 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.3 -32.47 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.316 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -65.24 -30.6 50.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.634 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.3 mtm -103.65 27.86 7.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 mtp -145.89 132.21 19.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.369 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.12 -179.57 7.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.1 136.61 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -169.13 143.9 3.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.62 110.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.327 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.77 167.45 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.49 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.94 143.56 49.19 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.327 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.15 163.44 82.31 Favored 'Cis proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.55 0.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.72 120.89 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.87 -130.64 4.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.5 139.78 94.45 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.71 160.65 19.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.64 1.56 . . . . 0.0 112.921 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.62 -18.47 64.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.268 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -66.37 -13.45 60.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.6 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -113.58 23.31 13.26 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.446 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 38.4 mt -62.25 -47.42 89.89 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.703 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.8 Cg_endo -76.5 -19.09 15.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 121.14 1.227 . . . . 0.0 112.848 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -77.97 -27.72 49.24 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 2.1 mp -98.11 35.03 1.81 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 t -88.01 139.73 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.272 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 t 60.9 32.62 20.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.542 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 mtp -95.6 135.76 36.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.33 145.29 24.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.502 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.54 174.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -92.46 -30.98 15.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -134.05 -177.54 4.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.41 149.34 46.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.207 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.8 90.51 36.03 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.51 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -78.63 176.4 9.93 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 121.829 1.686 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -62.59 137.75 58.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.749 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.59 -31.99 7.5 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 108.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.138 0.494 . . . . 0.0 110.519 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -63.01 118.61 8.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.43 113.47 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.5 mtt -99.73 158.42 32.15 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.34 -25.9 4.45 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 121.824 1.683 . . . . 0.0 112.714 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.06 -32.5 61.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.3 mtm -73.98 -36.02 64.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.56 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.84 104.54 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.37 127.42 32.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.441 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.16 -30.78 8.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 41.5 t80 . . . . . 0 C--N 1.331 -0.219 0 CA-C-O 121.05 0.452 . . . . 0.0 110.287 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.11 0.481 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.04 -171.74 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.352 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -119.33 87.03 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.376 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.7 153.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.376 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.28 122.22 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.56 30.76 3.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.87 167.73 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.1 tp -72.62 102.62 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mt -95.99 109.1 44.93 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.83 166.7 17.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.595 1.53 . . . . 0.0 112.643 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -73.29 154.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.37 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.38 32.28 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 m -132.38 146.59 52.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.405 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 148.75 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -80.5 169.83 17.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -150.19 170.31 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.11 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.87 -28.22 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.449 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mtp -97.15 29.13 3.26 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.29 150.13 31.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.212 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -160.13 167.23 28.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -107.51 103.13 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -142.05 146.77 35.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.91 125.64 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.316 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -153.31 156.75 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 t -109.72 145.05 31.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.357 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.09 161.61 85.0 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.49 0.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.99 113.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.37 -126.05 5.0 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.96 139.18 76.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.88 172.3 12.21 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.631 1.554 . . . . 0.0 112.688 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.38 -1.9 32.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.783 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.22 6.12 23.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.642 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.26 31.96 5.14 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.105 0.479 . . . . 0.0 110.55 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 33.5 mt -73.37 -46.39 7.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.206 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.1 Cg_endo -75.88 -24.29 11.62 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 121.065 1.177 . . . . 0.0 112.464 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.28 -18.79 48.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.992 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.422 ' CD1' ' CE1' ' A' ' 63' ' ' TYR . 6.4 mp -97.02 29.15 3.21 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -86.04 131.23 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.061 0.458 . . . . 0.0 110.304 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t 61.43 36.06 17.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.673 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.0 mtp -91.96 125.77 36.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -79.86 134.66 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.536 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.01 -177.51 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -110.28 -32.26 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.661 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 -177.06 4.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.43 129.01 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.453 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.19 100.77 42.07 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.152 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.87 -178.04 4.26 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.577 1.518 . . . . 0.0 112.682 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.35 148.04 52.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.6 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.74 52.58 24.21 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -135.19 118.18 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 m -61.52 100.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.552 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.31 113.67 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.1 mtt -96.14 165.21 16.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.318 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.76 -26.29 4.73 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.74 1.626 . . . . 0.0 112.616 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.79 -23.09 55.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.986 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -97.44 28.53 3.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.918 0.39 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 t -141.33 101.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.094 0.473 . . . . 0.0 110.133 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -64.08 124.46 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.453 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.58 7.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CE1' ' CD1' ' A' ' 40' ' ' LEU . 27.5 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.113 0.482 . . . . 0.0 110.433 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 121.103 0.477 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -98.46 175.69 5.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.37 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.84 147.98 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.25 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.7 t -145.61 149.9 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 102.3 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.299 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.28 -26.33 66.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -149.58 -178.0 6.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.4 101.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.601 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -96.06 123.8 54.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.2 159.93 15.31 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.623 1.549 . . . . 0.0 112.796 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.03 151.67 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.331 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.06 37.46 21.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.646 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -132.8 134.75 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.472 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 151.06 36.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.17 166.63 13.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.1 p -150.13 170.13 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.08 -32.97 73.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.03 -30.35 43.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.0 mtp -97.44 28.66 3.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.27 125.78 10.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -142.89 161.97 36.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -96.63 143.42 27.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.432 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -177.96 143.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 122.52 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 m -154.45 157.16 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.65 144.91 34.18 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.363 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.41 150.83 81.39 Favored 'Cis proline' 0 N--CA 1.481 0.754 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.462 0.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -59.45 104.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.799 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.44 -121.28 3.69 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.62 139.55 70.83 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -82.19 161.24 17.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.612 1.541 . . . . 0.0 112.92 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.98 64.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.313 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -13.18 61.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.489 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -113.75 25.09 11.51 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.609 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 39.6 mt -63.45 -47.58 83.29 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.642 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.1 Cg_endo -76.6 -16.31 16.86 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.105 1.203 . . . . 0.0 113.008 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -80.77 -27.27 36.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.773 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 2.1 mp -97.41 38.78 1.24 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.147 0.498 . . . . 0.0 110.721 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -89.68 141.76 13.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.231 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m 60.84 32.65 20.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.514 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 94.7 mmm -92.25 143.45 26.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -101.2 138.77 37.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.477 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.74 144.77 14.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.346 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.96 -28.24 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.716 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -122.72 168.17 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.103 0.477 . . . . 0.0 110.461 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.97 51.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.03 91.77 23.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.38 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.64 -175.13 2.53 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.68 1.587 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.65 149.39 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.506 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.47 61.6 6.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -140.62 111.93 7.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 104.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.54 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.5 109.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.498 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.5 mtt -93.92 165.02 18.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.72 -20.23 8.01 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 121.828 1.685 . . . . 0.0 113.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.81 -42.77 49.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.992 0.425 . . . . 0.0 110.722 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ptp -64.87 -28.16 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.992 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.63 97.42 6.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.094 0.473 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -66.05 127.66 33.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.364 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.06 -31.09 8.48 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 43.3 t80 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.246 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -101.57 -173.06 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -100.27 93.42 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.1 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.267 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.05 132.5 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.304 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.37 29.49 7.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -177.61 165.55 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.114 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.84 96.13 4.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -90.43 112.47 53.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.085 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.91 156.81 20.66 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.562 1.508 . . . . 0.0 112.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.71 154.58 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 m120 60.46 32.83 20.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 156.72 43.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 151.98 21.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -90.1 168.57 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.457 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -150.12 164.65 35.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.67 -32.06 72.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.448 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -66.29 -31.56 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.288 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.7 mtm -99.43 31.77 3.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.5 mtm -150.12 137.22 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -160.03 162.24 34.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 m -84.71 129.94 34.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.423 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -162.44 128.94 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.462 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.71 115.18 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.89 162.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -119.55 141.52 31.07 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.263 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.99 156.35 87.86 Favored 'Cis proline' 0 N--CA 1.482 0.821 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.523 0.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -61.11 112.28 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.38 -125.66 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.39 139.86 75.44 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.19 165.99 16.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.622 1.548 . . . . 0.0 112.817 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.21 60.01 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.613 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.99 -9.75 56.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.774 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.18 27.63 8.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.403 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 36.7 mt -65.81 -47.63 64.76 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.555 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.6 Cg_endo -77.96 -18.15 13.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.161 1.241 . . . . 0.0 112.532 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -79.24 -26.27 42.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -97.44 37.63 1.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.098 0.475 . . . . 0.0 110.893 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 t -89.05 135.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.162 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m 61.28 37.64 17.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 97.2 mmm -90.37 147.67 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.31 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.67 125.18 47.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.517 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -91.84 -177.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.376 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -108.74 -43.04 4.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.612 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -118.02 -177.49 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.55 121.87 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.507 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -111.91 91.97 16.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.203 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.12 -173.2 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.666 1.577 . . . . 0.0 112.778 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.0 mp -67.12 137.71 56.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 31.95 37.25 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -111.65 112.51 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.052 0.454 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.5 m -62.04 105.39 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.81 141.58 57.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.267 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 mmm -127.12 157.03 73.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.74 -20.79 7.57 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 121.803 1.669 . . . . 0.0 113.129 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -79.27 -44.41 21.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 ptm -68.08 -31.38 70.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.86 111.28 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -71.75 121.39 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.377 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.66 7.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.45 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 48.5 t80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 121.01 0.433 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 121.213 0.53 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.23 -177.42 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.91 149.63 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.6 t -145.96 153.68 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.136 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.79 121.38 25.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.368 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -99.84 30.54 3.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.99 161.62 0.95 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.988 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 tp -69.79 97.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.7 111.93 48.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.043 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.29 153.49 16.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.603 1.535 . . . . 0.0 112.598 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 tt -61.47 154.15 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.359 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 60.87 33.07 20.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -132.38 146.29 51.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.422 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 155.32 29.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.499 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.19 167.44 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.45 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.06 -33.26 74.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -69.7 -27.88 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.771 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -99.02 30.77 3.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.0 mtm -150.15 143.84 25.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -160.21 164.4 32.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -97.46 133.32 42.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -169.14 146.24 3.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.87 130.8 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -155.45 175.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -133.52 144.91 54.18 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.11 169.35 69.92 Favored 'Cis proline' 0 N--CA 1.482 0.843 0 C-N-CA 124.086 -1.214 . . . . 0.0 112.587 -0.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.58 110.94 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.352 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -111.01 -133.63 6.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.8 mt -65.75 139.74 97.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.98 168.28 17.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.576 1.517 . . . . 0.0 112.674 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.36 -2.77 36.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.694 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -90.82 19.82 5.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.624 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.39 30.1 1.96 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.608 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 25.4 mt -69.09 -46.97 30.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.111 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.7 Cg_endo -76.38 -21.3 13.47 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 121.129 1.219 . . . . 0.0 112.657 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -77.05 -26.74 53.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 5.3 mt -97.87 34.44 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 t -90.02 141.62 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.254 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m 60.8 34.75 19.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.8 mmm -97.03 129.56 44.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.32 136.42 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.407 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.95 163.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.402 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -112.76 32.23 5.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.414 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -178.84 161.13 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.429 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.36 126.6 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.91 94.97 47.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.17 179.85 5.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.07 142.04 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.25 56.4 6.3 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 m -134.7 118.03 16.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.36 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -62.07 100.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.88 110.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.0 mtt -95.37 163.08 22.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.71 -26.85 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.869 1.713 . . . . 0.0 112.685 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.16 -33.15 67.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.431 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.33 -36.6 68.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.432 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.89 110.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -71.88 122.64 21.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.444 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.49 -31.61 7.46 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 63.7 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.054 0.454 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -126.31 -177.48 3.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.37 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.16 87.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.354 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -89.52 147.8 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.309 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.84 129.97 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.452 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -107.9 31.08 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.74 158.09 0.77 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.05 98.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.56 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.1 mt -89.48 112.91 54.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.942 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.8 151.95 19.2 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.386 1.39 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.51 155.06 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.01 32.89 19.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.472 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -134.19 151.52 51.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.99 151.35 24.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.418 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.89 170.81 12.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.393 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -150.33 166.71 29.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.38 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.03 -32.39 72.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.356 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.43 -30.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.458 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.4 mtm -99.1 31.29 3.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.629 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.03 151.43 33.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.352 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.05 -177.2 6.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -120.77 100.63 7.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.91 144.33 37.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.84 129.03 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.324 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.05 154.02 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -114.18 139.53 23.86 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.36 142.14 59.53 Favored 'Cis proline' 0 N--CA 1.483 0.855 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.475 0.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.64 91.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.67 -111.94 0.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.67 139.05 58.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -79.69 173.04 13.45 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.544 1.496 . . . . 0.0 112.525 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.07 14.18 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.559 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 14.89 12.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.405 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -145.57 29.79 1.12 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 22.4 mt -60.94 -47.33 95.85 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -75.76 -16.95 18.3 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.142 1.228 . . . . 0.0 112.914 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -82.56 -25.66 33.12 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.417 HD12 ' CE1' ' A' ' 63' ' ' TYR . 3.3 mp -97.76 34.37 1.89 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.026 0.441 . . . . 0.0 110.731 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.59 134.22 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 t 60.86 35.8 19.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 74.8 mmm -84.51 129.25 34.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -81.44 129.82 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.428 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.23 172.86 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.404 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -106.55 -33.82 7.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.391 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.36 -177.63 3.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.32 141.44 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.504 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.27 91.08 23.69 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.44 -171.54 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.678 1.585 . . . . 0.0 112.671 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.0 143.32 56.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.438 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.83 49.75 27.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -132.85 114.42 14.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.321 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -61.86 104.57 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.73 111.22 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.5 mmt -97.2 163.84 19.05 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.223 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.79 -24.62 4.82 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 121.628 1.552 . . . . 0.0 112.941 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.77 -25.73 59.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.0 mtm -98.23 30.21 3.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -140.2 106.31 2.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.017 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.79 121.62 14.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -31.37 8.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CE1' HD12 ' A' ' 40' ' ' LEU . 37.0 t80 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.497 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m -131.17 -174.0 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.08 89.54 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.481 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.12 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.233 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.86 137.0 38.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.373 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -112.4 29.52 7.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.633 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.3 157.06 1.29 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.975 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.59 97.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.56 125.4 61.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.1 151.16 13.93 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.653 1.568 . . . . 0.0 112.518 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.13 152.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 59.79 36.66 22.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 m -133.31 159.56 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.439 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.15 150.47 22.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.464 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.2 175.1 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 p -144.6 -170.94 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.096 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.32 -38.7 26.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.775 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.52 -25.87 37.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.8 mtm -99.19 31.07 3.19 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.8 mtm -150.18 125.81 10.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -143.76 -178.95 6.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.399 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -114.76 126.58 55.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.406 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.5 136.41 10.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.33 112.36 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.06 149.06 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -108.51 145.16 30.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.38 164.26 80.05 Favored 'Cis proline' 0 N--CA 1.481 0.759 0 C-N-CA 124.106 -1.206 . . . . 0.0 112.532 0.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.56 118.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.439 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.33 -130.85 5.3 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.8 mt -72.84 139.37 80.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.85 161.9 18.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.632 1.555 . . . . 0.0 112.843 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.48 -23.96 66.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.082 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -59.84 -18.89 47.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.541 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.91 40.09 1.99 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 111.438 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 55.0 mt -85.69 -46.63 0.6 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.9 Cg_endo -78.07 -15.01 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.179 1.253 . . . . 0.0 113.078 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -86.17 -26.61 25.05 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.641 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 63' ' ' TYR . 11.1 mp -93.45 47.87 1.27 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.265 0.555 . . . . 0.0 110.588 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 t -90.15 134.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.4 m 61.24 32.88 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.45 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.8 mmm -86.02 140.36 30.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.316 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -96.88 144.39 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.522 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 m -110.41 175.55 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.411 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -90.52 -38.28 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -177.33 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.27 132.38 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.512 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -116.67 91.99 36.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.75 -171.23 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.748 1.632 . . . . 0.0 112.613 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -71.06 148.65 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.437 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.28 32.23 72.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.5 m -116.7 114.92 24.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 110.271 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 m -61.97 100.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.405 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.29 113.43 2.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.442 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.3 mtt -98.81 159.5 30.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.477 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.98 -27.71 2.36 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 121.918 1.745 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.09 -33.44 75.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.43 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.0 mtm -77.55 -33.51 54.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.382 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -79.85 102.71 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.46 125.82 27.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.71 -31.54 7.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.415 ' CE1' HD12 ' A' ' 40' ' ' LEU . 35.9 t80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.285 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 121.105 0.479 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.24 -172.41 2.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.9 151.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.278 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.14 150.17 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.28 120.88 25.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.368 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -99.7 31.54 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.59 166.16 1.74 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.058 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.0 tp -72.26 102.74 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.262 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.6 mt -103.58 103.37 35.71 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.3 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.79 163.79 20.78 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.563 1.509 . . . . 0.0 112.553 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -61.2 153.82 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.414 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 60.35 37.1 20.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.536 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 m -129.29 132.66 47.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 142.6 50.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.74 163.71 21.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.514 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -150.22 175.79 11.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.304 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.61 -34.14 77.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.336 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.95 -29.69 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.553 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.7 mtp -95.16 22.73 6.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.213 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mtm -150.5 143.04 24.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.112 0.482 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -160.04 177.53 10.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 m -111.41 137.19 49.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -171.72 139.06 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.83 123.54 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.301 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.56 173.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -128.33 145.34 55.35 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.365 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.74 -179.97 25.9 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.494 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.87 102.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.91 -131.47 7.37 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.8 mt -73.23 139.56 79.08 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -82.79 169.49 13.34 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.606 1.537 . . . . 0.0 112.902 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -24.89 65.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.47 -19.28 46.54 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.38 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.71 35.75 2.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.087 0.47 . . . . 0.0 111.45 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 46.9 mt -81.06 -46.7 1.15 Allowed Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.562 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.4 Cg_endo -77.43 -24.44 9.15 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.175 1.25 . . . . 0.0 112.529 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -78.41 -20.38 51.24 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.885 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 63' ' ' TYR . 6.7 mp -97.19 30.31 2.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.972 0.415 . . . . 0.0 110.793 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.39 135.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.135 0.493 . . . . 0.0 110.237 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.79 33.7 17.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 17.2 mtp -97.88 119.63 36.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.279 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -79.91 138.71 37.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.459 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.38 -179.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -110.13 -25.21 10.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -128.65 171.59 12.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.11 0.481 . . . . 0.0 110.544 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.45 144.36 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.9 92.49 12.67 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -78.91 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 121.632 1.555 . . . . 0.0 112.686 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.04 153.55 25.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.675 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.76 53.1 46.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -135.32 117.63 15.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.096 0.474 . . . . 0.0 110.354 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -63.01 104.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.475 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.83 114.41 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.451 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mtt -99.92 163.8 17.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.9 -24.79 5.64 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 121.738 1.625 . . . . 0.0 112.757 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.44 -32.31 64.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.453 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.9 mtm -71.67 -38.59 70.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.436 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.8 t -80.23 107.2 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.02 124.81 23.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.64 -29.8 10.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CE1' HD12 ' A' ' 40' ' ' LEU . 58.0 t80 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 110.335 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 121.186 0.517 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -93.6 -171.13 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.47 149.07 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.1 t -146.59 150.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.7 122.14 20.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.244 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.77 -17.79 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -149.27 174.5 12.34 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 0.0 110.576 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 100.64 1.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.733 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mt -89.98 116.94 67.58 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.937 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.68 147.88 15.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.436 1.424 . . . . 0.0 112.635 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.1 155.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.384 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 61.01 33.25 19.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -133.84 152.62 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.61 138.07 32.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.466 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.6 172.82 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.419 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -150.19 164.22 36.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.339 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.5 -31.57 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.484 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.44 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.7 mtm -99.56 35.85 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 0.0 110.544 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.6 mtm -149.99 149.34 30.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.594 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -157.17 166.78 32.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.348 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.6 t -102.5 92.33 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.508 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -126.81 140.02 52.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.19 131.18 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.358 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -152.84 -177.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -136.75 139.31 28.67 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.292 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -77.92 148.85 86.46 Favored 'Cis proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.119 -1.2 . . . . 0.0 112.436 0.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.92 91.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.621 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.41 -124.93 0.71 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.78 139.0 85.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.53 179.45 6.34 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.513 1.475 . . . . 0.0 112.617 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.92 13.45 14.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.67 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.56 -25.35 20.25 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.994 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -98.24 31.02 2.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 75.3 mt -66.99 -47.4 52.93 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.9 Cg_endo -76.51 -24.01 10.89 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 121.036 1.157 . . . . 0.0 112.572 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -26.78 53.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.698 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 6.3 mt -98.21 33.6 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.89 136.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.6 m 60.93 36.08 18.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.56 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 mmm -92.45 133.08 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -82.61 131.76 35.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.3 152.47 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.326 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -79.81 -21.86 43.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.05 -179.94 6.95 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.55 154.57 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.88 93.86 4.44 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.383 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.49 -176.79 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.683 1.588 . . . . 0.0 112.484 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.69 152.67 30.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.632 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.26 57.89 13.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -138.91 113.51 9.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.215 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -61.05 107.53 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.598 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.91 109.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.0 mtt -97.99 160.8 27.53 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.289 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.45 -23.88 5.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.834 1.689 . . . . 0.0 112.978 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -71.19 -43.28 67.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.0 ptp -67.08 -29.07 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.04 104.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.161 0.505 . . . . 0.0 110.167 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -66.66 121.91 16.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.27 -31.53 7.57 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 50.1 t80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.297 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.043 0.449 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.61 -171.96 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.425 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.39 85.73 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.92 152.28 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.323 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.88 126.61 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.78 31.97 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.55 164.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.2 tp -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.408 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.61 104.35 37.85 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.241 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.11 174.79 10.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.551 1.501 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.1 154.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.419 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 60.31 33.79 20.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -128.27 130.91 48.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.455 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 146.79 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.7 mt -87.43 164.96 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.473 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 p -150.27 -171.74 3.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.195 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.94 -45.62 57.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -64.57 -24.3 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.0 mtp -95.8 25.33 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.4 mtm -150.41 152.23 34.02 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 110.312 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -159.98 176.72 11.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.57 116.75 28.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -152.03 139.07 19.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.11 113.41 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.11 178.97 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.431 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -131.44 145.47 57.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.286 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.13 168.11 70.74 Favored 'Cis proline' 0 N--CA 1.481 0.772 0 C-N-CA 124.142 -1.191 . . . . 0.0 112.561 -0.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 95.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.372 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -122.1 3.46 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.88 139.51 46.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.01 165.82 14.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 121.664 1.576 . . . . 0.0 112.78 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.3 62.96 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -72.12 -7.99 52.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.704 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -116.34 28.94 8.26 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.166 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.447 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.8 mt -69.75 -46.99 24.84 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.9 Cg_endo -76.79 -16.21 16.5 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.127 1.218 . . . . 0.0 112.9 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -82.58 -25.3 33.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.715 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 3.4 mt -96.38 40.02 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.12 132.57 34.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.247 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 m 60.69 57.24 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mmm -119.88 133.07 55.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.429 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.85 133.18 33.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.505 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.1 -177.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -105.53 -35.65 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -133.03 -177.21 4.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.373 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.53 115.36 11.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.43 93.18 18.27 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.336 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.61 -176.26 3.09 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 121.75 1.633 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -62.17 147.92 46.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.4 44.63 64.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -127.87 116.72 20.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.147 0.498 . . . . 0.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.4 m -62.26 101.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.87 111.73 2.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.2 mtt -91.01 158.82 41.13 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.324 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.4 -26.38 4.09 Favored 'Trans proline' 0 N--CA 1.474 0.373 0 C-N-CA 121.793 1.662 . . . . 0.0 112.737 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.79 -31.94 59.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.501 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.4 mtp -68.38 -38.36 81.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.71 109.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.384 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.19 120.29 12.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.29 -31.85 7.1 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 46.3 t80 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 110.362 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.084 0.469 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -94.09 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 91.99 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.77 153.04 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.301 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 128.65 35.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.416 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.77 31.86 4.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.6 163.34 1.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.08 96.57 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.551 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 mt -90.08 111.77 48.63 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.019 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.01 153.9 16.98 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.524 1.483 . . . . 0.0 112.755 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.2 tt -61.39 154.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 60.2 33.63 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.556 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -130.61 159.66 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.84 151.53 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.401 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.0 165.77 13.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.439 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.2 p -148.28 165.45 30.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.381 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.7 -31.62 71.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.17 -31.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.314 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.0 mtm -99.26 31.07 3.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.593 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.5 mtm -150.05 140.49 22.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.435 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -160.1 -177.36 6.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.15 124.14 51.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.377 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.65 145.51 22.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.07 121.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.348 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.67 159.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -120.3 145.77 41.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.88 166.19 72.13 Favored 'Cis proline' 0 N--CA 1.481 0.736 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.651 -0.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.19 99.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.35 -123.57 3.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -76.35 139.55 68.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.25 164.37 17.13 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.71 1.607 . . . . 0.0 112.797 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.41 -21.17 65.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -64.03 -15.55 59.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.513 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.27 28.1 8.96 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.494 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.446 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 48.3 mt -71.09 -46.94 14.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -77.0 -19.32 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.204 1.269 . . . . 0.0 112.844 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -80.91 -24.72 38.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 2.1 mt -96.58 37.65 1.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.102 0.477 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -89.94 138.57 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.242 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 60.87 35.94 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 86.9 mmm -92.01 143.64 26.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.457 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -103.88 138.25 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.95 175.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -102.54 -31.38 10.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.561 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -121.83 -179.44 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.72 155.72 33.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.61 90.75 4.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.348 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -79.63 -175.29 2.65 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 121.705 1.603 . . . . 0.0 112.657 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -61.73 151.73 33.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.57 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 51.59 48.36 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -133.62 122.04 22.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.126 0.489 . . . . 0.0 110.427 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -66.64 102.59 0.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.452 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.54 114.05 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.6 mtt -98.44 161.22 25.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.378 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.6 -26.18 4.04 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.47 -32.86 60.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.361 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.52 -32.77 71.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.425 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -86.84 107.58 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.269 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -66.77 123.07 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.79 -30.95 8.44 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 56.7 t80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 121.134 0.492 . . . . 0.0 110.338 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.171 0.51 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -108.67 -175.07 2.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.398 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.68 149.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -150.14 149.6 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.95 127.58 32.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.345 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -105.62 30.68 5.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 160.31 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.121 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -69.48 98.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.43 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.47 112.24 50.43 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 160.94 18.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 121.568 1.512 . . . . 0.0 112.575 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -65.98 154.96 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.31 33.16 20.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 m -130.84 147.96 52.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.58 155.76 25.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.79 169.45 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.368 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.18 163.38 38.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.23 -32.83 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.44 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.65 -31.24 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.428 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.6 mtm -99.29 31.61 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.9 mtm -150.11 138.69 20.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -159.71 163.53 34.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.425 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -90.3 132.34 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.414 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -167.36 136.75 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.89 112.18 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -141.84 153.09 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 t -114.3 144.5 31.82 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.28 152.56 84.01 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.092 -1.212 . . . . 0.0 112.495 0.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.07 113.12 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.452 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.81 -113.05 3.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.19 139.5 42.18 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.42 165.74 18.38 Favored 'Trans proline' 0 N--CA 1.476 0.462 0 C-N-CA 121.612 1.541 . . . . 0.0 112.946 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.34 -13.54 62.09 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.4 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.02 -10.21 57.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.609 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.63 28.65 8.51 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.285 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.447 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.5 mt -71.12 -46.79 14.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.825 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.3 Cg_endo -77.35 -22.67 10.77 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.153 1.235 . . . . 0.0 112.71 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -79.03 -24.52 43.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 20.1 mt -97.22 35.86 1.54 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 t -90.12 137.42 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 p 56.51 45.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.802 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.9 mtp -104.14 142.26 34.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.485 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.89 136.55 32.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.33 176.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.431 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -93.87 -36.38 12.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -134.7 -177.07 4.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.564 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.79 121.17 21.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.44 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.94 101.79 31.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.151 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.34 176.82 9.26 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 121.51 1.473 . . . . 0.0 112.691 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.0 mp -61.23 151.06 32.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.565 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.07 54.9 29.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -135.82 116.71 14.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 m -61.99 108.86 1.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.5 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -61.3 113.06 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.29 156.39 38.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.346 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -79.9 -24.74 5.68 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.853 1.702 . . . . 0.0 112.778 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -74.64 -31.37 61.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.3 mtm -71.91 -37.78 70.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.73 102.08 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.357 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -66.93 128.72 37.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.61 -29.43 11.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 39.1 t80 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.341 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.068 0 CA-C-O 121.078 0.466 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.59 -171.99 2.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.22 86.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.474 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.88 151.38 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.979 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.91 39.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.896 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -115.22 -17.52 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.46 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -149.42 -179.92 7.45 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.069 0.461 . . . . 0.0 110.494 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.0 tp -71.08 101.36 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.4 mt -96.95 109.98 51.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.057 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.38 154.24 21.38 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.524 1.483 . . . . 0.0 112.782 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.49 155.45 4.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 60.28 40.99 17.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 m -139.22 138.45 36.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.64 150.53 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.401 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -90.24 164.72 14.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 p -150.08 175.24 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.443 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.28 -33.06 73.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.372 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.57 -28.35 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 mtp -97.65 29.09 3.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.8 mtm -150.27 140.32 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -148.14 177.52 9.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.398 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.78 108.24 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.458 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -146.62 144.58 29.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.34 120.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.345 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.51 165.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.399 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 t -122.7 145.45 45.24 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.33 174.98 43.82 Favored 'Cis proline' 0 N--CA 1.481 0.767 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.446 -0.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.22 108.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.49 -120.99 4.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.58 139.71 35.74 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -83.08 166.33 14.61 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.63 1.553 . . . . 0.0 112.68 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.47 -23.2 62.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.73 -13.9 60.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.475 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -110.76 24.37 13.03 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.603 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 43.6 mt -66.09 -46.88 63.27 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.706 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.4 Cg_endo -76.7 -15.61 17.01 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 121.122 1.215 . . . . 0.0 112.82 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.41 -25.75 33.41 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.71 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.26 36.24 1.49 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.787 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.06 139.72 16.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m 60.99 34.42 19.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.56 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.8 mmm -84.15 148.62 26.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.399 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -112.77 124.78 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -95.0 -178.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.299 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -129.98 33.22 4.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.53 163.55 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.475 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.93 49.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.397 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 12.5 t -149.75 98.27 3.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.054 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.61 -165.45 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.903 1.735 . . . . 0.0 112.923 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.68 154.13 39.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.16 58.58 13.3 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.418 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 9.8 t -132.48 136.18 46.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -75.61 104.65 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.113 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.39 108.14 6.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.29 164.75 18.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.904 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.459 ' CB ' ' CD1' ' A' ' 63' ' ' TYR . 39.9 Cg_endo -80.36 -35.7 0.59 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 121.586 1.524 . . . . 0.0 112.657 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.35 -42.36 99.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.399 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtm -63.51 -30.45 71.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.61 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -88.39 127.79 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -81.42 122.32 27.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.028 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.5 -28.59 7.4 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.459 ' CD1' ' CB ' ' A' ' 57' ' ' PRO . 9.0 t80 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 121.09 0.471 . . . . 0.0 110.536 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -74.55 126.83 31.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.426 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.27 152.56 18.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -134.22 -179.77 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.447 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.49 147.71 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.305 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.71 148.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.175 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.54 149.83 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -111.48 -23.1 10.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.32 178.44 8.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.974 0.416 . . . . 0.0 110.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.53 97.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.779 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.5 mt -89.79 118.48 69.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.78 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.39 147.68 16.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.522 1.481 . . . . 0.0 112.631 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.14 154.94 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.395 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 60.81 34.35 19.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -127.17 154.64 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.07 140.83 32.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.367 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.9 mt -82.53 167.13 18.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -143.92 -174.02 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.62 -31.9 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.36 -44.31 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.6 mtp -65.0 -29.11 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.728 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.46 149.08 23.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.345 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.06 179.35 8.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.84 135.81 51.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.381 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -178.0 141.92 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.7 121.85 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.247 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 167.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.457 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -125.73 138.97 33.01 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.315 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.59 137.17 42.01 Favored 'Cis proline' 0 N--CA 1.482 0.822 0 C-N-CA 124.075 -1.219 . . . . 0.0 112.481 0.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.26 106.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -112.62 2.78 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.91 139.46 85.59 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.41 172.69 13.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.525 1.483 . . . . 0.0 112.729 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.52 -0.13 32.03 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.784 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.99 19.79 5.38 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -140.14 29.95 2.01 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.429 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 20.7 mt -70.32 -46.85 20.31 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.147 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -76.66 -4.2 14.7 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.075 1.183 . . . . 0.0 113.263 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -96.87 -25.82 15.31 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -97.53 35.31 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.04 142.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 60.67 32.61 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.497 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.6 mmm -94.4 136.66 34.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.369 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -100.24 119.08 37.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -79.9 166.59 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.427 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -110.32 32.11 5.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.519 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -178.37 159.65 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.362 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.21 130.19 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -123.23 95.19 46.0 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.316 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.04 -174.96 2.47 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 121.675 1.583 . . . . 0.0 112.625 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.66 146.94 47.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.549 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.7 0.77 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 m -145.0 114.4 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 m -61.76 104.1 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -60.97 113.17 2.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.2 mtt -96.9 163.1 20.85 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.68 -26.34 3.18 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 121.861 1.707 . . . . 0.0 112.703 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.14 -32.81 61.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.468 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtm -71.66 -36.77 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -80.02 108.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -66.95 119.18 11.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.49 -31.91 7.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.45 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 52.3 t80 -80.64 103.17 10.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.158 0.504 . . . . 0.0 110.376 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.6 173.71 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.442 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -131.26 130.87 43.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.59 177.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.439 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -144.56 -174.4 4.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.72 89.0 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.76 152.87 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.294 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.33 128.02 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -103.62 30.53 4.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.611 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -178.02 160.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.74 96.69 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.41 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -90.74 111.62 48.88 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.125 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.97 159.27 18.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.632 1.555 . . . . 0.0 112.607 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.08 154.28 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 60.63 33.29 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -133.07 144.06 49.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.43 152.12 36.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.09 168.25 12.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.364 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -148.66 169.38 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.3 -33.19 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.73 -30.08 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.708 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.0 mtm -100.13 31.18 3.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.8 mtm -150.13 144.5 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.457 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -160.05 175.87 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.427 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 t -104.24 128.61 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.419 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.92 145.5 8.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.96 127.92 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.333 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 m -154.16 162.8 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -123.91 140.06 33.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.08 140.12 52.29 Favored 'Cis proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.155 -1.185 . . . . 0.0 112.452 0.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.59 107.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.818 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.38 -106.65 1.81 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -82.07 139.46 45.91 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.32 165.78 18.57 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.523 1.482 . . . . 0.0 112.702 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.3 -3.76 38.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.68 1.7 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.718 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -128.31 27.74 5.56 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.862 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 22.6 mt -62.2 -47.41 90.15 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.214 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.5 Cg_endo -75.78 -20.19 15.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.09 1.193 . . . . 0.0 112.674 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -77.1 -28.01 54.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -97.9 35.57 1.69 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.755 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.29 142.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m 60.67 32.44 20.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.6 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.2 mmm -95.59 139.94 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.473 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -89.25 140.88 29.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.491 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.75 148.01 7.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.303 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -79.81 -21.69 43.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.6 -178.36 5.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.16 24.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.57 92.53 24.24 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.292 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.3 179.44 6.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.742 1.628 . . . . 0.0 112.66 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.06 151.61 34.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.96 40.26 93.41 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 m -129.53 118.97 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -62.31 109.74 1.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.44 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.15 114.91 5.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.389 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 mtt -95.91 158.88 33.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.364 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.9 -26.89 3.35 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 121.827 1.685 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.91 -32.97 70.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.1 mtp -73.81 -33.73 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.03 104.83 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -65.22 121.09 13.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.48 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.16 -31.2 7.87 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 40' ' ' LEU . 56.1 t80 -88.58 149.77 23.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.061 0.458 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -166.38 103.81 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.396 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -136.08 133.28 37.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.4 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.06 160.01 29.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -129.7 -174.73 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.362 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.92 144.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.9 t -144.93 155.81 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.258 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.52 122.95 28.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.328 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -102.47 32.51 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.41 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.96 164.92 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.169 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.1 tp -71.94 104.44 3.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.17 104.15 38.83 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.07 164.59 19.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.58 1.52 . . . . 0.0 112.678 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.45 147.93 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.84 51.75 4.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.432 0.634 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -144.97 124.06 12.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.413 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.64 148.44 46.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.423 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.94 166.67 13.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.7 p -150.25 -172.14 4.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.179 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.63 -31.43 63.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 21' ' ' MET . 9.7 p -75.3 -26.59 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.407 ' N ' HG11 ' A' ' 20' ' ' VAL . 33.1 mtp -96.98 27.32 4.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.968 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.8 mtm -150.41 148.98 29.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.079 0.466 . . . . 0.0 110.426 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -160.02 178.18 9.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.406 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 t -117.65 126.54 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -159.74 145.73 15.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.09 110.5 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.312 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.59 164.41 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -115.9 145.29 34.44 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.5 169.84 63.82 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 C-N-CA 124.097 -1.21 . . . . 0.0 112.592 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.76 112.16 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.81 -129.6 6.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.59 139.64 58.98 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.08 163.22 17.88 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.58 1.52 . . . . 0.0 112.882 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -14.58 63.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.401 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.96 -10.92 59.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.695 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.28 26.76 9.68 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.37 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 47.0 mt -66.74 -47.09 56.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.811 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.7 Cg_endo -76.5 -22.52 12.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.13 1.22 . . . . 0.0 112.639 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -76.78 -25.02 52.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 3.5 mt -97.72 31.6 2.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.94 141.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.195 0.522 . . . . 0.0 110.249 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.4 m 60.97 34.87 19.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.86 151.72 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -109.46 132.37 54.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.5 160.49 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -80.23 -33.96 37.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -131.63 -177.88 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.528 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 133.46 36.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.64 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -120.7 112.06 34.12 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.71 -176.13 3.02 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.533 1.489 . . . . 0.0 112.672 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.28 155.17 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.499 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 33.76 88.1 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -112.41 118.77 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.057 0.456 . . . . 0.0 110.306 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -61.82 104.74 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.28 115.27 3.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.362 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 21.7 mtt -96.67 160.74 28.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.542 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.98 -26.98 3.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.917 1.744 . . . . 0.0 112.727 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.35 -33.14 61.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtm -68.21 -38.45 81.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.454 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.3 t -79.98 108.32 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -65.14 121.17 14.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.05 -31.39 7.74 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 44.1 t80 -79.46 128.22 33.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.362 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.7 150.57 40.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.463 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.443 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.7 p30 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -81.01 -11.08 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.41 110.71 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.392 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -90.74 -173.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.17 92.3 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.398 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.76 151.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.77 126.07 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -102.67 31.42 4.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.66 168.26 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.2 tp -72.49 102.63 3.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.388 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 mt -105.76 101.24 31.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.45 162.1 22.28 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.579 1.52 . . . . 0.0 112.58 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.15 155.6 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.536 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.27 45.16 9.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.47 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 m -147.22 126.77 13.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.31 147.11 54.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.394 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.69 168.96 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.41 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -150.32 -179.84 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.382 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mt -68.79 -37.84 79.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.34 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 m -71.19 -26.48 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.784 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.0 mtp -96.55 27.97 3.59 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.9 mtm -150.25 144.31 25.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.05 0.452 . . . . 0.0 110.453 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -156.07 166.25 34.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.08 117.71 34.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -148.88 151.27 34.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.61 121.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.12 155.16 6.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.414 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -118.34 144.29 34.8 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.289 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.83 156.3 88.47 Favored 'Cis proline' 0 N--CA 1.481 0.77 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.463 0.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.97 112.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.505 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.75 -121.1 4.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -75.5 139.61 71.35 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.16 159.11 17.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.689 1.592 . . . . 0.0 112.926 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.33 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.03 -13.86 60.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.541 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -113.72 25.67 11.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.567 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.8 mt -64.37 -47.46 77.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.703 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -76.72 -13.48 17.93 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.174 1.25 . . . . 0.0 113.011 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.64 -27.69 28.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.904 0.383 . . . . 0.0 110.647 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 1.8 mp -96.37 41.87 1.1 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.166 0.507 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.2 t -90.1 135.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.395 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t 60.3 37.5 20.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.611 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 95.8 mmm -91.5 140.24 29.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.22 143.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -110.47 160.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.386 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -113.43 31.93 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -178.59 172.43 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.6 142.33 37.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 92.06 7.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.4 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.33 -171.84 1.36 Allowed 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 121.743 1.629 . . . . 0.0 112.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.03 147.75 49.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.68 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.15 61.26 6.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -139.54 118.36 12.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 110.384 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -61.71 104.21 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.481 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.52 110.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.439 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtt -97.84 158.68 32.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.067 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.24 -18.51 11.07 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.734 1.623 . . . . 0.0 113.1 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -74.29 -40.26 62.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.954 0.407 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.2 ptp -68.77 -30.4 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.47 101.09 9.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.188 0.518 . . . . 0.0 110.11 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -64.47 126.96 29.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.27 -30.19 9.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 58.0 t80 -89.58 114.38 25.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.032 0.444 . . . . 0.0 110.434 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -61.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.414 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.5 m120 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.11 105.27 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.6 -178.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -145.2 -177.15 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.479 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.56 92.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.98 145.7 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.221 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.12 120.73 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -102.32 30.93 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.35 158.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.939 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.7 tp -69.82 97.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.411 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -89.74 117.8 68.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.032 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.8 153.48 17.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.544 1.496 . . . . 0.0 112.635 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.58 149.98 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.449 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.56 37.02 19.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.558 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -136.18 140.6 43.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.9 153.0 43.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.443 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -88.47 172.66 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.387 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.28 165.4 33.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.343 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.1 -32.96 73.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.342 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 -30.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.374 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 mtm -98.84 32.32 2.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.6 mtm -149.22 144.26 26.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.307 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.07 158.02 32.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.406 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -94.19 104.31 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.508 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -141.04 142.68 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.42 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.56 129.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.422 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -155.52 161.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -119.57 144.18 36.28 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.2 160.47 85.76 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.524 0.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.35 96.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.48 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.19 -126.86 4.66 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.66 139.19 77.34 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.11 -179.88 5.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.574 1.516 . . . . 0.0 112.471 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.55 17.12 7.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.565 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -90.4 -29.54 17.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.012 0.434 . . . . 0.0 110.599 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.09 31.81 2.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.958 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 71.9 mt -64.17 -47.55 78.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.8 Cg_endo -76.04 -22.12 13.35 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.052 1.168 . . . . 0.0 112.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -77.59 -25.35 49.87 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 4.2 mt -98.06 31.14 2.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -86.47 137.06 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.365 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t 61.09 43.1 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.483 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 84.8 mmm -100.09 134.64 42.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.433 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.82 123.04 32.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.85 158.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.386 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -82.29 -31.84 29.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -132.36 -177.36 4.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.37 144.49 48.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.75 90.49 16.53 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.373 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.01 -178.21 4.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.714 1.609 . . . . 0.0 112.642 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.27 144.66 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.68 56.63 8.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -143.95 119.7 10.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 m -63.47 124.13 20.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 tp -81.15 119.59 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.301 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 21.3 mtt -96.49 155.56 37.77 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.95 -27.1 3.19 Favored 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 121.788 1.659 . . . . 0.0 112.699 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.27 -32.61 64.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.381 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -73.36 -35.0 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.447 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.1 t -79.81 112.63 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -71.48 120.67 17.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.392 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.65 7.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.44 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 53.1 t80 -83.01 135.75 34.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.17 87.62 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.411 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.525 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.49 132.82 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.428 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.03 113.37 25.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.402 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -101.33 -173.4 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.71 147.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -142.3 150.65 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.55 114.6 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.327 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.14 -27.21 65.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.62 -178.23 6.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -71.11 102.63 2.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.721 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -89.95 127.41 53.92 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.015 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.77 150.89 14.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.632 1.555 . . . . 0.0 112.753 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -67.61 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.329 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.16 35.14 21.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 m -129.8 148.29 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 136.53 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.388 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.46 170.34 15.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -150.27 168.41 24.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.0 -33.28 74.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.7 -28.59 34.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.435 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mtp -94.74 24.23 4.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.302 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 mtm -150.14 132.57 15.63 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 121.051 0.453 . . . . 0.0 110.218 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -143.8 172.45 12.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 t -105.53 126.02 51.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.269 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -161.43 146.22 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.65 125.66 38.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.83 168.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.475 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t -124.54 146.09 51.3 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.44 169.24 66.39 Favored 'Cis proline' 0 N--CA 1.482 0.818 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.665 0.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.73 99.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.54 -127.14 4.87 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.1 mt -78.14 139.37 60.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.35 163.84 17.06 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.673 1.582 . . . . 0.0 112.894 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.54 -14.71 63.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.368 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -68.83 -10.89 59.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.656 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.52 30.61 7.11 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.36 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 43.5 mt -69.04 -47.36 29.85 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.795 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.2 Cg_endo -76.05 -24.37 11.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 120.992 1.128 . . . . 0.0 112.551 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -25.52 61.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.743 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 63' ' ' TYR . 1.6 mt -96.64 27.85 3.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.2 t -86.91 136.1 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t 61.04 32.69 19.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.437 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.2 mtp -94.33 134.48 36.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.244 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -86.18 145.31 27.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.545 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.66 -178.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.342 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.07 -22.39 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -137.52 -178.47 5.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.465 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.83 161.22 30.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.6 t -148.19 93.72 4.37 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.245 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.13 -176.01 3.0 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.683 1.589 . . . . 0.0 112.606 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.01 154.26 38.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.577 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.3 46.02 95.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.9 m -128.61 109.74 11.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 0.0 110.175 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -60.34 109.38 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.576 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.39 115.69 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.7 mtt -96.34 158.57 33.66 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.39 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.63 -26.39 3.88 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 121.826 1.684 . . . . 0.0 112.755 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.49 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 mtm -70.4 -38.56 74.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.492 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.31 110.32 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -70.15 123.43 21.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.372 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.01 -31.35 7.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' CD1' HD22 ' A' ' 40' ' ' LEU . 61.7 t80 -76.08 145.23 40.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.137 0.494 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -170.93 110.62 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.481 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.385 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 60.74 82.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.5 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.51 169.78 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.453 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 m -134.02 -172.19 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.45 89.4 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.364 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.82 151.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.0 128.45 35.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.476 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -103.28 30.16 5.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.559 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.25 161.21 1.42 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.5 tp -71.75 94.83 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.92 111.98 49.53 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.137 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.26 157.17 19.8 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.457 1.438 . . . . 0.0 112.575 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.08 154.83 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 61.25 33.23 19.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.484 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -130.51 153.17 49.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.87 148.16 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.453 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.91 170.27 10.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.458 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -148.18 173.26 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.456 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.21 -32.4 73.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.48 -29.94 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.705 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.0 mtm -100.29 32.16 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.105 0.479 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.5 mtm -150.05 114.17 5.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.75 -178.04 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -109.63 113.36 26.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -137.82 142.31 40.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.46 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.98 82.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -114.53 146.12 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.41 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 t -111.25 141.97 25.44 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.306 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.86 132.05 23.7 Favored 'Cis proline' 0 N--CA 1.482 0.828 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.441 0.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.26 111.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.862 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.09 -94.19 1.09 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.2 mt -90.01 139.73 27.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 167.05 16.29 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.677 1.585 . . . . 0.0 112.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -26.4 66.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.16 -18.1 56.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.4 35.73 3.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.407 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.8 mt -79.77 -46.84 1.49 Allowed Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.616 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.3 Cg_endo -77.13 -11.15 17.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.127 1.218 . . . . 0.0 113.084 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -85.68 -27.44 25.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.521 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 3.7 mt -94.16 46.64 1.17 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.16 133.89 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.309 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m 60.79 38.33 18.14 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.652 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 76.2 mmm -95.31 137.55 34.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.12 144.55 25.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.12 163.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.4 -33.6 20.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -126.95 -177.74 4.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.486 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.59 122.1 24.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.88 90.67 28.21 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.46 -172.86 1.64 Allowed 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 121.741 1.627 . . . . 0.0 112.662 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.0 152.83 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.71 39.02 90.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -130.79 118.06 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -61.9 108.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.73 114.95 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.265 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.3 mtt -93.22 150.03 38.43 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.19 -26.58 3.34 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.819 1.679 . . . . 0.0 112.635 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.46 -32.89 64.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mtm -74.27 -32.09 62.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.0 t -79.8 102.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.259 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -68.86 124.61 24.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.74 7.28 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.45 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 39.8 t80 -62.89 -67.28 0.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.341 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.07 49.05 12.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.839 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.639 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -79.37 109.31 13.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.406 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.86 125.7 29.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.432 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -92.02 -171.51 2.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.391 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.72 90.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.56 154.79 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.38 131.61 35.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.384 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -107.99 31.91 5.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.65 158.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.08 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 tp -70.28 97.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.9 mt -89.75 112.14 50.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.079 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.35 157.49 19.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.507 1.471 . . . . 0.0 112.683 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.05 153.79 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.394 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 60.65 32.52 20.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -133.04 137.08 46.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.442 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.34 156.14 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.07 169.9 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.0 p -150.1 174.62 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.41 -36.14 81.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.02 -30.1 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.443 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 mtp -96.78 26.79 4.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.1 mtm -150.36 141.68 23.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.343 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.69 -178.11 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -115.56 129.45 56.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -158.63 139.45 12.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.361 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.76 121.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -152.83 161.34 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.444 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.18 145.61 35.36 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.42 175.69 41.15 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 C-N-CA 124.12 -1.2 . . . . 0.0 112.563 0.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.55 117.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.414 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.57 -134.28 5.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.7 mt -72.92 139.33 79.9 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.65 164.18 16.26 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.663 1.575 . . . . 0.0 112.868 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -25.04 66.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -58.98 -19.75 46.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.478 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -107.65 38.72 2.08 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.192 0.52 . . . . 0.0 111.483 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.3 mt -84.06 -46.94 0.74 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.576 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -78.35 -19.08 12.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.229 1.286 . . . . 0.0 112.853 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -83.73 -20.66 33.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 63' ' ' TYR . 9.0 mp -97.31 32.01 2.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.008 0.433 . . . . 0.0 110.935 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -79.5 140.08 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.037 0.446 . . . . 0.0 110.168 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p 56.68 41.43 28.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 92.3 mmm -97.43 133.12 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.307 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -92.43 144.02 25.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.626 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -110.91 157.89 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.165 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.94 -30.19 39.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -128.04 -177.42 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.534 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.75 35.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.528 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.92 98.06 49.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.94 177.77 7.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.628 1.552 . . . . 0.0 112.714 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.32 150.11 46.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.573 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.2 32.22 75.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -116.81 117.94 31.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -61.87 104.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.464 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.85 115.53 4.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.3 mtt -100.35 160.26 27.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.65 -26.85 3.58 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 121.81 1.673 . . . . 0.0 112.615 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.83 -39.13 83.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 41.1 mtm -69.98 -32.18 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.77 95.36 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.236 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -66.02 127.37 31.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.7 -31.09 8.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' CE1' ' CD1' ' A' ' 40' ' ' LEU . 33.1 t80 -68.53 -70.29 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.266 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.54 85.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.925 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.472 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -143.08 149.89 38.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.407 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.49 160.55 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.438 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -149.87 -177.02 5.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.89 146.89 7.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -142.89 156.08 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.121 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.1 119.73 25.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -99.9 31.07 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.42 164.45 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.02 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.72 101.09 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 mt -96.5 108.93 45.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.269 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.73 -178.6 4.29 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.56 1.507 . . . . 0.0 112.589 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.04 154.66 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 60.62 33.98 20.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.526 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -130.42 131.47 45.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.2 157.1 36.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.525 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.18 165.55 13.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.484 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.3 p -150.08 171.14 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.336 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.26 -34.03 75.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -30.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.453 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.4 mtp -94.52 21.21 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.319 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.42 140.14 21.72 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.983 0.42 . . . . 0.0 110.425 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.13 176.37 11.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -103.05 142.81 33.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.372 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -170.88 140.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.467 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.67 96.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.19 172.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -131.46 145.72 58.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.5 167.33 71.16 Favored 'Cis proline' 0 N--CA 1.481 0.782 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.522 0.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.17 92.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.47 -126.61 2.31 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.88 139.66 76.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.18 163.69 15.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.661 1.574 . . . . 0.0 112.653 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.66 67.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.62 -22.42 45.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.9 37.98 2.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.149 0.499 . . . . 0.0 111.443 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 58.8 mt -81.31 -46.98 1.11 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.607 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -77.35 -22.35 11.02 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 121.164 1.243 . . . . 0.0 112.592 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -79.18 -22.56 44.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 63' ' ' TYR . 5.7 mp -96.83 28.78 3.31 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.29 145.21 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m 60.92 32.87 20.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 72.3 mmm -94.83 134.71 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.423 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.27 141.52 28.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.458 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 m -102.12 170.68 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.47 -31.4 15.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.614 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.74 167.91 21.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.0 120.36 13.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -105.89 114.29 62.89 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.123 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.2 -176.71 3.26 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 121.534 1.489 . . . . 0.0 112.604 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.58 157.16 38.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.416 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.41 31.93 82.41 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -113.33 118.71 35.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.065 0.459 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.9 m -61.81 105.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.27 115.5 3.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.484 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 35.4 mtt -101.46 155.65 36.11 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.38 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.1 -27.61 2.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.887 1.725 . . . . 0.0 112.629 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -64.84 -37.11 86.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.4 mtm -75.66 -34.8 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.404 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -79.94 111.2 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -82.82 129.75 35.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.85 -32.2 6.73 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE1' ' CA ' ' A' ' 65' ' ' ALA . 1.7 t80 -63.49 115.57 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.14 0.495 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -52.7 8.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.579 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' CA ' ' CE1' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.477 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.45 160.98 41.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.4 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.63 125.56 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.512 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -108.0 175.91 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.24 143.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.228 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.78 147.91 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.94 106.25 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.63 -28.69 67.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.8 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.79 -177.97 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.114 0.483 . . . . 0.0 110.364 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.81 103.56 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.627 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.2 mt -89.32 132.49 37.29 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.912 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.9 152.73 14.65 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.656 1.571 . . . . 0.0 112.744 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.2 tt -70.69 150.18 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 60.39 32.75 20.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.538 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -130.34 141.39 50.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.88 140.62 55.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -78.22 169.81 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.375 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -150.15 167.51 26.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.397 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.3 -32.47 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.316 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -65.24 -30.6 50.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.634 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.3 mtm -103.65 27.86 7.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 mtp -145.89 132.21 19.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.369 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.12 -179.57 7.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.1 136.61 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -169.13 143.9 3.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.62 110.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.327 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.77 167.45 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.49 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.94 143.56 49.19 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.327 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.15 163.44 82.31 Favored 'Cis proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.55 0.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.72 120.89 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.87 -130.64 4.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.5 139.78 94.45 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.71 160.65 19.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.64 1.56 . . . . 0.0 112.921 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.62 -18.47 64.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.268 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -66.37 -13.45 60.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.6 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -113.58 23.31 13.26 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.446 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 38.4 mt -62.25 -47.42 89.89 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.703 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.8 Cg_endo -76.5 -19.09 15.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 121.14 1.227 . . . . 0.0 112.848 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -77.97 -27.72 49.24 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 2.1 mp -98.11 35.03 1.81 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 t -88.01 139.73 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.272 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 t 60.9 32.62 20.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.542 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 mtp -95.6 135.76 36.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.33 145.29 24.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.502 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.54 174.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -92.46 -30.98 15.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -134.05 -177.54 4.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.41 149.34 46.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.207 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.8 90.51 36.03 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.51 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -78.63 176.4 9.93 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 121.829 1.686 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -62.59 137.75 58.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.749 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.59 -31.99 7.5 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 108.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.138 0.494 . . . . 0.0 110.519 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -63.01 118.61 8.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.43 113.47 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.5 mtt -99.73 158.42 32.15 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.34 -25.9 4.45 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 121.824 1.683 . . . . 0.0 112.714 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.06 -32.5 61.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.3 mtm -73.98 -36.02 64.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.56 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.84 104.54 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.37 127.42 32.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.441 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.16 -30.78 8.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 41.5 t80 -64.88 -66.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.05 0.452 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.9 79.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.636 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.605 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 60.55 101.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.27 176.48 9.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.04 -171.74 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.352 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -119.33 87.03 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.376 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.7 153.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.376 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.28 122.22 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.56 30.76 3.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.87 167.73 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.1 tp -72.62 102.62 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mt -95.99 109.1 44.93 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.21 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.83 166.7 17.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.595 1.53 . . . . 0.0 112.643 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -73.29 154.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.37 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.38 32.28 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 m -132.38 146.59 52.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.405 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 148.75 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -80.5 169.83 17.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -150.19 170.31 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.11 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.87 -28.22 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.449 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mtp -97.15 29.13 3.26 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.29 150.13 31.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.212 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -160.13 167.23 28.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -107.51 103.13 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -142.05 146.77 35.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.91 125.64 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.316 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -153.31 156.75 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 t -109.72 145.05 31.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.357 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.09 161.61 85.0 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.49 0.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.99 113.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.37 -126.05 5.0 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.96 139.18 76.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.88 172.3 12.21 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.631 1.554 . . . . 0.0 112.688 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.38 -1.9 32.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.783 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.22 6.12 23.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.642 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.26 31.96 5.14 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.105 0.479 . . . . 0.0 110.55 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 33.5 mt -73.37 -46.39 7.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.206 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.1 Cg_endo -75.88 -24.29 11.62 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 121.065 1.177 . . . . 0.0 112.464 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.28 -18.79 48.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.992 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.422 ' CD1' ' CE1' ' A' ' 63' ' ' TYR . 6.4 mp -97.02 29.15 3.21 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -86.04 131.23 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.061 0.458 . . . . 0.0 110.304 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t 61.43 36.06 17.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.673 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.0 mtp -91.96 125.77 36.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -79.86 134.66 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.536 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.01 -177.51 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -110.28 -32.26 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.661 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 -177.06 4.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.43 129.01 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.453 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.19 100.77 42.07 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.152 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.87 -178.04 4.26 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.577 1.518 . . . . 0.0 112.682 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.35 148.04 52.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.6 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.74 52.58 24.21 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -135.19 118.18 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 m -61.52 100.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.552 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.31 113.67 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.1 mtt -96.14 165.21 16.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.318 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.76 -26.29 4.73 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.74 1.626 . . . . 0.0 112.616 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.79 -23.09 55.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.986 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -97.44 28.53 3.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.918 0.39 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 t -141.33 101.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.094 0.473 . . . . 0.0 110.133 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -64.08 124.46 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.453 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.58 7.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CE1' ' CD1' ' A' ' 40' ' ' LEU . 27.5 t80 -72.68 140.44 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.113 0.482 . . . . 0.0 110.433 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -162.0 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.43 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.445 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -75.58 158.17 32.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.54 106.11 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.406 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -98.46 175.69 5.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.37 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.84 147.98 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.25 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.7 t -145.61 149.9 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 102.3 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.299 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.28 -26.33 66.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -149.58 -178.0 6.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.4 101.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.601 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -96.06 123.8 54.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.2 159.93 15.31 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.623 1.549 . . . . 0.0 112.796 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.03 151.67 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.331 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.06 37.46 21.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.646 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -132.8 134.75 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.472 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 151.06 36.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.17 166.63 13.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.1 p -150.13 170.13 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.08 -32.97 73.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.03 -30.35 43.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.0 mtp -97.44 28.66 3.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.27 125.78 10.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -142.89 161.97 36.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -96.63 143.42 27.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.432 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -177.96 143.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 122.52 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 m -154.45 157.16 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.65 144.91 34.18 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.363 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.41 150.83 81.39 Favored 'Cis proline' 0 N--CA 1.481 0.754 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.462 0.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -59.45 104.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.799 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.44 -121.28 3.69 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.62 139.55 70.83 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -82.19 161.24 17.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.612 1.541 . . . . 0.0 112.92 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.98 64.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.313 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -13.18 61.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.489 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -113.75 25.09 11.51 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.609 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 39.6 mt -63.45 -47.58 83.29 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.642 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.1 Cg_endo -76.6 -16.31 16.86 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.105 1.203 . . . . 0.0 113.008 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -80.77 -27.27 36.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.773 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 2.1 mp -97.41 38.78 1.24 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.147 0.498 . . . . 0.0 110.721 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -89.68 141.76 13.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.231 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m 60.84 32.65 20.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.514 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 94.7 mmm -92.25 143.45 26.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -101.2 138.77 37.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.477 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.74 144.77 14.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.346 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.96 -28.24 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.716 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -122.72 168.17 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.103 0.477 . . . . 0.0 110.461 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.97 51.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.03 91.77 23.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.38 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.64 -175.13 2.53 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.68 1.587 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.65 149.39 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.506 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.47 61.6 6.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -140.62 111.93 7.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 104.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.54 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.5 109.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.498 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.5 mtt -93.92 165.02 18.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.72 -20.23 8.01 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 121.828 1.685 . . . . 0.0 113.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.81 -42.77 49.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.992 0.425 . . . . 0.0 110.722 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ptp -64.87 -28.16 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.992 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.63 97.42 6.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.094 0.473 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -66.05 127.66 33.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.364 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.06 -31.09 8.48 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 43.3 t80 -66.88 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.36 51.79 5.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.568 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.587 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -87.98 -32.4 18.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.451 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.94 108.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.437 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -101.57 -173.06 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -100.27 93.42 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.1 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.267 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.05 132.5 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.304 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.37 29.49 7.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -177.61 165.55 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.114 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.84 96.13 4.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -90.43 112.47 53.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.085 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.91 156.81 20.66 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.562 1.508 . . . . 0.0 112.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.71 154.58 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 m120 60.46 32.83 20.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 156.72 43.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 151.98 21.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -90.1 168.57 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.457 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -150.12 164.65 35.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.67 -32.06 72.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.448 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -66.29 -31.56 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.288 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.7 mtm -99.43 31.77 3.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.5 mtm -150.12 137.22 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -160.03 162.24 34.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 m -84.71 129.94 34.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.423 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -162.44 128.94 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.462 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.71 115.18 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.89 162.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -119.55 141.52 31.07 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.263 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.99 156.35 87.86 Favored 'Cis proline' 0 N--CA 1.482 0.821 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.523 0.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -61.11 112.28 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.38 -125.66 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.39 139.86 75.44 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.19 165.99 16.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.622 1.548 . . . . 0.0 112.817 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.21 60.01 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.613 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.99 -9.75 56.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.774 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.18 27.63 8.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.403 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 36.7 mt -65.81 -47.63 64.76 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.555 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.6 Cg_endo -77.96 -18.15 13.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.161 1.241 . . . . 0.0 112.532 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -79.24 -26.27 42.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -97.44 37.63 1.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.098 0.475 . . . . 0.0 110.893 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 t -89.05 135.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.162 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m 61.28 37.64 17.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 97.2 mmm -90.37 147.67 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.31 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.67 125.18 47.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.517 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -91.84 -177.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.376 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -108.74 -43.04 4.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.612 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -118.02 -177.49 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.55 121.87 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.507 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -111.91 91.97 16.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.203 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.12 -173.2 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.666 1.577 . . . . 0.0 112.778 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.0 mp -67.12 137.71 56.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 31.95 37.25 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.9 m -111.65 112.51 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.052 0.454 . . . . 0.0 110.311 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.5 m -62.04 105.39 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.81 141.58 57.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.267 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 mmm -127.12 157.03 73.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.74 -20.79 7.57 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 121.803 1.669 . . . . 0.0 113.129 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -79.27 -44.41 21.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 ptm -68.08 -31.38 70.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.86 111.28 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -71.75 121.39 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.377 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.66 7.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.45 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 48.5 t80 -85.09 110.69 19.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.01 0.433 . . . . 0.0 110.417 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.96 -69.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.384 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.396 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.29 31.28 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.41 125.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.566 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.23 -177.42 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.91 149.63 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.6 t -145.96 153.68 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.136 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.79 121.38 25.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.368 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -99.84 30.54 3.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.99 161.62 0.95 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.988 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 tp -69.79 97.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.7 111.93 48.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.043 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.29 153.49 16.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.603 1.535 . . . . 0.0 112.598 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 tt -61.47 154.15 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.359 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 60.87 33.07 20.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -132.38 146.29 51.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.422 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 155.32 29.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.499 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.19 167.44 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.45 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.06 -33.26 74.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -69.7 -27.88 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.771 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -99.02 30.77 3.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.585 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.0 mtm -150.15 143.84 25.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -160.21 164.4 32.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -97.46 133.32 42.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -169.14 146.24 3.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.87 130.8 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -155.45 175.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -133.52 144.91 54.18 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.11 169.35 69.92 Favored 'Cis proline' 0 N--CA 1.482 0.843 0 C-N-CA 124.086 -1.214 . . . . 0.0 112.587 -0.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.58 110.94 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.352 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -111.01 -133.63 6.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.8 mt -65.75 139.74 97.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.98 168.28 17.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.576 1.517 . . . . 0.0 112.674 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.36 -2.77 36.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.694 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -90.82 19.82 5.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.624 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.39 30.1 1.96 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.608 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 25.4 mt -69.09 -46.97 30.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.111 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.7 Cg_endo -76.38 -21.3 13.47 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 121.129 1.219 . . . . 0.0 112.657 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -77.05 -26.74 53.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 5.3 mt -97.87 34.44 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 t -90.02 141.62 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.254 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m 60.8 34.75 19.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.8 mmm -97.03 129.56 44.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.32 136.42 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.407 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.95 163.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.402 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -112.76 32.23 5.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.414 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -178.84 161.13 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.429 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.36 126.6 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.91 94.97 47.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.17 179.85 5.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.07 142.04 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.25 56.4 6.3 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 m -134.7 118.03 16.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.36 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -62.07 100.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.88 110.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.0 mtt -95.37 163.08 22.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.71 -26.85 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.869 1.713 . . . . 0.0 112.685 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.16 -33.15 67.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.431 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.33 -36.6 68.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.432 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.89 110.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -71.88 122.64 21.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.444 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.49 -31.61 7.46 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 63.7 t80 -78.95 157.08 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -160.13 124.37 3.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.448 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.423 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -61.11 166.99 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.514 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.79 160.63 20.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.424 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -126.31 -177.48 3.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.37 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.16 87.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.354 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -89.52 147.8 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.309 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.84 129.97 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.452 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -107.9 31.08 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.74 158.09 0.77 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.05 98.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.56 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.1 mt -89.48 112.91 54.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.942 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.8 151.95 19.2 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.386 1.39 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.51 155.06 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.01 32.89 19.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.472 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -134.19 151.52 51.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.99 151.35 24.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.418 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.89 170.81 12.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.393 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -150.33 166.71 29.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.38 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.03 -32.39 72.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.356 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.43 -30.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.458 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.4 mtm -99.1 31.29 3.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.629 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.03 151.43 33.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.352 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.05 -177.2 6.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -120.77 100.63 7.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.91 144.33 37.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.84 129.03 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.324 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.05 154.02 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -114.18 139.53 23.86 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.36 142.14 59.53 Favored 'Cis proline' 0 N--CA 1.483 0.855 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.475 0.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.64 91.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.67 -111.94 0.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.67 139.05 58.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -79.69 173.04 13.45 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.544 1.496 . . . . 0.0 112.525 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.07 14.18 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.559 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 14.89 12.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.405 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -145.57 29.79 1.12 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 22.4 mt -60.94 -47.33 95.85 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -75.76 -16.95 18.3 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.142 1.228 . . . . 0.0 112.914 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -82.56 -25.66 33.12 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.417 HD12 ' CE1' ' A' ' 63' ' ' TYR . 3.3 mp -97.76 34.37 1.89 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.026 0.441 . . . . 0.0 110.731 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.59 134.22 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 t 60.86 35.8 19.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 74.8 mmm -84.51 129.25 34.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -81.44 129.82 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.428 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.23 172.86 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.404 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -106.55 -33.82 7.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.391 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.36 -177.63 3.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.32 141.44 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.504 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.27 91.08 23.69 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.44 -171.54 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.678 1.585 . . . . 0.0 112.671 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.0 143.32 56.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.438 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.83 49.75 27.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -132.85 114.42 14.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.321 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -61.86 104.57 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.73 111.22 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.5 mmt -97.2 163.84 19.05 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.223 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.79 -24.62 4.82 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 121.628 1.552 . . . . 0.0 112.941 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.77 -25.73 59.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.0 mtm -98.23 30.21 3.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -140.2 106.31 2.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.017 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.79 121.62 14.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -31.37 8.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CE1' HD12 ' A' ' 40' ' ' LEU . 37.0 t80 -90.22 139.27 30.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 91.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.562 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.47 118.15 27.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.44 167.15 4.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.357 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m -131.17 -174.0 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.08 89.54 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.481 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.12 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.233 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.86 137.0 38.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.373 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -112.4 29.52 7.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.633 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.3 157.06 1.29 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.975 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -70.59 97.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.56 125.4 61.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.1 151.16 13.93 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.653 1.568 . . . . 0.0 112.518 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.13 152.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 59.79 36.66 22.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 m -133.31 159.56 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.439 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.15 150.47 22.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.464 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.2 175.1 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 p -144.6 -170.94 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.096 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.32 -38.7 26.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.775 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.52 -25.87 37.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.8 mtm -99.19 31.07 3.19 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.8 mtm -150.18 125.81 10.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -143.76 -178.95 6.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.399 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -114.76 126.58 55.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.406 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.5 136.41 10.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.33 112.36 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.06 149.06 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -108.51 145.16 30.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.38 164.26 80.05 Favored 'Cis proline' 0 N--CA 1.481 0.759 0 C-N-CA 124.106 -1.206 . . . . 0.0 112.532 0.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.56 118.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.439 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.33 -130.85 5.3 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.8 mt -72.84 139.37 80.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.85 161.9 18.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.632 1.555 . . . . 0.0 112.843 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.48 -23.96 66.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.082 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -59.84 -18.89 47.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.541 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.91 40.09 1.99 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 111.438 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 55.0 mt -85.69 -46.63 0.6 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.9 Cg_endo -78.07 -15.01 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.179 1.253 . . . . 0.0 113.078 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -86.17 -26.61 25.05 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.641 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 63' ' ' TYR . 11.1 mp -93.45 47.87 1.27 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.265 0.555 . . . . 0.0 110.588 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 t -90.15 134.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.4 m 61.24 32.88 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.45 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.8 mmm -86.02 140.36 30.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.316 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -96.88 144.39 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.522 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 m -110.41 175.55 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.411 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -90.52 -38.28 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -177.33 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.27 132.38 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.512 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -116.67 91.99 36.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.75 -171.23 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.748 1.632 . . . . 0.0 112.613 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -71.06 148.65 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.437 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.28 32.23 72.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.5 m -116.7 114.92 24.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 110.271 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 m -61.97 100.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.405 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.29 113.43 2.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.442 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.3 mtt -98.81 159.5 30.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.477 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.98 -27.71 2.36 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 121.918 1.745 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.09 -33.44 75.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.43 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.0 mtm -77.55 -33.51 54.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.382 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -79.85 102.71 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.46 125.82 27.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.71 -31.54 7.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.415 ' CE1' HD12 ' A' ' 40' ' ' LEU . 35.9 t80 -82.54 149.97 27.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.285 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.89 132.36 13.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.347 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -116.95 155.24 29.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.366 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.2 135.12 46.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.24 -172.41 2.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.9 151.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.278 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.14 150.17 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.28 120.88 25.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.368 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -99.7 31.54 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.59 166.16 1.74 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.058 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.0 tp -72.26 102.74 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.262 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.6 mt -103.58 103.37 35.71 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.3 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.79 163.79 20.78 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.563 1.509 . . . . 0.0 112.553 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -61.2 153.82 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.414 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 60.35 37.1 20.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.536 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 m -129.29 132.66 47.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 142.6 50.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.9 mt -82.74 163.71 21.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.514 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -150.22 175.79 11.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.304 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.61 -34.14 77.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.336 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.95 -29.69 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.553 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.7 mtp -95.16 22.73 6.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.213 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mtm -150.5 143.04 24.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.112 0.482 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -160.04 177.53 10.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 m -111.41 137.19 49.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -171.72 139.06 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.83 123.54 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.301 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.56 173.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -128.33 145.34 55.35 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.365 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.74 -179.97 25.9 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.494 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.87 102.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.91 -131.47 7.37 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.8 mt -73.23 139.56 79.08 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -82.79 169.49 13.34 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.606 1.537 . . . . 0.0 112.902 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -24.89 65.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.47 -19.28 46.54 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.38 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.71 35.75 2.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.087 0.47 . . . . 0.0 111.45 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 46.9 mt -81.06 -46.7 1.15 Allowed Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.562 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.4 Cg_endo -77.43 -24.44 9.15 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.175 1.25 . . . . 0.0 112.529 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -78.41 -20.38 51.24 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.885 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 63' ' ' TYR . 6.7 mp -97.19 30.31 2.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.972 0.415 . . . . 0.0 110.793 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.39 135.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.135 0.493 . . . . 0.0 110.237 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.79 33.7 17.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 17.2 mtp -97.88 119.63 36.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.279 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -79.91 138.71 37.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.459 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.38 -179.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -110.13 -25.21 10.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -128.65 171.59 12.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.11 0.481 . . . . 0.0 110.544 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.45 144.36 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.9 92.49 12.67 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -78.91 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 121.632 1.555 . . . . 0.0 112.686 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.04 153.55 25.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.675 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.76 53.1 46.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -135.32 117.63 15.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.096 0.474 . . . . 0.0 110.354 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -63.01 104.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.475 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.83 114.41 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.451 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mtt -99.92 163.8 17.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.9 -24.79 5.64 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 121.738 1.625 . . . . 0.0 112.757 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.44 -32.31 64.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.453 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.9 mtm -71.67 -38.59 70.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.436 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.8 t -80.23 107.2 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.02 124.81 23.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.64 -29.8 10.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CE1' HD12 ' A' ' 40' ' ' LEU . 58.0 t80 -87.27 128.08 35.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -161.21 100.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.403 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.46 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 86.25 -50.47 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.163 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.23 113.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.186 0.517 . . . . 0.0 110.425 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -93.6 -171.13 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.47 149.07 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.1 t -146.59 150.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.7 122.14 20.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.244 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.77 -17.79 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -149.27 174.5 12.34 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 0.0 110.576 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 100.64 1.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.733 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mt -89.98 116.94 67.58 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.937 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.68 147.88 15.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.436 1.424 . . . . 0.0 112.635 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.1 155.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.384 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 61.01 33.25 19.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -133.84 152.62 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.61 138.07 32.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.466 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.6 172.82 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.419 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -150.19 164.22 36.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.339 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.5 -31.57 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.484 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.44 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.7 mtm -99.56 35.85 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 0.0 110.544 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.6 mtm -149.99 149.34 30.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.594 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -157.17 166.78 32.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.348 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.6 t -102.5 92.33 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.508 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -126.81 140.02 52.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.19 131.18 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.358 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -152.84 -177.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -136.75 139.31 28.67 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.292 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -77.92 148.85 86.46 Favored 'Cis proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.119 -1.2 . . . . 0.0 112.436 0.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.92 91.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.621 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.41 -124.93 0.71 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.78 139.0 85.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.53 179.45 6.34 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.513 1.475 . . . . 0.0 112.617 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.92 13.45 14.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.67 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.56 -25.35 20.25 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.994 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -98.24 31.02 2.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 75.3 mt -66.99 -47.4 52.93 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.9 Cg_endo -76.51 -24.01 10.89 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 121.036 1.157 . . . . 0.0 112.572 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -26.78 53.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.698 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 6.3 mt -98.21 33.6 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.89 136.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.6 m 60.93 36.08 18.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.56 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 mmm -92.45 133.08 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -82.61 131.76 35.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.3 152.47 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.326 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -79.81 -21.86 43.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.05 -179.94 6.95 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.55 154.57 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.88 93.86 4.44 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.383 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.49 -176.79 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.683 1.588 . . . . 0.0 112.484 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.69 152.67 30.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.632 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.26 57.89 13.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -138.91 113.51 9.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.215 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -61.05 107.53 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.598 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.91 109.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.0 mtt -97.99 160.8 27.53 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.289 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.45 -23.88 5.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.834 1.689 . . . . 0.0 112.978 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -71.19 -43.28 67.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.0 ptp -67.08 -29.07 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.04 104.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.161 0.505 . . . . 0.0 110.167 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -66.66 121.91 16.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.27 -31.53 7.57 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 50.1 t80 -90.17 89.31 7.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.19 113.66 27.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.458 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.415 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 60.69 98.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.39 156.12 39.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.495 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.61 -171.96 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.425 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.39 85.73 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.92 152.28 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.323 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.88 126.61 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.78 31.97 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.55 164.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.2 tp -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.408 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.61 104.35 37.85 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.241 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.11 174.79 10.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.551 1.501 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.1 154.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.419 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 60.31 33.79 20.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -128.27 130.91 48.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.455 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 146.79 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.7 mt -87.43 164.96 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.473 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 p -150.27 -171.74 3.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.195 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.94 -45.62 57.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -64.57 -24.3 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.0 mtp -95.8 25.33 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.4 mtm -150.41 152.23 34.02 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 110.312 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -159.98 176.72 11.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.57 116.75 28.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -152.03 139.07 19.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.11 113.41 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.11 178.97 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.431 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -131.44 145.47 57.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.286 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.13 168.11 70.74 Favored 'Cis proline' 0 N--CA 1.481 0.772 0 C-N-CA 124.142 -1.191 . . . . 0.0 112.561 -0.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 95.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.372 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -122.1 3.46 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.88 139.51 46.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.01 165.82 14.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 121.664 1.576 . . . . 0.0 112.78 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.3 62.96 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -72.12 -7.99 52.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.704 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -116.34 28.94 8.26 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.166 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.8 mt -69.75 -46.99 24.84 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.9 Cg_endo -76.79 -16.21 16.5 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.127 1.218 . . . . 0.0 112.9 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -82.58 -25.3 33.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.715 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 3.4 mt -96.38 40.02 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.12 132.57 34.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.247 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 m 60.69 57.24 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mmm -119.88 133.07 55.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.429 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.85 133.18 33.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.505 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.1 -177.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -105.53 -35.65 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -133.03 -177.21 4.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.373 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.53 115.36 11.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.43 93.18 18.27 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.336 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.61 -176.26 3.09 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 121.75 1.633 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -62.17 147.92 46.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.4 44.63 64.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -127.87 116.72 20.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.147 0.498 . . . . 0.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.4 m -62.26 101.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.87 111.73 2.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.2 mtt -91.01 158.82 41.13 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.324 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.4 -26.38 4.09 Favored 'Trans proline' 0 N--CA 1.474 0.373 0 C-N-CA 121.793 1.662 . . . . 0.0 112.737 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.79 -31.94 59.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.501 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.4 mtp -68.38 -38.36 81.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.71 109.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.384 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.19 120.29 12.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.29 -31.85 7.1 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 46.3 t80 -80.31 98.85 7.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 110.362 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.47 -63.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.448 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 60.65 158.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.11 131.18 23.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.408 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -94.09 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 91.99 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.77 153.04 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.301 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 128.65 35.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.416 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.77 31.86 4.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.6 163.34 1.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.08 96.57 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.551 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 mt -90.08 111.77 48.63 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.019 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.01 153.9 16.98 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.524 1.483 . . . . 0.0 112.755 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.2 tt -61.39 154.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 60.2 33.63 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.556 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.6 m -130.61 159.66 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.84 151.53 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.401 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.0 165.77 13.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.439 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.2 p -148.28 165.45 30.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.381 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.7 -31.62 71.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.17 -31.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.314 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.0 mtm -99.26 31.07 3.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.593 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.5 mtm -150.05 140.49 22.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.435 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -160.1 -177.36 6.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.15 124.14 51.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.377 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.65 145.51 22.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.07 121.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.348 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.67 159.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -120.3 145.77 41.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.88 166.19 72.13 Favored 'Cis proline' 0 N--CA 1.481 0.736 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.651 -0.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.19 99.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.35 -123.57 3.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -76.35 139.55 68.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.25 164.37 17.13 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.71 1.607 . . . . 0.0 112.797 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.41 -21.17 65.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -64.03 -15.55 59.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.513 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.27 28.1 8.96 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.494 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.446 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 48.3 mt -71.09 -46.94 14.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.6 Cg_endo -77.0 -19.32 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.204 1.269 . . . . 0.0 112.844 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -80.91 -24.72 38.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 2.1 mt -96.58 37.65 1.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.102 0.477 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -89.94 138.57 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.242 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 60.87 35.94 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 86.9 mmm -92.01 143.64 26.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.457 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -103.88 138.25 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.95 175.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -102.54 -31.38 10.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.561 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -121.83 -179.44 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.72 155.72 33.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.61 90.75 4.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.348 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -79.63 -175.29 2.65 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 121.705 1.603 . . . . 0.0 112.657 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -61.73 151.73 33.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.57 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 51.59 48.36 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -133.62 122.04 22.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.126 0.489 . . . . 0.0 110.427 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -66.64 102.59 0.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.452 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.54 114.05 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.6 mtt -98.44 161.22 25.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.378 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.6 -26.18 4.04 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.47 -32.86 60.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.361 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.52 -32.77 71.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.425 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -86.84 107.58 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.269 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -66.77 123.07 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.79 -30.95 8.44 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 56.7 t80 -77.45 121.18 23.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.134 0.492 . . . . 0.0 110.338 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.68 -64.36 1.3 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.428 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.453 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -145.05 -178.04 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.445 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.23 118.68 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.428 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -108.67 -175.07 2.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.398 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.68 149.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -150.14 149.6 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.95 127.58 32.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.345 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -105.62 30.68 5.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 160.31 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.121 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -69.48 98.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.43 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.47 112.24 50.43 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 160.94 18.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 121.568 1.512 . . . . 0.0 112.575 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -65.98 154.96 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.31 33.16 20.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 m -130.84 147.96 52.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.58 155.76 25.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.79 169.45 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.368 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.18 163.38 38.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.23 -32.83 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.44 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.65 -31.24 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.428 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.6 mtm -99.29 31.61 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.9 mtm -150.11 138.69 20.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -159.71 163.53 34.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.425 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -90.3 132.34 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.414 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -167.36 136.75 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.89 112.18 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -141.84 153.09 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 t -114.3 144.5 31.82 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.28 152.56 84.01 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.092 -1.212 . . . . 0.0 112.495 0.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.07 113.12 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.452 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.81 -113.05 3.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.19 139.5 42.18 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.42 165.74 18.38 Favored 'Trans proline' 0 N--CA 1.476 0.462 0 C-N-CA 121.612 1.541 . . . . 0.0 112.946 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.34 -13.54 62.09 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.4 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.02 -10.21 57.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.609 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.63 28.65 8.51 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.285 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 49.5 mt -71.12 -46.79 14.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.825 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 39.3 Cg_endo -77.35 -22.67 10.77 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.153 1.235 . . . . 0.0 112.71 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -79.03 -24.52 43.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 20.1 mt -97.22 35.86 1.54 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 t -90.12 137.42 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 p 56.51 45.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.802 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.9 mtp -104.14 142.26 34.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.485 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.89 136.55 32.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.33 176.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.431 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -93.87 -36.38 12.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -134.7 -177.07 4.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.564 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.79 121.17 21.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.44 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.94 101.79 31.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.151 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.34 176.82 9.26 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 121.51 1.473 . . . . 0.0 112.691 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.0 mp -61.23 151.06 32.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.565 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.07 54.9 29.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -135.82 116.71 14.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 m -61.99 108.86 1.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.5 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -61.3 113.06 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.29 156.39 38.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.346 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -79.9 -24.74 5.68 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.853 1.702 . . . . 0.0 112.778 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -74.64 -31.37 61.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.3 mtm -71.91 -37.78 70.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.73 102.08 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.357 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -66.93 128.72 37.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.61 -29.43 11.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 39.1 t80 -61.98 -67.24 0.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.341 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.14 48.8 12.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.386 0.612 . . . . 0.0 110.799 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.544 179.899 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.4 m120 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 60.71 104.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.553 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.48 158.24 28.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.309 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.59 -171.99 2.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.22 86.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.474 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.88 151.38 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.979 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.91 39.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.896 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -115.22 -17.52 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.46 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -149.42 -179.92 7.45 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.069 0.461 . . . . 0.0 110.494 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.0 tp -71.08 101.36 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.4 mt -96.95 109.98 51.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.057 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.38 154.24 21.38 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.524 1.483 . . . . 0.0 112.782 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -61.49 155.45 4.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 60.28 40.99 17.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 m -139.22 138.45 36.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.64 150.53 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.401 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -90.24 164.72 14.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 p -150.08 175.24 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.443 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.28 -33.06 73.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.372 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.57 -28.35 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 mtp -97.65 29.09 3.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.8 mtm -150.27 140.32 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -148.14 177.52 9.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.398 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.78 108.24 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.458 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -146.62 144.58 29.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.34 120.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.345 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.51 165.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.399 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 t -122.7 145.45 45.24 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.33 174.98 43.82 Favored 'Cis proline' 0 N--CA 1.481 0.767 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.446 -0.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.22 108.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.49 -120.99 4.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.58 139.71 35.74 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -83.08 166.33 14.61 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.63 1.553 . . . . 0.0 112.68 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.47 -23.2 62.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.73 -13.9 60.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.475 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -110.76 24.37 13.03 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.603 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 43.6 mt -66.09 -46.88 63.27 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.706 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 38.4 Cg_endo -76.7 -15.61 17.01 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 121.122 1.215 . . . . 0.0 112.82 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.41 -25.75 33.41 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.71 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.26 36.24 1.49 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.787 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.06 139.72 16.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m 60.99 34.42 19.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.56 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.8 mmm -84.15 148.62 26.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.399 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -112.77 124.78 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -95.0 -178.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.299 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -129.98 33.22 4.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.53 163.55 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.475 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.93 49.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.397 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 12.5 t -149.75 98.27 3.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.054 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.61 -165.45 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.903 1.735 . . . . 0.0 112.923 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.68 154.13 39.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.16 58.58 13.3 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.418 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 9.8 t -132.48 136.18 46.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -75.61 104.65 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.113 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.39 108.14 6.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.29 164.75 18.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.904 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.459 ' CB ' ' CD1' ' A' ' 63' ' ' TYR . 39.9 Cg_endo -80.36 -35.7 0.59 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 121.586 1.524 . . . . 0.0 112.657 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.35 -42.36 99.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.399 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtm -63.51 -30.45 71.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.61 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.7 t -88.39 127.79 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -81.42 122.32 27.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.028 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.5 -28.59 7.4 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.459 ' CD1' ' CB ' ' A' ' 57' ' ' PRO . 9.0 t80 -57.31 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.09 0.471 . . . . 0.0 110.536 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.38 100.45 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.46 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.412 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 121.07 0.462 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -134.22 -179.77 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.447 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.49 147.71 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.305 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.71 148.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.175 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.54 149.83 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -111.48 -23.1 10.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.32 178.44 8.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.974 0.416 . . . . 0.0 110.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 10' ' ' LEU . 31.9 tp -68.53 97.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.779 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.709 HG23 ' CE ' ' A' ' 21' ' ' MET . 43.5 mt -89.79 118.48 69.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.78 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.39 147.68 16.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.522 1.481 . . . . 0.0 112.631 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.0 tt -61.14 154.94 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.395 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 60.81 34.35 19.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -127.17 154.64 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.07 140.83 32.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.367 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 43' ' ' MET . 47.9 mt -82.53 167.13 18.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.473 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -143.92 -174.02 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -75.62 -31.9 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.36 -44.31 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.709 ' CE ' HG23 ' A' ' 11' ' ' ILE . 11.6 mtp -65.0 -29.11 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.728 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.46 149.08 23.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.345 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.06 179.35 8.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.84 135.81 51.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.381 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -178.0 141.92 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.7 121.85 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.247 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 167.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.457 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -125.73 138.97 33.01 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.315 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.59 137.17 42.01 Favored 'Cis proline' 0 N--CA 1.482 0.822 0 C-N-CA 124.075 -1.219 . . . . 0.0 112.481 0.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.5 m -59.26 106.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -112.62 2.78 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' C ' ' A' ' 56' ' ' MET . 63.9 mt -70.91 139.46 85.59 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.41 172.69 13.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.525 1.483 . . . . 0.0 112.729 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.52 -0.13 32.03 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.784 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.99 19.79 5.38 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 40' ' ' LEU . 70.1 m-20 -140.14 29.95 2.01 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.429 . . . . 0.0 110.751 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 20.7 mt -70.32 -46.85 20.31 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.147 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -76.66 -4.2 14.7 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.075 1.183 . . . . 0.0 113.263 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -96.87 -25.82 15.31 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -97.53 35.31 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.04 142.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 60.67 32.61 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.497 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.606 ' HB2' HD12 ' A' ' 17' ' ' LEU . 49.6 mmm -94.4 136.66 34.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -100.24 119.08 37.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -79.9 166.59 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.427 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -110.32 32.11 5.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.519 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.61 ' HA ' HD12 ' A' ' 13' ' ' ILE . 9.4 ptm180 -178.37 159.65 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.21 130.19 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -123.23 95.19 46.0 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.316 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.04 -174.96 2.47 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 121.675 1.583 . . . . 0.0 112.625 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 51' ' ' LEU . 2.4 mp -61.66 146.94 47.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.549 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.7 0.77 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 m -145.0 114.4 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' PRO . 3.3 m -61.76 104.1 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.495 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -60.97 113.17 2.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.565 ' C ' HD11 ' A' ' 32' ' ' ILE . 10.2 mtt -96.9 163.1 20.85 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.68 -26.34 3.18 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 121.861 1.707 . . . . 0.0 112.703 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.14 -32.81 61.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.468 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtm -71.66 -36.77 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 56' ' ' MET . 28.6 t -80.02 108.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -66.95 119.18 11.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.49 -31.91 7.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 52.3 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.158 0.504 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.139 0.495 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -144.56 -174.4 4.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.72 89.0 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.76 152.87 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.294 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.33 128.02 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -103.62 30.53 4.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.611 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -178.02 160.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.74 96.69 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.41 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 ' CD2' ' A' ' 17' ' ' LEU . 19.6 mt -90.74 111.62 48.88 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.97 159.27 18.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.632 1.555 . . . . 0.0 112.607 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.08 154.28 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 60.63 33.29 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -133.07 144.06 49.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -76.43 152.12 36.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 43' ' ' MET . 19.4 mt -90.09 168.25 12.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.364 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -148.66 169.38 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -65.3 -33.19 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.73 -30.08 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.708 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.0 mtm -100.13 31.18 3.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.443 ' HE3' HG23 ' A' ' 37' ' ' ILE . 27.8 mtm -150.13 144.5 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.457 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -160.05 175.87 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.427 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 t -104.24 128.61 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.419 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.92 145.5 8.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.96 127.92 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.333 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 m -154.16 162.8 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -123.91 140.06 33.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.08 140.12 52.29 Favored 'Cis proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.155 -1.185 . . . . 0.0 112.452 0.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.59 107.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.818 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.38 -106.65 1.81 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.546 HD11 ' C ' ' A' ' 56' ' ' MET . 55.9 mt -82.07 139.46 45.91 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.32 165.78 18.57 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.523 1.482 . . . . 0.0 112.702 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -76.3 -3.76 38.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.68 1.7 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.718 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' HD12 ' A' ' 40' ' ' LEU . 42.7 m-20 -128.31 27.74 5.56 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.6 mt -62.2 -47.41 90.15 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.214 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.614 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.5 Cg_endo -75.78 -20.19 15.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.09 1.193 . . . . 0.0 112.674 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -77.1 -28.01 54.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -97.9 35.57 1.69 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.755 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' PRO . 24.3 t -90.29 142.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.327 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.441 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 5.2 m 60.67 32.44 20.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.6 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.61 ' HB2' HD12 ' A' ' 17' ' ' LEU . 38.2 mmm -95.59 139.94 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.473 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -89.25 140.88 29.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.491 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.75 148.01 7.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.303 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -79.81 -21.69 43.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.6 -178.36 5.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.16 24.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.57 92.53 24.24 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.292 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.3 179.44 6.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.742 1.628 . . . . 0.0 112.66 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.9 mp -62.06 151.61 34.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.599 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.96 40.26 93.41 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 m -129.53 118.97 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -62.31 109.74 1.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.44 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.15 114.91 5.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.389 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.546 ' C ' HD11 ' A' ' 32' ' ' ILE . 19.9 mtt -95.91 158.88 33.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.9 -26.89 3.35 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 121.827 1.685 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.91 -32.97 70.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.1 mtp -73.81 -33.73 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 56' ' ' MET . 26.3 t -80.03 104.83 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -65.22 121.09 13.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.48 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.16 -31.2 7.87 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 40' ' ' LEU . 56.1 t80 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.061 0.458 . . . . 0.0 110.367 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.049 0.452 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -129.7 -174.73 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.362 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -107.92 144.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 7' ' ' ALA . 24.9 t -144.93 155.81 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -82.52 122.95 28.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -102.47 32.51 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.41 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.472 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -178.96 164.92 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.169 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' HD11 ' A' ' 51' ' ' LEU . 19.1 tp -71.94 104.44 3.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG23 ' CE ' ' A' ' 21' ' ' MET . 52.3 mt -103.17 104.15 38.83 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.07 164.59 19.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.58 1.52 . . . . 0.0 112.678 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.45 147.93 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 60.84 51.75 4.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.432 0.634 . . . . 0.0 110.451 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -144.97 124.06 12.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.413 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.64 148.44 46.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.423 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 43' ' ' MET . 21.0 mt -88.94 166.67 13.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.513 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.646 ' OG1' HG12 ' A' ' 20' ' ' VAL . 30.7 p -150.25 -172.14 4.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.179 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.63 -31.43 63.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 p -75.3 -26.59 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG3' HG13 ' A' ' 20' ' ' VAL . 33.1 mtp -96.98 27.32 4.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.968 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.491 ' HE3' HG23 ' A' ' 37' ' ' ILE . 25.8 mtm -150.41 148.98 29.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.079 0.466 . . . . 0.0 110.426 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -160.02 178.18 9.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.406 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 t -117.65 126.54 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -159.74 145.73 15.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.09 110.5 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.312 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.59 164.41 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -115.9 145.29 34.44 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.5 169.84 63.82 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 C-N-CA 124.097 -1.21 . . . . 0.0 112.592 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.1 p -61.76 112.16 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.81 -129.6 6.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.643 HD11 ' C ' ' A' ' 56' ' ' MET . 52.3 mt -78.59 139.64 58.98 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.08 163.22 17.88 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.58 1.52 . . . . 0.0 112.882 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.03 -14.58 63.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.401 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.96 -10.92 59.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.695 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.28 26.76 9.68 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.37 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 HD11 ' HB1' ' A' ' 34' ' ' ALA . 47.0 mt -66.74 -47.09 56.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.811 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.5 -22.52 12.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.13 1.22 . . . . 0.0 112.639 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -76.78 -25.02 52.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.5 mt -97.72 31.6 2.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.8 t -88.94 141.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.195 0.522 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.4 m 60.97 34.87 19.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.73 ' HB2' HD12 ' A' ' 17' ' ' LEU . 88.1 mmm -94.86 151.72 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.441 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -109.46 132.37 54.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.5 160.49 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 59' ' ' MET . 4.6 p30 -80.23 -33.96 37.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -131.63 -177.88 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.528 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 133.46 36.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.64 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 53' ' ' THR . 23.6 t -120.7 112.06 34.12 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.71 -176.13 3.02 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.533 1.489 . . . . 0.0 112.672 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.4 mp -69.28 155.17 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.499 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 33.76 88.1 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 49' ' ' VAL . 25.8 m -112.41 118.77 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.057 0.456 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -61.82 104.74 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.28 115.27 3.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.362 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.643 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.7 mtt -96.67 160.74 28.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.542 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.98 -26.98 3.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.917 1.744 . . . . 0.0 112.727 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.35 -33.14 61.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.433 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.9 mtm -68.21 -38.45 81.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.454 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 40' ' ' LEU . 23.3 t -79.98 108.32 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.359 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -65.14 121.17 14.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.05 -31.39 7.74 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.642 ' CD2' HD21 ' A' ' 40' ' ' LEU . 44.1 t80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -90.74 -173.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.17 92.3 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.398 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.76 151.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.77 126.07 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -102.67 31.42 4.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.66 168.26 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.2 tp -72.49 102.63 3.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.484 HG12 ' HE3' ' A' ' 21' ' ' MET . 47.4 mt -105.76 101.24 31.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.316 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.45 162.1 22.28 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.579 1.52 . . . . 0.0 112.58 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.15 155.6 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.536 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.27 45.16 9.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.47 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 m -147.22 126.77 13.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -65.31 147.11 54.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.394 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 43' ' ' MET . 18.2 mt -81.69 168.96 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.41 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -150.32 -179.84 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.382 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mt -68.79 -37.84 79.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.34 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 21' ' ' MET . 23.4 m -71.19 -26.48 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.484 ' HE3' HG12 ' A' ' 11' ' ' ILE . 29.0 mtp -96.55 27.97 3.59 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.523 ' HE3' HG23 ' A' ' 37' ' ' ILE . 28.9 mtm -150.25 144.31 25.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.05 0.452 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -156.07 166.25 34.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.08 117.71 34.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -148.88 151.27 34.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.61 121.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.12 155.16 6.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.414 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -118.34 144.29 34.8 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.289 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.83 156.3 88.47 Favored 'Cis proline' 0 N--CA 1.481 0.77 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.463 0.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -60.97 112.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.505 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.75 -121.1 4.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 56' ' ' MET . 57.5 mt -75.5 139.61 71.35 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.16 159.11 17.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.689 1.592 . . . . 0.0 112.926 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -18.33 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.03 -13.86 60.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.541 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.9 m-20 -113.72 25.67 11.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.567 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 34' ' ' ALA . 40.8 mt -64.37 -47.46 77.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.703 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -76.72 -13.48 17.93 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.174 1.25 . . . . 0.0 113.011 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.64 -27.69 28.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.904 0.383 . . . . 0.0 110.647 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.609 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -96.37 41.87 1.1 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.166 0.507 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 38' ' ' PRO . 23.2 t -90.1 135.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.395 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.594 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.8 t 60.3 37.5 20.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.611 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.615 ' HB2' HD12 ' A' ' 17' ' ' LEU . 95.8 mmm -91.5 140.24 29.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.268 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.22 143.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -110.47 160.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.386 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -113.43 31.93 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -178.59 172.43 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.6 142.33 37.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 92.06 7.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.4 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.33 -171.84 1.36 Allowed 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 121.743 1.629 . . . . 0.0 112.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.6 mp -63.03 147.75 49.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.68 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.15 61.26 6.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -139.54 118.36 12.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 110.384 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -61.71 104.21 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.481 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.52 110.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.439 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.406 ' C ' HD11 ' A' ' 32' ' ' ILE . 3.2 mtt -97.84 158.68 32.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.067 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.24 -18.51 11.07 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.734 1.623 . . . . 0.0 113.1 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -74.29 -40.26 62.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.954 0.407 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 60' ' ' VAL . 10.2 ptp -68.77 -30.4 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.457 HG23 ' HG3' ' A' ' 59' ' ' MET . 41.1 t -85.47 101.09 9.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.188 0.518 . . . . 0.0 110.11 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -64.47 126.96 29.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.27 -30.19 9.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.609 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 121.032 0.444 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 121.116 0.484 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -145.2 -177.15 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.479 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PRO . 20.5 t -98.56 92.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.98 145.7 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.221 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -68.12 120.73 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.448 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -102.32 30.93 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.35 158.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.939 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.7 tp -69.82 97.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.411 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.3 mt -89.74 117.8 68.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.8 153.48 17.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.544 1.496 . . . . 0.0 112.635 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.58 149.98 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.449 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 60.56 37.02 19.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.558 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -136.18 140.6 43.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -70.9 153.0 43.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.443 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 67.0 mt -88.47 172.66 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.28 165.4 33.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.343 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.1 -32.96 73.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.342 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 -30.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.374 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 mtm -98.84 32.32 2.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HE3' HG23 ' A' ' 37' ' ' ILE . 26.6 mtm -149.22 144.26 26.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.307 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.07 158.02 32.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.406 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -94.19 104.31 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.508 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -141.04 142.68 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.42 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.56 129.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.422 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -155.52 161.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -119.57 144.18 36.28 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.2 160.47 85.76 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.524 0.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.35 96.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.48 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.19 -126.86 4.66 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.587 HD11 ' C ' ' A' ' 56' ' ' MET . 54.0 mt -73.66 139.19 77.34 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 5' ' ' VAL . 39.7 Cg_endo -81.11 -179.88 5.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.574 1.516 . . . . 0.0 112.471 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.55 17.12 7.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.565 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -90.4 -29.54 17.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.012 0.434 . . . . 0.0 110.599 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -99.09 31.81 2.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.958 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.74 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.9 mt -64.17 -47.55 78.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.607 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.04 -22.12 13.35 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.052 1.168 . . . . 0.0 112.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -77.59 -25.35 49.87 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.655 HD21 ' CG ' ' A' ' 63' ' ' TYR . 4.2 mt -98.06 31.14 2.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 38' ' ' PRO . 29.3 t -86.47 137.06 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.572 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 46.4 t 61.09 43.1 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.483 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 84.8 mmm -100.09 134.64 42.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.433 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.82 123.04 32.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.85 158.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.386 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -82.29 -31.84 29.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -132.36 -177.36 4.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.37 144.49 48.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.75 90.49 16.53 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.373 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 39.9 Cg_endo -80.01 -178.21 4.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.714 1.609 . . . . 0.0 112.642 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.27 144.66 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.68 56.63 8.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -143.95 119.7 10.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 m -63.47 124.13 20.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 tp -81.15 119.59 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.301 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.587 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.3 mtt -96.49 155.56 37.77 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.95 -27.1 3.19 Favored 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 121.788 1.659 . . . . 0.0 112.699 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.27 -32.61 64.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.381 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -73.36 -35.0 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.447 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' MET . 22.1 t -79.81 112.63 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -71.48 120.67 17.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.392 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.65 7.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 40' ' ' LEU . 53.1 t80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.097 0.475 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -101.33 -173.4 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.71 147.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -142.3 150.65 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.55 114.6 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.327 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.14 -27.21 65.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.62 -178.23 6.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.4 tp -71.11 102.63 2.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.721 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.835 HG23 ' CE ' ' A' ' 21' ' ' MET . 25.4 mt -89.95 127.41 53.92 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.77 150.89 14.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.632 1.555 . . . . 0.0 112.753 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.6 tt -67.61 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.16 35.14 21.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 m -129.8 148.29 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -77.19 136.53 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.46 170.34 15.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -150.27 168.41 24.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.0 -33.28 74.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.7 -28.59 34.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.435 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.835 ' CE ' HG23 ' A' ' 11' ' ' ILE . 26.3 mtp -94.74 24.23 4.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.302 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 mtm -150.14 132.57 15.63 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 121.051 0.453 . . . . 0.0 110.218 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -143.8 172.45 12.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 t -105.53 126.02 51.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.269 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -161.43 146.22 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.65 125.66 38.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.83 168.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.475 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t -124.54 146.09 51.3 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.44 169.24 66.39 Favored 'Cis proline' 0 N--CA 1.482 0.818 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.665 0.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.73 99.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.54 -127.14 4.87 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.517 HD11 ' C ' ' A' ' 56' ' ' MET . 55.1 mt -78.14 139.37 60.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.35 163.84 17.06 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.673 1.582 . . . . 0.0 112.894 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.54 -14.71 63.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.368 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -68.83 -10.89 59.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.656 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -118.52 30.61 7.11 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.36 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.575 HD11 ' HB1' ' A' ' 34' ' ' ALA . 43.5 mt -69.04 -47.36 29.85 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.795 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.2 Cg_endo -76.05 -24.37 11.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 120.992 1.128 . . . . 0.0 112.551 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -25.52 61.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.743 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' A' ' 43' ' ' MET . 1.6 mt -96.64 27.85 3.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.2 t -86.91 136.1 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.09 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 42.5 t 61.04 32.69 19.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.733 ' SD ' HD23 ' A' ' 40' ' ' LEU . 15.2 mtp -94.33 134.48 36.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.244 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -86.18 145.31 27.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.545 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.66 -178.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.342 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.07 -22.39 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.2 ptp180 -137.52 -178.47 5.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.83 161.22 30.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.6 t -148.19 93.72 4.37 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.245 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -80.13 -176.01 3.0 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.683 1.589 . . . . 0.0 112.606 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 51' ' ' LEU . 6.2 mp -65.01 154.26 38.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.577 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.3 46.02 95.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.9 m -128.61 109.74 11.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 0.0 110.175 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -60.34 109.38 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.576 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.39 115.69 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.517 ' C ' HD11 ' A' ' 32' ' ' ILE . 5.7 mtt -96.34 158.57 33.66 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.39 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.63 -26.39 3.88 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 121.826 1.684 . . . . 0.0 112.755 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.49 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 mtm -70.4 -38.56 74.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.492 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HE1' ' A' ' 43' ' ' MET . 23.2 t -80.31 110.32 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -70.15 123.43 21.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.372 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.01 -31.35 7.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.137 0.494 . . . . 0.0 110.292 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.154 0.502 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 m -134.02 -172.19 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.45 89.4 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.364 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.82 151.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.0 128.45 35.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.476 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -103.28 30.16 5.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.559 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.25 161.21 1.42 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.453 ' N ' HD11 ' A' ' 51' ' ' LEU . 35.5 tp -71.75 94.83 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.61 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.4 mt -89.92 111.98 49.53 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.137 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.26 157.17 19.8 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.457 1.438 . . . . 0.0 112.575 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.08 154.83 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 61.25 33.23 19.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.484 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -130.51 153.17 49.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -86.87 148.16 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 ' CD2' HG21 ' A' ' 11' ' ' ILE . 14.7 mt -89.91 170.27 10.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -148.18 173.26 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.456 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.21 -32.4 73.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.48 -29.94 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.705 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.0 mtm -100.29 32.16 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.105 0.479 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.5 mtm -150.05 114.17 5.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.75 -178.04 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -109.63 113.36 26.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -137.82 142.31 40.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.46 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.98 82.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -114.53 146.12 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.41 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 t -111.25 141.97 25.44 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.306 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.86 132.05 23.7 Favored 'Cis proline' 0 N--CA 1.482 0.828 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.441 0.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.26 111.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.09 -94.19 1.09 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.475 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -90.01 139.73 27.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 167.05 16.29 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.677 1.585 . . . . 0.0 112.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.38 -26.4 66.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.837 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.16 -18.1 56.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' HD12 ' A' ' 40' ' ' LEU . 4.1 m-20 -110.4 35.73 3.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.407 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.8 mt -79.77 -46.84 1.49 Allowed Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.616 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 Cg_endo -77.13 -11.15 17.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.127 1.218 . . . . 0.0 113.084 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -85.68 -27.44 25.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.521 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' HG3' ' A' ' 43' ' ' MET . 3.7 mt -94.16 46.64 1.17 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' PRO . 32.8 t -90.16 133.89 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.309 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.513 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.2 m 60.79 38.33 18.14 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.652 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.651 ' HG3' HD23 ' A' ' 40' ' ' LEU . 76.2 mmm -95.31 137.55 34.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.12 144.55 25.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.12 163.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.4 -33.6 20.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -126.95 -177.74 4.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.486 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.59 122.1 24.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.88 90.67 28.21 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.46 -172.86 1.64 Allowed 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 121.741 1.627 . . . . 0.0 112.662 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -66.0 152.83 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.71 39.02 90.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -130.79 118.06 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.7 m -61.9 108.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD23 HD12 ' A' ' 32' ' ' ILE . 12.8 tp -61.73 114.95 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.604 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.3 mtt -93.22 150.03 38.43 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.345 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.19 -26.58 3.34 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.819 1.679 . . . . 0.0 112.635 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.46 -32.89 64.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mtm -74.27 -32.09 62.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 56' ' ' MET . 29.0 t -79.8 102.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.259 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -68.86 124.61 24.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.74 7.28 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.8 t80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -92.02 -171.51 2.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.391 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.72 90.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 7' ' ' ALA . 25.4 t -90.56 154.79 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -80.38 131.61 35.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.384 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -107.99 31.91 5.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.65 158.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.08 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -70.28 97.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.501 HG21 ' CD2' ' A' ' 17' ' ' LEU . 14.9 mt -89.75 112.14 50.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.079 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.35 157.49 19.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.507 1.471 . . . . 0.0 112.683 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.05 153.79 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.394 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 60.65 32.52 20.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -133.04 137.08 46.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.442 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -74.34 156.14 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' CD2' HG21 ' A' ' 11' ' ' ILE . 21.5 mt -90.07 169.9 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.0 p -150.1 174.62 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.41 -36.14 81.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.02 -30.1 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.443 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 mtp -96.78 26.79 4.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.1 mtm -150.36 141.68 23.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.343 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.69 -178.11 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -115.56 129.45 56.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -158.63 139.45 12.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.361 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.76 121.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -152.83 161.34 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.444 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.18 145.61 35.36 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.42 175.69 41.15 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 C-N-CA 124.12 -1.2 . . . . 0.0 112.563 0.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -65.55 117.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.57 -134.28 5.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.507 HD11 ' C ' ' A' ' 56' ' ' MET . 57.7 mt -72.92 139.33 79.9 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.65 164.18 16.26 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.663 1.575 . . . . 0.0 112.868 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.46 -25.04 66.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.946 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -58.98 -19.75 46.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.478 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HD13 ' A' ' 40' ' ' LEU . 65.6 m-20 -107.65 38.72 2.08 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.192 0.52 . . . . 0.0 111.483 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.3 mt -84.06 -46.94 0.74 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.576 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.4 Cg_endo -78.35 -19.08 12.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.229 1.286 . . . . 0.0 112.853 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -83.73 -20.66 33.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.957 HD11 ' CE1' ' A' ' 63' ' ' TYR . 9.0 mp -97.31 32.01 2.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.008 0.433 . . . . 0.0 110.935 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.7 t -79.5 140.08 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.037 0.446 . . . . 0.0 110.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.3 p 56.68 41.43 28.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.435 ' HB2' HD12 ' A' ' 17' ' ' LEU . 92.3 mmm -97.43 133.12 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -92.43 144.02 25.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.626 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -110.91 157.89 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.165 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.94 -30.19 39.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -128.04 -177.42 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.534 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.75 35.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.528 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.92 98.06 49.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.94 177.77 7.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.628 1.552 . . . . 0.0 112.714 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.566 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.3 mp -64.32 150.11 46.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.2 32.22 75.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -116.81 117.94 31.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -61.87 104.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.464 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.85 115.53 4.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.507 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.3 mtt -100.35 160.26 27.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.65 -26.85 3.58 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 121.81 1.673 . . . . 0.0 112.615 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.83 -39.13 83.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 41.1 mtm -69.98 -32.18 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' MET . 42.8 t -82.77 95.36 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -66.02 127.37 31.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.7 -31.09 8.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.957 ' CE1' HD11 ' A' ' 40' ' ' LEU . 33.1 t80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.266 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 121.09 0.471 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -149.87 -177.02 5.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.89 146.89 7.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 7' ' ' ALA . 26.1 t -142.89 156.08 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.121 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.436 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -85.1 119.73 25.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -99.9 31.07 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.534 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -179.42 164.45 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.02 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.658 ' N ' HD11 ' A' ' 51' ' ' LEU . 23.2 tp -71.72 101.09 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.479 HG23 ' CE ' ' A' ' 21' ' ' MET . 31.2 mt -96.5 108.93 45.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.73 -178.6 4.29 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.56 1.507 . . . . 0.0 112.589 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.04 154.66 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 60.62 33.98 20.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.526 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -130.42 131.47 45.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.2 157.1 36.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' A' ' 43' ' ' MET . 86.5 mt -90.18 165.55 13.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.3 p -150.08 171.14 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.336 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.26 -34.03 75.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -30.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.453 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' HG23 ' A' ' 11' ' ' ILE . 25.4 mtp -94.52 21.21 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.42 140.14 21.72 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.983 0.42 . . . . 0.0 110.425 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.13 176.37 11.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -103.05 142.81 33.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.372 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -170.88 140.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.467 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.67 96.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.19 172.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -131.46 145.72 58.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.5 167.33 71.16 Favored 'Cis proline' 0 N--CA 1.481 0.782 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.522 0.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.17 92.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.47 -126.61 2.31 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 56' ' ' MET . 44.0 mt -73.88 139.66 76.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.18 163.69 15.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.661 1.574 . . . . 0.0 112.653 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.66 67.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.62 -22.42 45.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 m-20 -109.9 37.98 2.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.149 0.499 . . . . 0.0 111.443 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 58.8 mt -81.31 -46.98 1.11 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.607 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.35 -22.35 11.02 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 121.164 1.243 . . . . 0.0 112.592 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -79.18 -22.56 44.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 36' ' ' ASP . 5.7 mp -96.83 28.78 3.31 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.1 t -84.29 145.21 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.566 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.8 m 60.92 32.87 20.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.651 ' HB2' HD12 ' A' ' 17' ' ' LEU . 72.3 mmm -94.83 134.71 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.423 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.27 141.52 28.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.458 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 m -102.12 170.68 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.47 -31.4 15.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.614 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.74 167.91 21.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.0 120.36 13.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 53' ' ' THR . 22.9 t -105.89 114.29 62.89 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.123 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.2 -176.71 3.26 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 121.534 1.489 . . . . 0.0 112.604 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 10' ' ' LEU . 6.4 mp -70.58 157.16 38.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.416 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.41 31.93 82.41 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 49' ' ' VAL . 13.3 m -113.33 118.71 35.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.065 0.459 . . . . 0.0 110.385 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.9 m -61.81 105.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.27 115.5 3.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.484 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 60' ' ' VAL . 35.4 mtt -101.46 155.65 36.11 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.1 -27.61 2.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.887 1.725 . . . . 0.0 112.629 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -64.84 -37.11 86.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.4 mtm -75.66 -34.8 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.404 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 56' ' ' MET . 26.5 t -79.94 111.2 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.289 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -82.82 129.75 35.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.85 -32.2 6.73 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' CE1' HD11 ' A' ' 40' ' ' LEU . 1.7 t80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.14 0.495 . . . . 0.0 110.346 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -108.0 175.91 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.24 143.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.228 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.78 147.91 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.94 106.25 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.63 -28.69 67.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.8 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.505 ' HA ' HD21 ' A' ' 51' ' ' LEU . 4.2 pt20 -149.79 -177.97 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.114 0.483 . . . . 0.0 110.364 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.3 tp -70.81 103.56 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.627 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.2 mt -89.32 132.49 37.29 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.912 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.9 152.73 14.65 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.656 1.571 . . . . 0.0 112.744 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.2 tt -70.69 150.18 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 60.39 32.75 20.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.538 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -130.34 141.39 50.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.88 140.62 55.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HG21 ' A' ' 11' ' ' ILE . 74.0 mt -78.22 169.81 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -150.15 167.51 26.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.397 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.3 -32.47 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.316 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -65.24 -30.6 50.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.634 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.432 ' CE ' HG23 ' A' ' 11' ' ' ILE . 14.3 mtm -103.65 27.86 7.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 mtp -145.89 132.21 19.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.369 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.12 -179.57 7.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.1 136.61 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -169.13 143.9 3.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.62 110.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.327 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.77 167.45 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.49 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.94 143.56 49.19 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.327 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.15 163.44 82.31 Favored 'Cis proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.55 0.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.6 p -61.72 120.89 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.87 -130.64 4.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.46 HD11 ' C ' ' A' ' 56' ' ' MET . 67.5 mt -67.5 139.78 94.45 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.71 160.65 19.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.64 1.56 . . . . 0.0 112.921 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -18.47 64.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -66.37 -13.45 60.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.6 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 40' ' ' LEU . 61.9 m-20 -113.58 23.31 13.26 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.532 HD11 ' HB1' ' A' ' 34' ' ' ALA . 38.4 mt -62.25 -47.42 89.89 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.703 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.62 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.5 -19.09 15.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 121.14 1.227 . . . . 0.0 112.848 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -77.97 -27.72 49.24 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -98.11 35.03 1.81 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' PRO . 30.1 t -88.01 139.73 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.272 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 1.6 t 60.9 32.62 20.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.542 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 mtp -95.6 135.76 36.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.33 145.29 24.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.502 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.54 174.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -92.46 -30.98 15.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HA ' HD12 ' A' ' 13' ' ' ILE . 7.3 ptp180 -134.05 -177.54 4.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.339 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.41 149.34 46.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.207 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.8 90.51 36.03 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.51 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 10' ' ' LEU . 38.8 Cg_endo -78.63 176.4 9.93 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 121.829 1.686 . . . . 0.0 112.611 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -62.59 137.75 58.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.749 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.59 -31.99 7.5 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 108.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.138 0.494 . . . . 0.0 110.519 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -63.01 118.61 8.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.43 113.47 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -99.73 158.42 32.15 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.34 -25.9 4.45 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 121.824 1.683 . . . . 0.0 112.714 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.06 -32.5 61.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.3 mtm -73.98 -36.02 64.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.56 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 56' ' ' MET . 25.6 t -79.84 104.54 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.281 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.37 127.42 32.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.441 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.16 -30.78 8.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CE1' HD11 ' A' ' 40' ' ' LEU . 41.5 t80 . . . . . 0 C--N 1.331 -0.219 0 CA-C-O 121.05 0.452 . . . . 0.0 110.287 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.11 0.481 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.04 -171.74 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.352 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -119.33 87.03 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.376 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.7 153.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.376 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.28 122.22 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.56 30.76 3.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.87 167.73 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.1 tp -72.62 102.62 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 27.1 mt -95.99 109.1 44.93 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.21 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.83 166.7 17.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.595 1.53 . . . . 0.0 112.643 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -73.29 154.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.37 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.38 32.28 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 m -132.38 146.59 52.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.405 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -82.07 148.75 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 11' ' ' ILE . 68.6 mt -80.5 169.83 17.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -150.19 170.31 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.11 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.87 -28.22 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.449 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mtp -97.15 29.13 3.26 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.29 150.13 31.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.212 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -160.13 167.23 28.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -107.51 103.13 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -142.05 146.77 35.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.91 125.64 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.316 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -153.31 156.75 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 t -109.72 145.05 31.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.357 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.09 161.61 85.0 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.49 0.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.99 113.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.37 -126.05 5.0 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 56' ' ' MET . 56.9 mt -73.96 139.18 76.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.88 172.3 12.21 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.631 1.554 . . . . 0.0 112.688 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.38 -1.9 32.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.783 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.22 6.12 23.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.642 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 40' ' ' LEU . 42.3 m-20 -127.26 31.96 5.14 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.105 0.479 . . . . 0.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 33.5 mt -73.37 -46.39 7.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.206 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.1 Cg_endo -75.88 -24.29 11.62 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 121.065 1.177 . . . . 0.0 112.464 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.28 -18.79 48.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.992 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.778 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.4 mp -97.02 29.15 3.21 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -86.04 131.23 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.061 0.458 . . . . 0.0 110.304 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.708 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 22.9 t 61.43 36.06 17.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.673 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.599 ' HE1' HG12 ' A' ' 60' ' ' VAL . 13.0 mtp -91.96 125.77 36.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -79.86 134.66 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.536 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.01 -177.51 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -110.28 -32.26 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.661 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 -177.06 4.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.43 129.01 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.453 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.19 100.77 42.07 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.152 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.87 -178.04 4.26 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.577 1.518 . . . . 0.0 112.682 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.7 mp -66.35 148.04 52.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.6 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.74 52.58 24.21 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -135.19 118.18 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 m -61.52 100.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.552 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.31 113.67 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.6 ' O ' HD11 ' A' ' 32' ' ' ILE . 19.1 mtt -96.14 165.21 16.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.76 -26.29 4.73 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.74 1.626 . . . . 0.0 112.616 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.79 -23.09 55.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.986 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -97.44 28.53 3.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.918 0.39 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HE1' ' A' ' 43' ' ' MET . 34.5 t -141.33 101.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.094 0.473 . . . . 0.0 110.133 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -64.08 124.46 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.453 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.58 7.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.778 ' CE1' HD11 ' A' ' 40' ' ' LEU . 27.5 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.113 0.482 . . . . 0.0 110.433 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 121.103 0.477 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -98.46 175.69 5.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.37 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.84 147.98 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.25 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.7 t -145.61 149.9 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 102.3 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.299 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.28 -26.33 66.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.583 ' OE1' HG12 ' A' ' 20' ' ' VAL . 17.3 pt20 -149.58 -178.0 6.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' PRO . 31.5 tp -70.4 101.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.601 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.819 HG23 ' CE ' ' A' ' 21' ' ' MET . 38.2 mt -96.06 123.8 54.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.01 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.2 159.93 15.31 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.623 1.549 . . . . 0.0 112.796 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 46' ' ' ASN . 13.8 tt -71.03 151.67 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.06 37.46 21.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.646 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -132.8 134.75 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.472 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -62.02 151.06 36.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 43' ' ' MET . 82.7 mt -90.17 166.63 13.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.1 p -150.13 170.13 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.3 mp -62.08 -32.97 73.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' OE1' ' A' ' 9' ' ' GLN . 21.6 t -70.03 -30.35 43.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 11' ' ' ILE . 29.0 mtp -97.44 28.66 3.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HE3' HG23 ' A' ' 37' ' ' ILE . 29.6 mtm -150.27 125.78 10.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -142.89 161.97 36.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -96.63 143.42 27.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.432 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -177.96 143.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 122.52 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 m -154.45 157.16 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.65 144.91 34.18 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.363 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.41 150.83 81.39 Favored 'Cis proline' 0 N--CA 1.481 0.754 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.462 0.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.7 m -59.45 104.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.44 -121.28 3.69 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -75.62 139.55 70.83 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -82.19 161.24 17.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.612 1.541 . . . . 0.0 112.92 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.63 -16.98 64.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -13.18 61.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.489 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 40' ' ' LEU . 51.0 m-20 -113.75 25.09 11.51 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.609 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 34' ' ' ALA . 39.6 mt -63.45 -47.58 83.29 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.642 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.1 Cg_endo -76.6 -16.31 16.86 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.105 1.203 . . . . 0.0 113.008 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -80.77 -27.27 36.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.773 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.601 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -97.41 38.78 1.24 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.147 0.498 . . . . 0.0 110.721 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.68 141.76 13.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.231 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.502 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.2 m 60.84 32.65 20.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.499 ' HB2' HD12 ' A' ' 17' ' ' LEU . 94.7 mmm -92.25 143.45 26.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -101.2 138.77 37.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.477 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.74 144.77 14.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.346 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.2 p-10 -79.96 -28.24 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.716 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -122.72 168.17 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.103 0.477 . . . . 0.0 110.461 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.97 51.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.03 91.77 23.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.38 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.6 Cg_endo -80.64 -175.13 2.53 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.68 1.587 . . . . 0.0 112.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -61.65 149.39 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.47 61.6 6.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -140.62 111.93 7.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 104.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.54 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.5 109.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.498 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.556 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mtt -93.92 165.02 18.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.72 -20.23 8.01 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 121.828 1.685 . . . . 0.0 113.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.81 -42.77 49.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.992 0.425 . . . . 0.0 110.722 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.418 ' HG3' HG23 ' A' ' 60' ' ' VAL . 3.9 ptp -64.87 -28.16 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.992 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HG3' ' A' ' 59' ' ' MET . 43.5 t -88.63 97.42 6.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.094 0.473 . . . . 0.0 110.247 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -66.05 127.66 33.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.364 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.06 -31.09 8.48 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.601 ' CE1' HD11 ' A' ' 40' ' ' LEU . 43.3 t80 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.246 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -101.57 -173.06 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -100.27 93.42 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 25' ' ' GLU . 38.7 t -90.1 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.267 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.05 132.5 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.304 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.37 29.49 7.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -177.61 165.55 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.114 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.84 96.13 4.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.2 mt -90.43 112.47 53.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.085 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.91 156.81 20.66 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.562 1.508 . . . . 0.0 112.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.71 154.58 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 m120 60.46 32.83 20.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 156.72 43.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 151.98 21.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.695 ' CD2' HG21 ' A' ' 11' ' ' ILE . 65.5 mt -90.1 168.57 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.457 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -150.12 164.65 35.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.67 -32.06 72.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.448 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -66.29 -31.56 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.288 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.7 mtm -99.43 31.77 3.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.5 mtm -150.12 137.22 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -160.03 162.24 34.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 m -84.71 129.94 34.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.423 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.8 tt0 -162.44 128.94 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.462 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.71 115.18 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.89 162.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -119.55 141.52 31.07 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.263 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 54' ' ' THR . 39.3 Cg_endo -79.99 156.35 87.86 Favored 'Cis proline' 0 N--CA 1.482 0.821 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.523 0.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.4 p -61.11 112.28 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.38 -125.66 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 40' ' ' LEU . 53.8 mt -74.39 139.86 75.44 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.19 165.99 16.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.622 1.548 . . . . 0.0 112.817 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -12.21 60.01 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.613 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.99 -9.75 56.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.774 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.2 m-20 -118.18 27.63 8.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.403 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD11 ' HB1' ' A' ' 34' ' ' ALA . 36.7 mt -65.81 -47.63 64.76 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.555 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.6 Cg_endo -77.96 -18.15 13.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.161 1.241 . . . . 0.0 112.532 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -79.24 -26.27 42.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.67 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -97.44 37.63 1.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.098 0.475 . . . . 0.0 110.893 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 31.7 t -89.05 135.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.162 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m 61.28 37.64 17.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 97.2 mmm -90.37 147.67 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.31 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.67 125.18 47.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.517 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -91.84 -177.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.376 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -108.74 -43.04 4.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.612 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -118.02 -177.49 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.55 121.87 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.507 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 53' ' ' THR . 22.4 t -111.91 91.97 16.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.12 -173.2 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.666 1.577 . . . . 0.0 112.778 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -67.12 137.71 56.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.529 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 31.95 37.25 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.441 HG21 HG13 ' A' ' 49' ' ' VAL . 24.9 m -111.65 112.51 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.052 0.454 . . . . 0.0 110.311 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.5 m -62.04 105.39 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.81 141.58 57.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.267 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 24.4 mmm -127.12 157.03 73.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.74 -20.79 7.57 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 121.803 1.669 . . . . 0.0 113.129 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -79.27 -44.41 21.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 ptm -68.08 -31.38 70.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 27.4 t -79.86 111.28 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -71.75 121.39 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.377 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.66 7.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.67 ' CD2' HD21 ' A' ' 40' ' ' LEU . 48.5 t80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 121.01 0.433 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 121.213 0.53 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.23 -177.42 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.91 149.63 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.6 t -145.96 153.68 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.136 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 11' ' ' ILE . . . -79.79 121.38 25.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.368 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -99.84 30.54 3.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.99 161.62 0.95 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.988 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -69.79 97.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.433 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 17' ' ' LEU . 10.7 mt -89.7 111.93 48.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.043 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.29 153.49 16.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.603 1.535 . . . . 0.0 112.598 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 tt -61.47 154.15 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.359 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 60.87 33.07 20.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -132.38 146.29 51.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.422 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 155.32 29.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.499 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 11' ' ' ILE . 88.1 mt -90.19 167.44 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.45 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.06 -33.26 74.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' MET . 17.7 m -69.7 -27.88 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.771 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG3' HG23 ' A' ' 20' ' ' VAL . 75.9 mtm -99.02 30.77 3.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.416 ' HE3' ' O ' ' A' ' 37' ' ' ILE . 31.0 mtm -150.15 143.84 25.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -160.21 164.4 32.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -97.46 133.32 42.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -169.14 146.24 3.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.87 130.8 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -155.45 175.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -133.52 144.91 54.18 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.11 169.35 69.92 Favored 'Cis proline' 0 N--CA 1.482 0.843 0 C-N-CA 124.086 -1.214 . . . . 0.0 112.587 -0.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 30' ' ' VAL . 10.9 p -61.58 110.94 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -111.01 -133.63 6.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.469 HD11 ' C ' ' A' ' 56' ' ' MET . 68.8 mt -65.75 139.74 97.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.98 168.28 17.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.576 1.517 . . . . 0.0 112.674 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.36 -2.77 36.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.694 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -90.82 19.82 5.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.624 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -140.39 30.1 1.96 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.608 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 25.4 mt -69.09 -46.97 30.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.111 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.38 -21.3 13.47 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 121.129 1.219 . . . . 0.0 112.657 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -77.05 -26.74 53.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.632 HD21 ' CD1' ' A' ' 63' ' ' TYR . 5.3 mt -97.87 34.44 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.0 t -90.02 141.62 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m 60.8 34.75 19.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.8 mmm -97.03 129.56 44.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.32 136.42 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.407 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.95 163.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.402 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -112.76 32.23 5.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.414 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -178.84 161.13 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.429 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.36 126.6 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.91 94.97 47.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.17 179.85 5.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.07 142.04 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.549 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.25 56.4 6.3 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 m -134.7 118.03 16.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.36 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -62.07 100.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.88 110.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.469 ' C ' HD11 ' A' ' 32' ' ' ILE . 24.0 mtt -95.37 163.08 22.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.455 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.71 -26.85 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.869 1.713 . . . . 0.0 112.685 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.16 -33.15 67.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.431 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.33 -36.6 68.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.432 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 56' ' ' MET . 24.9 t -79.89 110.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -71.88 122.64 21.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.444 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.49 -31.61 7.46 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 63.7 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.054 0.454 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -126.31 -177.48 3.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.37 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.16 87.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.354 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -89.52 147.8 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.309 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -72.84 129.97 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.452 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -107.9 31.08 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.74 158.09 0.77 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.05 98.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.56 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.1 mt -89.48 112.91 54.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.942 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.8 151.95 19.2 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.386 1.39 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.51 155.06 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.01 32.89 19.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.472 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -134.19 151.52 51.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.99 151.35 24.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.608 ' CD2' HG21 ' A' ' 11' ' ' ILE . 23.6 mt -84.89 170.81 12.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.393 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -150.33 166.71 29.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.38 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.03 -32.39 72.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.356 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.43 -30.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.458 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.4 mtm -99.1 31.29 3.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.629 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' HE2' ' A' ' 22' ' ' MET . 26.5 mtm -150.03 151.43 33.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.05 -177.2 6.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -120.77 100.63 7.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.91 144.33 37.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.84 129.03 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.324 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.05 154.02 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -114.18 139.53 23.86 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.6 Cg_endo -80.36 142.14 59.53 Favored 'Cis proline' 0 N--CA 1.483 0.855 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.475 0.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 30' ' ' VAL . 14.0 m -60.64 91.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.874 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.67 -111.94 0.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 56' ' ' MET . 58.4 mt -78.67 139.05 58.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -79.69 173.04 13.45 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.544 1.496 . . . . 0.0 112.525 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.07 14.18 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.559 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 14.89 12.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.405 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -145.57 29.79 1.12 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.4 mt -60.94 -47.33 95.85 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -75.76 -16.95 18.3 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.142 1.228 . . . . 0.0 112.914 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -82.56 -25.66 33.12 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 63' ' ' TYR . 3.3 mp -97.76 34.37 1.89 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.026 0.441 . . . . 0.0 110.731 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -83.59 134.22 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.309 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.523 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.7 t 60.86 35.8 19.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' LEU . 74.8 mmm -84.51 129.25 34.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.459 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -81.44 129.82 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.428 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.23 172.86 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.404 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -106.55 -33.82 7.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.391 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.36 -177.63 3.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.32 141.44 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.504 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.27 91.08 23.69 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.3 Cg_endo -80.44 -171.54 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.678 1.585 . . . . 0.0 112.671 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -67.0 143.32 56.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.438 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.83 49.75 27.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -132.85 114.42 14.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.321 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.6 m -61.86 104.57 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.73 111.22 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.591 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mmt -97.2 163.84 19.05 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.79 -24.62 4.82 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 121.628 1.552 . . . . 0.0 112.941 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.77 -25.73 59.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.0 mtm -98.23 30.21 3.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 56' ' ' MET . 48.2 t -140.2 106.31 2.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.017 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.79 121.62 14.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -31.37 8.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.472 ' CE1' HD11 ' A' ' 40' ' ' LEU . 37.0 t80 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.497 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m -131.17 -174.0 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.08 89.54 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.481 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.12 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.233 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -77.86 137.0 38.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.373 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -112.4 29.52 7.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.633 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.3 157.06 1.29 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.975 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 10' ' ' LEU . 32.8 tp -70.59 97.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.583 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -89.56 125.4 61.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.1 151.16 13.93 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.653 1.568 . . . . 0.0 112.518 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.13 152.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 59.79 36.66 22.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 16' ' ' ALA . 25.7 m -133.31 159.56 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.439 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -89.15 150.47 22.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.464 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.583 ' CD2' HG21 ' A' ' 11' ' ' ILE . 16.6 mt -90.2 175.1 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 p -144.6 -170.94 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.096 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.32 -38.7 26.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.775 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.52 -25.87 37.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.8 mtm -99.19 31.07 3.19 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 37' ' ' ILE . 13.8 mtm -150.18 125.81 10.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -143.76 -178.95 6.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.399 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -114.76 126.58 55.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.406 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.5 136.41 10.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.33 112.36 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.06 149.06 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -108.51 145.16 30.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.38 164.26 80.05 Favored 'Cis proline' 0 N--CA 1.481 0.759 0 C-N-CA 124.106 -1.206 . . . . 0.0 112.532 0.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.7 p -61.56 118.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.33 -130.85 5.3 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.431 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -72.84 139.37 80.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.85 161.9 18.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.632 1.555 . . . . 0.0 112.843 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.48 -23.96 66.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -59.84 -18.89 47.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.541 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 40' ' ' LEU . 7.3 m-20 -109.91 40.09 1.99 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 111.438 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 55.0 mt -85.69 -46.63 0.6 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -78.07 -15.01 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.179 1.253 . . . . 0.0 113.078 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -86.17 -26.61 25.05 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.641 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 63' ' ' TYR . 11.1 mp -93.45 47.87 1.27 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.265 0.555 . . . . 0.0 110.588 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 38' ' ' PRO . 28.6 t -90.15 134.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.251 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.717 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 51.4 m 61.24 32.88 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.45 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.8 mmm -86.02 140.36 30.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.316 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -96.88 144.39 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.522 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 49' ' ' VAL . 25.7 m -110.41 175.55 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -90.52 -38.28 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -177.33 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.27 132.38 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.512 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 45' ' ' VAL . 22.1 t -116.67 91.99 36.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.0 Cg_endo -80.75 -171.23 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.748 1.632 . . . . 0.0 112.613 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.1 mp -71.06 148.65 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.28 32.23 72.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.5 m -116.7 114.92 24.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 110.271 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 m -61.97 100.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.405 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.29 113.43 2.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.442 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 60' ' ' VAL . 7.3 mtt -98.81 159.5 30.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.98 -27.71 2.36 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 121.918 1.745 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.09 -33.44 75.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.43 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.0 mtm -77.55 -33.51 54.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.382 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 56' ' ' MET . 29.5 t -79.85 102.71 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.46 125.82 27.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.71 -31.54 7.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.789 ' CE1' HD11 ' A' ' 40' ' ' LEU . 35.9 t80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.285 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 121.105 0.479 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.24 -172.41 2.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.9 151.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.278 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.14 150.17 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.28 120.88 25.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.368 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -99.7 31.54 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.59 166.16 1.74 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.058 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' HD11 ' A' ' 51' ' ' LEU . 21.0 tp -72.26 102.74 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.262 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.494 HG12 ' HE3' ' A' ' 21' ' ' MET . 46.6 mt -103.58 103.37 35.71 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.79 163.79 20.78 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.563 1.509 . . . . 0.0 112.553 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -61.2 153.82 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.414 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 60.35 37.1 20.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.536 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 m -129.29 132.66 47.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 142.6 50.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 43' ' ' MET . 35.9 mt -82.74 163.71 21.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -150.22 175.79 11.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.304 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.61 -34.14 77.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.336 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.95 -29.69 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.553 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.494 ' HE3' HG12 ' A' ' 11' ' ' ILE . 28.7 mtp -95.16 22.73 6.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.213 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mtm -150.5 143.04 24.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.112 0.482 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -160.04 177.53 10.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 m -111.41 137.19 49.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -171.72 139.06 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.83 123.54 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.301 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.56 173.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -128.33 145.34 55.35 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.365 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.74 -179.97 25.9 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.494 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.87 102.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.91 -131.47 7.37 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.564 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -73.23 139.56 79.08 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -82.79 169.49 13.34 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.606 1.537 . . . . 0.0 112.902 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.18 -24.89 65.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.47 -19.28 46.54 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.38 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 40' ' ' LEU . 39.5 m-20 -106.71 35.75 2.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.087 0.47 . . . . 0.0 111.45 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 34' ' ' ALA . 46.9 mt -81.06 -46.7 1.15 Allowed Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.562 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -77.43 -24.44 9.15 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.175 1.25 . . . . 0.0 112.529 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -78.41 -20.38 51.24 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.885 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.758 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.7 mp -97.19 30.31 2.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.972 0.415 . . . . 0.0 110.793 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.5 t -88.39 135.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.135 0.493 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.79 33.7 17.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.438 ' HE1' ' HB2' ' A' ' 63' ' ' TYR . 17.2 mtp -97.88 119.63 36.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.279 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -79.91 138.71 37.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.459 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.38 -179.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -110.13 -25.21 10.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -128.65 171.59 12.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.11 0.481 . . . . 0.0 110.544 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.45 144.36 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.9 92.49 12.67 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -78.91 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 121.632 1.555 . . . . 0.0 112.686 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.6 mp -61.04 153.55 25.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.675 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.76 53.1 46.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -135.32 117.63 15.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.096 0.474 . . . . 0.0 110.354 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -63.01 104.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.475 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.538 HD23 HD23 ' A' ' 40' ' ' LEU . 7.9 tp -60.83 114.41 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.451 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.564 ' C ' HD11 ' A' ' 32' ' ' ILE . 30.4 mtt -99.92 163.8 17.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.9 -24.79 5.64 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 121.738 1.625 . . . . 0.0 112.757 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.44 -32.31 64.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.453 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.9 mtm -71.67 -38.59 70.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.436 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.8 t -80.23 107.2 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.02 124.81 23.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.64 -29.8 10.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 110.335 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 121.186 0.517 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -93.6 -171.13 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.47 149.07 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.1 t -146.59 150.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.7 122.14 20.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.244 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.77 -17.79 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -149.27 174.5 12.34 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 0.0 110.576 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 100.64 1.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.733 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.68 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.7 mt -89.98 116.94 67.58 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.937 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.68 147.88 15.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.436 1.424 . . . . 0.0 112.635 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.4 tt -61.1 155.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 61.01 33.25 19.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -133.84 152.62 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.61 138.07 32.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' CD2' HG21 ' A' ' 11' ' ' ILE . 18.7 mt -74.6 172.82 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.419 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -150.19 164.22 36.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.339 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.3 mp -62.5 -31.57 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.484 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.44 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.7 mtm -99.56 35.85 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 0.0 110.544 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.6 mtm -149.99 149.34 30.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.594 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -157.17 166.78 32.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.348 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.6 t -102.5 92.33 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.508 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -126.81 140.02 52.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.6 t -80.19 131.18 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -152.84 -177.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -136.75 139.31 28.67 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.292 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -77.92 148.85 86.46 Favored 'Cis proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.119 -1.2 . . . . 0.0 112.436 0.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.92 91.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.621 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.41 -124.93 0.71 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 56' ' ' MET . 64.7 mt -70.78 139.0 85.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.53 179.45 6.34 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.513 1.475 . . . . 0.0 112.617 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -89.92 13.45 14.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.56 -25.35 20.25 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.994 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 40' ' ' LEU . 11.8 m-20 -98.24 31.02 2.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 34' ' ' ALA . 75.3 mt -66.99 -47.4 52.93 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.51 -24.01 10.89 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 121.036 1.157 . . . . 0.0 112.572 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -26.78 53.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.698 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.759 HD21 ' CD2' ' A' ' 63' ' ' TYR . 6.3 mt -98.21 33.6 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.3 t -88.89 136.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.724 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 64.6 m 60.93 36.08 18.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 mmm -92.45 133.08 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -82.61 131.76 35.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.3 152.47 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.326 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -79.81 -21.86 43.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -145.05 -179.94 6.95 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.55 154.57 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.88 93.86 4.44 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.383 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.49 -176.79 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.683 1.588 . . . . 0.0 112.484 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.69 152.67 30.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.26 57.89 13.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -138.91 113.51 9.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.215 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -61.05 107.53 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.598 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.91 109.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.574 ' C ' HD11 ' A' ' 32' ' ' ILE . 17.0 mtt -97.99 160.8 27.53 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.289 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.45 -23.88 5.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.834 1.689 . . . . 0.0 112.978 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -71.19 -43.28 67.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.0 ptp -67.08 -29.07 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.04 104.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.161 0.505 . . . . 0.0 110.167 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -66.66 121.91 16.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.27 -31.53 7.57 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.759 ' CD2' HD21 ' A' ' 40' ' ' LEU . 50.1 t80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.297 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.043 0.449 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.61 -171.96 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.425 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.39 85.73 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.92 152.28 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.323 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.88 126.61 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.78 31.97 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -178.55 164.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 10' ' ' LEU . 30.2 tp -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.408 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 17' ' ' LEU . 45.6 mt -102.61 104.35 37.85 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.11 174.79 10.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.551 1.501 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.1 154.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.419 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 60.31 33.79 20.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -128.27 130.91 48.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.455 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 146.79 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' MET . 26.7 mt -87.43 164.96 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.473 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 p -150.27 -171.74 3.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.195 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.94 -45.62 57.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG23 ' HG3' ' A' ' 21' ' ' MET . 29.2 m -64.57 -24.3 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.006 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.463 ' HG3' HG23 ' A' ' 20' ' ' VAL . 27.0 mtp -95.8 25.33 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.4 mtm -150.41 152.23 34.02 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 110.312 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -159.98 176.72 11.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.57 116.75 28.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' OE1' HG13 ' A' ' 27' ' ' VAL . 4.0 tm-20 -152.03 139.07 19.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.11 113.41 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.429 HG13 ' OE1' ' A' ' 25' ' ' GLU . 27.4 m -140.11 178.97 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.431 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -131.44 145.47 57.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.286 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.13 168.11 70.74 Favored 'Cis proline' 0 N--CA 1.481 0.772 0 C-N-CA 124.142 -1.191 . . . . 0.0 112.561 -0.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 95.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.372 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -122.1 3.46 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.88 139.51 46.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.01 165.82 14.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 121.664 1.576 . . . . 0.0 112.78 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -68.99 -14.3 62.96 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -72.12 -7.99 52.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.704 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -116.34 28.94 8.26 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.166 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 49.8 mt -69.75 -46.99 24.84 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.79 -16.21 16.5 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.127 1.218 . . . . 0.0 112.9 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -82.58 -25.3 33.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.715 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.4 mt -96.38 40.02 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -90.12 132.57 34.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.247 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 m 60.69 57.24 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.582 ' HB2' HD12 ' A' ' 17' ' ' LEU . 68.4 mmm -119.88 133.07 55.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.429 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.85 133.18 33.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.505 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.1 -177.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -105.53 -35.65 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -133.03 -177.21 4.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.373 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.53 115.36 11.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.481 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -111.43 93.18 18.27 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.336 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.61 -176.26 3.09 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 121.75 1.633 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 51' ' ' LEU . 2.4 mp -62.17 147.92 46.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.4 44.63 64.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.481 HG21 HG13 ' A' ' 49' ' ' VAL . 26.1 m -127.87 116.72 20.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.147 0.498 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.4 m -62.26 101.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.87 111.73 2.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.2 mtt -91.01 158.82 41.13 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.324 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.4 -26.38 4.09 Favored 'Trans proline' 0 N--CA 1.474 0.373 0 C-N-CA 121.793 1.662 . . . . 0.0 112.737 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.79 -31.94 59.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.501 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.4 mtp -68.38 -38.36 81.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.71 109.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.384 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.19 120.29 12.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.29 -31.85 7.1 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.615 ' CD2' HD21 ' A' ' 40' ' ' LEU . 46.3 t80 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 110.362 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.084 0.469 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -94.09 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 91.99 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.77 153.04 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.301 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 128.65 35.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.416 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.77 31.86 4.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.6 163.34 1.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 10' ' ' LEU . 33.5 tp -73.08 96.57 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.7 mt -90.08 111.77 48.63 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.01 153.9 16.98 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.524 1.483 . . . . 0.0 112.755 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 46' ' ' ASN . 14.2 tt -61.39 154.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.417 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 60.2 33.63 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.556 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 16' ' ' ALA . 10.6 m -130.61 159.66 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' N ' HG22 ' A' ' 15' ' ' THR . . . -89.84 151.53 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 72.9 mt -90.0 165.77 13.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.439 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.2 p -148.28 165.45 30.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.381 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.7 -31.62 71.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.17 -31.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.314 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.0 mtm -99.26 31.07 3.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.593 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.5 mtm -150.05 140.49 22.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.435 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -160.1 -177.36 6.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.15 124.14 51.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.377 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.65 145.51 22.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.07 121.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.348 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.67 159.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -120.3 145.77 41.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.88 166.19 72.13 Favored 'Cis proline' 0 N--CA 1.481 0.736 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.651 -0.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.19 99.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.35 -123.57 3.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.545 HD11 ' C ' ' A' ' 56' ' ' MET . 57.2 mt -76.35 139.55 68.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.25 164.37 17.13 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.71 1.607 . . . . 0.0 112.797 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.41 -21.17 65.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.223 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -64.03 -15.55 59.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.513 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' O ' HD12 ' A' ' 40' ' ' LEU . 2.1 m-20 -110.27 28.1 8.96 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.494 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 mt -71.09 -46.94 14.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.0 -19.32 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.204 1.269 . . . . 0.0 112.844 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -80.91 -24.72 38.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 2.1 mt -96.58 37.65 1.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.102 0.477 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.94 138.57 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.242 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 60.87 35.94 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.627 ' HG3' HD23 ' A' ' 40' ' ' LEU . 86.9 mmm -92.01 143.64 26.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.457 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -103.88 138.25 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.95 175.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.4 p-10 -102.54 -31.38 10.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.561 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -121.83 -179.44 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.72 155.72 33.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.451 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -150.61 90.75 4.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -79.63 -175.29 2.65 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 121.705 1.603 . . . . 0.0 112.657 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -61.73 151.73 33.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.57 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 51.59 48.36 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.451 HG21 HG13 ' A' ' 49' ' ' VAL . 24.7 m -133.62 122.04 22.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.126 0.489 . . . . 0.0 110.427 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -66.64 102.59 0.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.452 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.54 114.05 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.545 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.6 mtt -98.44 161.22 25.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.378 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.6 -26.18 4.04 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.47 -32.86 60.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.361 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.52 -32.77 71.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.425 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -86.84 107.58 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.269 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -66.77 123.07 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.79 -30.95 8.44 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 56.7 t80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 121.134 0.492 . . . . 0.0 110.338 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.171 0.51 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -108.67 -175.07 2.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.398 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.68 149.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -150.14 149.6 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.95 127.58 32.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.345 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -105.62 30.68 5.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 160.31 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.121 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -69.48 98.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.43 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.47 112.24 50.43 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 160.94 18.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 121.568 1.512 . . . . 0.0 112.575 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -65.98 154.96 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.31 33.16 20.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 m -130.84 147.96 52.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -81.58 155.76 25.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.432 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.79 169.45 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.368 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.18 163.38 38.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.23 -32.83 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.44 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.65 -31.24 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.428 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.6 mtm -99.29 31.61 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.9 mtm -150.11 138.69 20.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -159.71 163.53 34.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.425 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -90.3 132.34 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.414 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -167.36 136.75 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.89 112.18 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -141.84 153.09 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 t -114.3 144.5 31.82 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.28 152.56 84.01 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.092 -1.212 . . . . 0.0 112.495 0.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.07 113.12 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.452 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.81 -113.05 3.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 40' ' ' LEU . 57.2 mt -83.19 139.5 42.18 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.42 165.74 18.38 Favored 'Trans proline' 0 N--CA 1.476 0.462 0 C-N-CA 121.612 1.541 . . . . 0.0 112.946 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.34 -13.54 62.09 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.4 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.02 -10.21 57.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.609 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 m-20 -115.63 28.65 8.51 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.285 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 HD11 ' HB1' ' A' ' 34' ' ' ALA . 49.5 mt -71.12 -46.79 14.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.825 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 Cg_endo -77.35 -22.67 10.77 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.153 1.235 . . . . 0.0 112.71 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -79.03 -24.52 43.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 63' ' ' TYR . 20.1 mt -97.22 35.86 1.54 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.6 t -90.12 137.42 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.5 p 56.51 45.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.802 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.648 ' SD ' HD23 ' A' ' 40' ' ' LEU . 14.9 mtp -104.14 142.26 34.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.89 136.55 32.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.33 176.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.431 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -93.87 -36.38 12.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -134.7 -177.07 4.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.564 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.79 121.17 21.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.44 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.94 101.79 31.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.151 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.34 176.82 9.26 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 121.51 1.473 . . . . 0.0 112.691 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.0 mp -61.23 151.06 32.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.565 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.07 54.9 29.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -135.82 116.71 14.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 m -61.99 108.86 1.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.5 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -61.3 113.06 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.472 ' C ' HD11 ' A' ' 32' ' ' ILE . 6.7 mmt -94.29 156.39 38.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.346 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -79.9 -24.74 5.68 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.853 1.702 . . . . 0.0 112.778 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -74.64 -31.37 61.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.3 mtm -71.91 -37.78 70.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.73 102.08 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.357 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -66.93 128.72 37.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.61 -29.43 11.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.751 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.1 t80 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.341 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.068 0 CA-C-O 121.078 0.466 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.59 -171.99 2.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -112.22 86.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.566 HG21 HG11 ' A' ' 27' ' ' VAL . 60.0 t -89.88 151.38 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -66.97 154.91 39.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -115.22 -17.52 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.46 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.451 ' HA ' HD21 ' A' ' 51' ' ' LEU . 6.7 pt20 -149.42 -179.92 7.45 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.069 0.461 . . . . 0.0 110.494 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' HD11 ' A' ' 51' ' ' LEU . 31.0 tp -71.08 101.36 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.783 HG23 ' CE ' ' A' ' 21' ' ' MET . 37.4 mt -96.95 109.98 51.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.38 154.24 21.38 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.524 1.483 . . . . 0.0 112.782 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.1 tt -61.49 155.45 4.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 60.28 40.99 17.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 m -139.22 138.45 36.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.64 150.53 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.401 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 ' HB2' ' A' ' 43' ' ' MET . 50.5 mt -90.24 164.72 14.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 p -150.08 175.24 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.443 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.28 -33.06 73.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.372 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.57 -28.35 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.783 ' CE ' HG23 ' A' ' 11' ' ' ILE . 32.4 mtp -97.65 29.09 3.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.8 mtm -150.27 140.32 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -148.14 177.52 9.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.398 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.78 108.24 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.458 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -146.62 144.58 29.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.34 120.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.345 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 6' ' ' VAL . 27.6 m -144.51 165.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.399 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 t -122.7 145.45 45.24 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.33 174.98 43.82 Favored 'Cis proline' 0 N--CA 1.481 0.767 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.446 -0.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.22 108.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.49 -120.99 4.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.654 HD13 ' CD2' ' A' ' 40' ' ' LEU . 55.5 mt -85.58 139.71 35.74 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -83.08 166.33 14.61 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.63 1.553 . . . . 0.0 112.68 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -70.47 -23.2 62.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.73 -13.9 60.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.475 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 40' ' ' LEU . 73.1 m-20 -110.76 24.37 13.03 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.603 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 43.6 mt -66.09 -46.88 63.27 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.706 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -76.7 -15.61 17.01 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 121.122 1.215 . . . . 0.0 112.82 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.41 -25.75 33.41 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.71 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD2' HD13 ' A' ' 32' ' ' ILE . 5.1 mp -97.26 36.24 1.49 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.787 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.2 t -86.06 139.72 16.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m 60.99 34.42 19.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.56 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.791 ' HB2' HD12 ' A' ' 17' ' ' LEU . 21.8 mmm -84.15 148.62 26.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.399 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -112.77 124.78 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -95.0 -178.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.299 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -129.98 33.22 4.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -177.53 163.55 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.475 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.93 49.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.397 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.017 HG12 HG21 ' A' ' 53' ' ' THR . 12.5 t -149.75 98.27 3.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.054 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 10' ' ' LEU . 40.6 Cg_endo -81.61 -165.45 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.903 1.735 . . . . 0.0 112.923 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.5 mp -73.68 154.13 39.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.16 58.58 13.3 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.017 HG21 HG12 ' A' ' 49' ' ' VAL . 9.8 t -132.48 136.18 46.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -75.61 104.65 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.113 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.39 108.14 6.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -95.29 164.75 18.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.904 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 39.9 Cg_endo -80.36 -35.7 0.59 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 121.586 1.524 . . . . 0.0 112.657 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.35 -42.36 99.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.399 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtm -63.51 -30.45 71.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.61 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 56' ' ' MET . 31.7 t -88.39 127.79 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -81.42 122.32 27.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.028 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.5 -28.59 7.4 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 57' ' ' PRO . 9.0 t80 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 121.09 0.471 . . . . 0.0 110.536 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -74.55 126.83 31.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.426 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.27 152.56 18.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -134.22 -179.77 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.447 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.49 147.71 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.305 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.71 148.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.175 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.54 149.83 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -111.48 -23.1 10.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.32 178.44 8.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.974 0.416 . . . . 0.0 110.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 10' ' ' LEU . 31.9 tp -68.53 97.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.779 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.709 HG23 ' CE ' ' A' ' 21' ' ' MET . 43.5 mt -89.79 118.48 69.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.78 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.39 147.68 16.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.522 1.481 . . . . 0.0 112.631 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.0 tt -61.14 154.94 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.395 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 60.81 34.35 19.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -127.17 154.64 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.07 140.83 32.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.367 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 43' ' ' MET . 47.9 mt -82.53 167.13 18.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.473 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -143.92 -174.02 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -75.62 -31.9 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.36 -44.31 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.709 ' CE ' HG23 ' A' ' 11' ' ' ILE . 11.6 mtp -65.0 -29.11 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.728 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.46 149.08 23.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.345 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.06 179.35 8.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.84 135.81 51.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.381 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -178.0 141.92 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.7 121.85 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.247 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 167.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.457 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -125.73 138.97 33.01 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.315 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.59 137.17 42.01 Favored 'Cis proline' 0 N--CA 1.482 0.822 0 C-N-CA 124.075 -1.219 . . . . 0.0 112.481 0.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.5 m -59.26 106.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -112.62 2.78 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' C ' ' A' ' 56' ' ' MET . 63.9 mt -70.91 139.46 85.59 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.41 172.69 13.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.525 1.483 . . . . 0.0 112.729 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.52 -0.13 32.03 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.784 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.99 19.79 5.38 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 40' ' ' LEU . 70.1 m-20 -140.14 29.95 2.01 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.429 . . . . 0.0 110.751 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 20.7 mt -70.32 -46.85 20.31 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.147 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -76.66 -4.2 14.7 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.075 1.183 . . . . 0.0 113.263 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -96.87 -25.82 15.31 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -97.53 35.31 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.04 142.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 60.67 32.61 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.497 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.606 ' HB2' HD12 ' A' ' 17' ' ' LEU . 49.6 mmm -94.4 136.66 34.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -100.24 119.08 37.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -79.9 166.59 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.427 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -110.32 32.11 5.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.519 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.61 ' HA ' HD12 ' A' ' 13' ' ' ILE . 9.4 ptm180 -178.37 159.65 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.21 130.19 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -123.23 95.19 46.0 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.316 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.04 -174.96 2.47 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 121.675 1.583 . . . . 0.0 112.625 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 51' ' ' LEU . 2.4 mp -61.66 146.94 47.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.549 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.7 0.77 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 m -145.0 114.4 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' PRO . 3.3 m -61.76 104.1 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.495 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -60.97 113.17 2.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.565 ' C ' HD11 ' A' ' 32' ' ' ILE . 10.2 mtt -96.9 163.1 20.85 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.68 -26.34 3.18 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 121.861 1.707 . . . . 0.0 112.703 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.14 -32.81 61.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.468 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtm -71.66 -36.77 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 56' ' ' MET . 28.6 t -80.02 108.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -66.95 119.18 11.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.49 -31.91 7.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 52.3 t80 -80.64 103.17 10.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.158 0.504 . . . . 0.0 110.376 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.6 173.71 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.442 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -131.26 130.87 43.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.59 177.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.439 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -144.56 -174.4 4.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.72 89.0 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.76 152.87 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.294 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.33 128.02 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -103.62 30.53 4.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.611 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -178.02 160.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.74 96.69 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.41 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 ' CD2' ' A' ' 17' ' ' LEU . 19.6 mt -90.74 111.62 48.88 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.97 159.27 18.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.632 1.555 . . . . 0.0 112.607 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.08 154.28 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 60.63 33.29 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -133.07 144.06 49.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -76.43 152.12 36.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 43' ' ' MET . 19.4 mt -90.09 168.25 12.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.364 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -148.66 169.38 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -65.3 -33.19 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.73 -30.08 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.708 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.0 mtm -100.13 31.18 3.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.443 ' HE3' HG23 ' A' ' 37' ' ' ILE . 27.8 mtm -150.13 144.5 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.457 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -160.05 175.87 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.427 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 t -104.24 128.61 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.419 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.92 145.5 8.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.96 127.92 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.333 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 m -154.16 162.8 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -123.91 140.06 33.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.08 140.12 52.29 Favored 'Cis proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.155 -1.185 . . . . 0.0 112.452 0.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.59 107.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.818 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.38 -106.65 1.81 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.546 HD11 ' C ' ' A' ' 56' ' ' MET . 55.9 mt -82.07 139.46 45.91 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.32 165.78 18.57 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.523 1.482 . . . . 0.0 112.702 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -76.3 -3.76 38.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.68 1.7 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.718 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' HD12 ' A' ' 40' ' ' LEU . 42.7 m-20 -128.31 27.74 5.56 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.6 mt -62.2 -47.41 90.15 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.214 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.614 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.5 Cg_endo -75.78 -20.19 15.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.09 1.193 . . . . 0.0 112.674 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -77.1 -28.01 54.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -97.9 35.57 1.69 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.755 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' PRO . 24.3 t -90.29 142.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.327 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.441 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 5.2 m 60.67 32.44 20.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.6 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.61 ' HB2' HD12 ' A' ' 17' ' ' LEU . 38.2 mmm -95.59 139.94 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.473 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -89.25 140.88 29.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.491 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.75 148.01 7.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.303 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -79.81 -21.69 43.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.6 -178.36 5.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.16 24.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.57 92.53 24.24 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.292 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.3 179.44 6.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.742 1.628 . . . . 0.0 112.66 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.9 mp -62.06 151.61 34.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.599 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.96 40.26 93.41 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 m -129.53 118.97 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -62.31 109.74 1.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.44 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.15 114.91 5.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.389 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.546 ' C ' HD11 ' A' ' 32' ' ' ILE . 19.9 mtt -95.91 158.88 33.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.9 -26.89 3.35 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 121.827 1.685 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.91 -32.97 70.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.1 mtp -73.81 -33.73 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 56' ' ' MET . 26.3 t -80.03 104.83 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -65.22 121.09 13.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.48 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.16 -31.2 7.87 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 40' ' ' LEU . 56.1 t80 -88.58 149.77 23.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.061 0.458 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -166.38 103.81 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.396 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' NE2' HG21 ' A' ' 30' ' ' VAL . 25.1 pt20 -136.08 133.28 37.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.4 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.06 160.01 29.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -129.7 -174.73 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.362 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -107.92 144.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 7' ' ' ALA . 24.9 t -144.93 155.81 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -82.52 122.95 28.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -102.47 32.51 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.41 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.472 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -178.96 164.92 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.169 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' HD11 ' A' ' 51' ' ' LEU . 19.1 tp -71.94 104.44 3.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG23 ' CE ' ' A' ' 21' ' ' MET . 52.3 mt -103.17 104.15 38.83 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.07 164.59 19.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.58 1.52 . . . . 0.0 112.678 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.45 147.93 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 60.84 51.75 4.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.432 0.634 . . . . 0.0 110.451 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -144.97 124.06 12.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.413 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.64 148.44 46.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.423 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 43' ' ' MET . 21.0 mt -88.94 166.67 13.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.513 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.646 ' OG1' HG12 ' A' ' 20' ' ' VAL . 30.7 p -150.25 -172.14 4.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.179 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.63 -31.43 63.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 p -75.3 -26.59 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG3' HG13 ' A' ' 20' ' ' VAL . 33.1 mtp -96.98 27.32 4.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.968 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.491 ' HE3' HG23 ' A' ' 37' ' ' ILE . 25.8 mtm -150.41 148.98 29.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.079 0.466 . . . . 0.0 110.426 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -160.02 178.18 9.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.406 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 t -117.65 126.54 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -159.74 145.73 15.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.09 110.5 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.312 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.59 164.41 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -115.9 145.29 34.44 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.5 169.84 63.82 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 C-N-CA 124.097 -1.21 . . . . 0.0 112.592 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.1 p -61.76 112.16 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.81 -129.6 6.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.643 HD11 ' C ' ' A' ' 56' ' ' MET . 52.3 mt -78.59 139.64 58.98 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.08 163.22 17.88 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.58 1.52 . . . . 0.0 112.882 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.03 -14.58 63.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.401 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.96 -10.92 59.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.695 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.28 26.76 9.68 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.37 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 HD11 ' HB1' ' A' ' 34' ' ' ALA . 47.0 mt -66.74 -47.09 56.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.811 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.5 -22.52 12.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.13 1.22 . . . . 0.0 112.639 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -76.78 -25.02 52.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.5 mt -97.72 31.6 2.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.8 t -88.94 141.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.195 0.522 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.4 m 60.97 34.87 19.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.73 ' HB2' HD12 ' A' ' 17' ' ' LEU . 88.1 mmm -94.86 151.72 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.441 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -109.46 132.37 54.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.5 160.49 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 59' ' ' MET . 4.6 p30 -80.23 -33.96 37.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -131.63 -177.88 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.528 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 133.46 36.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.64 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 53' ' ' THR . 23.6 t -120.7 112.06 34.12 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.71 -176.13 3.02 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.533 1.489 . . . . 0.0 112.672 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.4 mp -69.28 155.17 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.499 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 33.76 88.1 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 49' ' ' VAL . 25.8 m -112.41 118.77 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.057 0.456 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -61.82 104.74 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.28 115.27 3.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.362 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.643 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.7 mtt -96.67 160.74 28.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.542 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.98 -26.98 3.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.917 1.744 . . . . 0.0 112.727 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.35 -33.14 61.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.433 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.9 mtm -68.21 -38.45 81.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.454 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 40' ' ' LEU . 23.3 t -79.98 108.32 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.359 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -65.14 121.17 14.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.05 -31.39 7.74 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.642 ' CD2' HD21 ' A' ' 40' ' ' LEU . 44.1 t80 -79.46 128.22 33.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.362 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.7 150.57 40.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.463 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.443 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.7 p30 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -81.01 -11.08 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.41 110.71 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.392 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -90.74 -173.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.17 92.3 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.398 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.76 151.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.77 126.07 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -102.67 31.42 4.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.66 168.26 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.2 tp -72.49 102.63 3.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG12 ' HE3' ' A' ' 21' ' ' MET . 47.4 mt -105.76 101.24 31.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.316 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.45 162.1 22.28 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.579 1.52 . . . . 0.0 112.58 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.15 155.6 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.536 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.27 45.16 9.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.47 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 m -147.22 126.77 13.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -65.31 147.11 54.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.394 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 43' ' ' MET . 18.2 mt -81.69 168.96 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.41 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -150.32 -179.84 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.382 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mt -68.79 -37.84 79.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.34 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 21' ' ' MET . 23.4 m -71.19 -26.48 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.484 ' HE3' HG12 ' A' ' 11' ' ' ILE . 29.0 mtp -96.55 27.97 3.59 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.523 ' HE3' HG23 ' A' ' 37' ' ' ILE . 28.9 mtm -150.25 144.31 25.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.05 0.452 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -156.07 166.25 34.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.08 117.71 34.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -148.88 151.27 34.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.61 121.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.12 155.16 6.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.414 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -118.34 144.29 34.8 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.289 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.83 156.3 88.47 Favored 'Cis proline' 0 N--CA 1.481 0.77 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.463 0.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -60.97 112.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.505 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.75 -121.1 4.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 56' ' ' MET . 57.5 mt -75.5 139.61 71.35 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.16 159.11 17.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.689 1.592 . . . . 0.0 112.926 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -18.33 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.03 -13.86 60.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.541 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.9 m-20 -113.72 25.67 11.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.567 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 34' ' ' ALA . 40.8 mt -64.37 -47.46 77.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.703 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -76.72 -13.48 17.93 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.174 1.25 . . . . 0.0 113.011 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.64 -27.69 28.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.904 0.383 . . . . 0.0 110.647 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.609 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -96.37 41.87 1.1 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.166 0.507 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 38' ' ' PRO . 23.2 t -90.1 135.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.395 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.594 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.8 t 60.3 37.5 20.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.611 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.615 ' HB2' HD12 ' A' ' 17' ' ' LEU . 95.8 mmm -91.5 140.24 29.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.268 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.22 143.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -110.47 160.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.386 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -113.43 31.93 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -178.59 172.43 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.6 142.33 37.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 92.06 7.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.4 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.33 -171.84 1.36 Allowed 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 121.743 1.629 . . . . 0.0 112.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.6 mp -63.03 147.75 49.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.68 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.15 61.26 6.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -139.54 118.36 12.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 110.384 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -61.71 104.21 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.481 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.52 110.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.439 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.406 ' C ' HD11 ' A' ' 32' ' ' ILE . 3.2 mtt -97.84 158.68 32.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.067 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.24 -18.51 11.07 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.734 1.623 . . . . 0.0 113.1 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -74.29 -40.26 62.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.954 0.407 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 60' ' ' VAL . 10.2 ptp -68.77 -30.4 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.457 HG23 ' HG3' ' A' ' 59' ' ' MET . 41.1 t -85.47 101.09 9.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.188 0.518 . . . . 0.0 110.11 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -64.47 126.96 29.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.27 -30.19 9.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.609 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 -89.58 114.38 25.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.032 0.444 . . . . 0.0 110.434 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -61.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.414 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.5 m120 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.11 105.27 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.6 -178.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -145.2 -177.15 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.479 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PRO . 20.5 t -98.56 92.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.98 145.7 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.221 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -68.12 120.73 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.448 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -102.32 30.93 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.35 158.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.939 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.7 tp -69.82 97.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.411 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.3 mt -89.74 117.8 68.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.8 153.48 17.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.544 1.496 . . . . 0.0 112.635 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.58 149.98 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.449 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 60.56 37.02 19.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.558 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -136.18 140.6 43.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -70.9 153.0 43.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.443 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 67.0 mt -88.47 172.66 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.28 165.4 33.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.343 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.1 -32.96 73.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.342 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 -30.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.374 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 mtm -98.84 32.32 2.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.422 ' HE3' HG23 ' A' ' 37' ' ' ILE . 26.6 mtm -149.22 144.26 26.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.307 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.07 158.02 32.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.406 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -94.19 104.31 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.508 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -141.04 142.68 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.42 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.56 129.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.422 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -155.52 161.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -119.57 144.18 36.28 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.2 160.47 85.76 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.524 0.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.35 96.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.48 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.19 -126.86 4.66 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.587 HD11 ' C ' ' A' ' 56' ' ' MET . 54.0 mt -73.66 139.19 77.34 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 5' ' ' VAL . 39.7 Cg_endo -81.11 -179.88 5.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.574 1.516 . . . . 0.0 112.471 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.55 17.12 7.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.565 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -90.4 -29.54 17.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.012 0.434 . . . . 0.0 110.599 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -99.09 31.81 2.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.958 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.74 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.9 mt -64.17 -47.55 78.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.607 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.04 -22.12 13.35 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.052 1.168 . . . . 0.0 112.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -77.59 -25.35 49.87 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.655 HD21 ' CG ' ' A' ' 63' ' ' TYR . 4.2 mt -98.06 31.14 2.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 38' ' ' PRO . 29.3 t -86.47 137.06 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.572 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 46.4 t 61.09 43.1 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.483 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 84.8 mmm -100.09 134.64 42.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.433 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.82 123.04 32.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.85 158.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.386 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -82.29 -31.84 29.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -132.36 -177.36 4.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.37 144.49 48.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.75 90.49 16.53 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.373 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 39.9 Cg_endo -80.01 -178.21 4.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.714 1.609 . . . . 0.0 112.642 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.27 144.66 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.68 56.63 8.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -143.95 119.7 10.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 m -63.47 124.13 20.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 tp -81.15 119.59 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.301 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.587 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.3 mtt -96.49 155.56 37.77 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.95 -27.1 3.19 Favored 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 121.788 1.659 . . . . 0.0 112.699 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.27 -32.61 64.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.381 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -73.36 -35.0 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.447 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' MET . 22.1 t -79.81 112.63 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -71.48 120.67 17.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.392 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.65 7.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 40' ' ' LEU . 53.1 t80 -83.01 135.75 34.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.17 87.62 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.411 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.525 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' OE1' HG11 ' A' ' 30' ' ' VAL . 2.0 tt0 -102.49 132.82 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.03 113.37 25.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.402 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -101.33 -173.4 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.71 147.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -142.3 150.65 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.55 114.6 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.327 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.14 -27.21 65.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.62 -178.23 6.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.4 tp -71.11 102.63 2.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.721 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.835 HG23 ' CE ' ' A' ' 21' ' ' MET . 25.4 mt -89.95 127.41 53.92 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.77 150.89 14.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.632 1.555 . . . . 0.0 112.753 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.6 tt -67.61 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.16 35.14 21.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 m -129.8 148.29 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -77.19 136.53 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.46 170.34 15.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -150.27 168.41 24.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.0 -33.28 74.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.7 -28.59 34.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.435 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.835 ' CE ' HG23 ' A' ' 11' ' ' ILE . 26.3 mtp -94.74 24.23 4.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.302 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 mtm -150.14 132.57 15.63 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 121.051 0.453 . . . . 0.0 110.218 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -143.8 172.45 12.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 t -105.53 126.02 51.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.269 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -161.43 146.22 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.65 125.66 38.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.83 168.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.475 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t -124.54 146.09 51.3 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.44 169.24 66.39 Favored 'Cis proline' 0 N--CA 1.482 0.818 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.665 0.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG11 ' OE1' ' A' ' 2' ' ' GLN . 21.0 t -61.73 99.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.414 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.54 -127.14 4.87 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.517 HD11 ' C ' ' A' ' 56' ' ' MET . 55.1 mt -78.14 139.37 60.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.35 163.84 17.06 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.673 1.582 . . . . 0.0 112.894 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.54 -14.71 63.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.368 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -68.83 -10.89 59.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.656 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -118.52 30.61 7.11 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.36 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.575 HD11 ' HB1' ' A' ' 34' ' ' ALA . 43.5 mt -69.04 -47.36 29.85 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.795 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.2 Cg_endo -76.05 -24.37 11.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 120.992 1.128 . . . . 0.0 112.551 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -25.52 61.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.743 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' A' ' 43' ' ' MET . 1.6 mt -96.64 27.85 3.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.2 t -86.91 136.1 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.09 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 42.5 t 61.04 32.69 19.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.733 ' SD ' HD23 ' A' ' 40' ' ' LEU . 15.2 mtp -94.33 134.48 36.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.244 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -86.18 145.31 27.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.545 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.66 -178.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.342 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.07 -22.39 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.2 ptp180 -137.52 -178.47 5.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.83 161.22 30.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.6 t -148.19 93.72 4.37 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.245 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -80.13 -176.01 3.0 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.683 1.589 . . . . 0.0 112.606 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.496 ' H ' HD12 ' A' ' 51' ' ' LEU . 6.2 mp -65.01 154.26 38.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.577 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.3 46.02 95.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.9 m -128.61 109.74 11.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 0.0 110.175 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -60.34 109.38 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.576 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.39 115.69 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.517 ' C ' HD11 ' A' ' 32' ' ' ILE . 5.7 mtt -96.34 158.57 33.66 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.39 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.63 -26.39 3.88 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 121.826 1.684 . . . . 0.0 112.755 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.49 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 mtm -70.4 -38.56 74.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.492 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HE1' ' A' ' 43' ' ' MET . 23.2 t -80.31 110.32 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -70.15 123.43 21.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.372 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.01 -31.35 7.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -76.08 145.23 40.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.137 0.494 . . . . 0.0 110.292 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -170.93 110.62 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.481 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.385 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 60.74 82.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.5 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.51 169.78 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.453 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 m -134.02 -172.19 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.45 89.4 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.364 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.82 151.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.0 128.45 35.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.476 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -103.28 30.16 5.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.559 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.25 161.21 1.42 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' N ' HD11 ' A' ' 51' ' ' LEU . 35.5 tp -71.75 94.83 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.61 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.4 mt -89.92 111.98 49.53 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.137 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.26 157.17 19.8 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.457 1.438 . . . . 0.0 112.575 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.08 154.83 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 61.25 33.23 19.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.484 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -130.51 153.17 49.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -86.87 148.16 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 ' CD2' HG21 ' A' ' 11' ' ' ILE . 14.7 mt -89.91 170.27 10.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -148.18 173.26 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.456 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.21 -32.4 73.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.48 -29.94 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.705 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.0 mtm -100.29 32.16 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.105 0.479 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.5 mtm -150.05 114.17 5.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.75 -178.04 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -109.63 113.36 26.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -137.82 142.31 40.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.46 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.98 82.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -114.53 146.12 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.41 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 t -111.25 141.97 25.44 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.306 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.86 132.05 23.7 Favored 'Cis proline' 0 N--CA 1.482 0.828 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.441 0.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.26 111.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.09 -94.19 1.09 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.475 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -90.01 139.73 27.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 167.05 16.29 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.677 1.585 . . . . 0.0 112.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.38 -26.4 66.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.837 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.16 -18.1 56.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' HD12 ' A' ' 40' ' ' LEU . 4.1 m-20 -110.4 35.73 3.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.407 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.8 mt -79.77 -46.84 1.49 Allowed Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.616 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 Cg_endo -77.13 -11.15 17.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.127 1.218 . . . . 0.0 113.084 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -85.68 -27.44 25.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.521 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' HG3' ' A' ' 43' ' ' MET . 3.7 mt -94.16 46.64 1.17 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' PRO . 32.8 t -90.16 133.89 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.309 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.513 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.2 m 60.79 38.33 18.14 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.652 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.651 ' HG3' HD23 ' A' ' 40' ' ' LEU . 76.2 mmm -95.31 137.55 34.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.12 144.55 25.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.12 163.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.4 -33.6 20.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -126.95 -177.74 4.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.486 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.59 122.1 24.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.88 90.67 28.21 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.46 -172.86 1.64 Allowed 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 121.741 1.627 . . . . 0.0 112.662 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -66.0 152.83 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.71 39.02 90.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -130.79 118.06 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.7 m -61.9 108.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD23 HD12 ' A' ' 32' ' ' ILE . 12.8 tp -61.73 114.95 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.604 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.3 mtt -93.22 150.03 38.43 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.345 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.19 -26.58 3.34 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.819 1.679 . . . . 0.0 112.635 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.46 -32.89 64.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mtm -74.27 -32.09 62.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 56' ' ' MET . 29.0 t -79.8 102.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.259 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -68.86 124.61 24.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.74 7.28 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.8 t80 -62.89 -67.28 0.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.341 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.07 49.05 12.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.839 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.639 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -79.37 109.31 13.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.406 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.86 125.7 29.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.432 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -92.02 -171.51 2.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.391 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.72 90.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 7' ' ' ALA . 25.4 t -90.56 154.79 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -80.38 131.61 35.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.384 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -107.99 31.91 5.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.65 158.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.08 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -70.28 97.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG21 ' CD2' ' A' ' 17' ' ' LEU . 14.9 mt -89.75 112.14 50.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.079 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.35 157.49 19.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.507 1.471 . . . . 0.0 112.683 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.05 153.79 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.394 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 60.65 32.52 20.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -133.04 137.08 46.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.442 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -74.34 156.14 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' CD2' HG21 ' A' ' 11' ' ' ILE . 21.5 mt -90.07 169.9 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.0 p -150.1 174.62 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.41 -36.14 81.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.02 -30.1 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.443 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 mtp -96.78 26.79 4.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.1 mtm -150.36 141.68 23.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.343 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.69 -178.11 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -115.56 129.45 56.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -158.63 139.45 12.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.361 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.76 121.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -152.83 161.34 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.444 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.18 145.61 35.36 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.42 175.69 41.15 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 C-N-CA 124.12 -1.2 . . . . 0.0 112.563 0.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -65.55 117.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.57 -134.28 5.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.507 HD11 ' C ' ' A' ' 56' ' ' MET . 57.7 mt -72.92 139.33 79.9 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.65 164.18 16.26 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.663 1.575 . . . . 0.0 112.868 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.46 -25.04 66.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.946 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -58.98 -19.75 46.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.478 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HD13 ' A' ' 40' ' ' LEU . 65.6 m-20 -107.65 38.72 2.08 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.192 0.52 . . . . 0.0 111.483 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.3 mt -84.06 -46.94 0.74 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.576 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.4 Cg_endo -78.35 -19.08 12.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.229 1.286 . . . . 0.0 112.853 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -83.73 -20.66 33.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.957 HD11 ' CE1' ' A' ' 63' ' ' TYR . 9.0 mp -97.31 32.01 2.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.008 0.433 . . . . 0.0 110.935 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.7 t -79.5 140.08 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.037 0.446 . . . . 0.0 110.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.3 p 56.68 41.43 28.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.435 ' HB2' HD12 ' A' ' 17' ' ' LEU . 92.3 mmm -97.43 133.12 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -92.43 144.02 25.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.626 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -110.91 157.89 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.165 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.94 -30.19 39.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -128.04 -177.42 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.534 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.75 35.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.528 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.92 98.06 49.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.94 177.77 7.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.628 1.552 . . . . 0.0 112.714 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -64.32 150.11 46.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.2 32.22 75.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -116.81 117.94 31.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -61.87 104.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.464 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.85 115.53 4.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.507 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.3 mtt -100.35 160.26 27.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.65 -26.85 3.58 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 121.81 1.673 . . . . 0.0 112.615 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.83 -39.13 83.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 41.1 mtm -69.98 -32.18 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' MET . 42.8 t -82.77 95.36 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -66.02 127.37 31.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.7 -31.09 8.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.957 ' CE1' HD11 ' A' ' 40' ' ' LEU . 33.1 t80 -68.53 -70.29 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.266 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.54 85.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.925 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.688 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.472 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -143.08 149.89 38.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.407 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.49 160.55 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.438 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -149.87 -177.02 5.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.89 146.89 7.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 7' ' ' ALA . 26.1 t -142.89 156.08 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.121 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -85.1 119.73 25.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -99.9 31.07 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.534 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -179.42 164.45 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.02 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.658 ' N ' HD11 ' A' ' 51' ' ' LEU . 23.2 tp -71.72 101.09 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.479 HG23 ' CE ' ' A' ' 21' ' ' MET . 31.2 mt -96.5 108.93 45.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.73 -178.6 4.29 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.56 1.507 . . . . 0.0 112.589 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.04 154.66 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 60.62 33.98 20.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.526 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -130.42 131.47 45.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.2 157.1 36.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' A' ' 43' ' ' MET . 86.5 mt -90.18 165.55 13.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.3 p -150.08 171.14 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.336 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.26 -34.03 75.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -30.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.453 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' HG23 ' A' ' 11' ' ' ILE . 25.4 mtp -94.52 21.21 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.42 140.14 21.72 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.983 0.42 . . . . 0.0 110.425 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.13 176.37 11.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -103.05 142.81 33.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.372 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -170.88 140.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.467 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.67 96.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.19 172.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -131.46 145.72 58.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.5 167.33 71.16 Favored 'Cis proline' 0 N--CA 1.481 0.782 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.522 0.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.17 92.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.47 -126.61 2.31 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 56' ' ' MET . 44.0 mt -73.88 139.66 76.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.18 163.69 15.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.661 1.574 . . . . 0.0 112.653 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.66 67.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.62 -22.42 45.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 m-20 -109.9 37.98 2.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.149 0.499 . . . . 0.0 111.443 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 58.8 mt -81.31 -46.98 1.11 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.607 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.35 -22.35 11.02 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 121.164 1.243 . . . . 0.0 112.592 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -79.18 -22.56 44.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 36' ' ' ASP . 5.7 mp -96.83 28.78 3.31 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.1 t -84.29 145.21 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.566 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.8 m 60.92 32.87 20.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.651 ' HB2' HD12 ' A' ' 17' ' ' LEU . 72.3 mmm -94.83 134.71 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.423 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.27 141.52 28.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.458 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 m -102.12 170.68 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.47 -31.4 15.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.614 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.74 167.91 21.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.0 120.36 13.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 53' ' ' THR . 22.9 t -105.89 114.29 62.89 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.123 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.2 -176.71 3.26 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 121.534 1.489 . . . . 0.0 112.604 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 10' ' ' LEU . 6.4 mp -70.58 157.16 38.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.416 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.41 31.93 82.41 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 49' ' ' VAL . 13.3 m -113.33 118.71 35.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.065 0.459 . . . . 0.0 110.385 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.9 m -61.81 105.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.27 115.5 3.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.484 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 60' ' ' VAL . 35.4 mtt -101.46 155.65 36.11 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.1 -27.61 2.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.887 1.725 . . . . 0.0 112.629 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -64.84 -37.11 86.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.4 mtm -75.66 -34.8 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.404 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 56' ' ' MET . 26.5 t -79.94 111.2 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.289 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -82.82 129.75 35.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.85 -32.2 6.73 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.732 ' CZ ' ' HB2' ' A' ' 65' ' ' ALA . 1.7 t80 -63.49 115.57 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.14 0.495 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -52.7 8.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.579 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.732 ' HB2' ' CZ ' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.477 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.45 160.98 41.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.4 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.63 125.56 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.512 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -108.0 175.91 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.24 143.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.228 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.78 147.91 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.94 106.25 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.63 -28.69 67.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.8 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.505 ' HA ' HD21 ' A' ' 51' ' ' LEU . 4.2 pt20 -149.79 -177.97 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.114 0.483 . . . . 0.0 110.364 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.3 tp -70.81 103.56 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.627 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.2 mt -89.32 132.49 37.29 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.912 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.9 152.73 14.65 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.656 1.571 . . . . 0.0 112.744 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.2 tt -70.69 150.18 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 60.39 32.75 20.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.538 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -130.34 141.39 50.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.88 140.62 55.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HG21 ' A' ' 11' ' ' ILE . 74.0 mt -78.22 169.81 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -150.15 167.51 26.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.397 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.3 -32.47 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.316 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -65.24 -30.6 50.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.634 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.432 ' CE ' HG23 ' A' ' 11' ' ' ILE . 14.3 mtm -103.65 27.86 7.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 mtp -145.89 132.21 19.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.369 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.12 -179.57 7.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.1 136.61 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -169.13 143.9 3.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.62 110.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.327 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.77 167.45 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.49 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.94 143.56 49.19 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.327 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.15 163.44 82.31 Favored 'Cis proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.55 0.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.6 p -61.72 120.89 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.87 -130.64 4.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.46 HD11 ' C ' ' A' ' 56' ' ' MET . 67.5 mt -67.5 139.78 94.45 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.71 160.65 19.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.64 1.56 . . . . 0.0 112.921 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -18.47 64.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -66.37 -13.45 60.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.6 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 40' ' ' LEU . 61.9 m-20 -113.58 23.31 13.26 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.532 HD11 ' HB1' ' A' ' 34' ' ' ALA . 38.4 mt -62.25 -47.42 89.89 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.703 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.62 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.5 -19.09 15.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 121.14 1.227 . . . . 0.0 112.848 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -77.97 -27.72 49.24 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -98.11 35.03 1.81 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' PRO . 30.1 t -88.01 139.73 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.272 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 1.6 t 60.9 32.62 20.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.542 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 mtp -95.6 135.76 36.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.33 145.29 24.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.502 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.54 174.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -92.46 -30.98 15.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HA ' HD12 ' A' ' 13' ' ' ILE . 7.3 ptp180 -134.05 -177.54 4.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.339 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.41 149.34 46.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.207 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.8 90.51 36.03 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.51 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 10' ' ' LEU . 38.8 Cg_endo -78.63 176.4 9.93 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 121.829 1.686 . . . . 0.0 112.611 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -62.59 137.75 58.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.749 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.59 -31.99 7.5 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 108.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.138 0.494 . . . . 0.0 110.519 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -63.01 118.61 8.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.43 113.47 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -99.73 158.42 32.15 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.34 -25.9 4.45 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 121.824 1.683 . . . . 0.0 112.714 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.06 -32.5 61.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.3 mtm -73.98 -36.02 64.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.56 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 56' ' ' MET . 25.6 t -79.84 104.54 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.281 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.37 127.42 32.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.441 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.16 -30.78 8.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CE1' HD11 ' A' ' 40' ' ' LEU . 41.5 t80 -64.88 -66.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.05 0.452 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.9 79.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.636 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.605 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 60.55 101.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.27 176.48 9.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.04 -171.74 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.352 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -119.33 87.03 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.376 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.7 153.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.376 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.28 122.22 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.56 30.76 3.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.87 167.73 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.1 tp -72.62 102.62 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 27.1 mt -95.99 109.1 44.93 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.21 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.83 166.7 17.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.595 1.53 . . . . 0.0 112.643 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -73.29 154.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.37 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.38 32.28 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 m -132.38 146.59 52.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.405 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -82.07 148.75 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 11' ' ' ILE . 68.6 mt -80.5 169.83 17.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -150.19 170.31 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.11 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.87 -28.22 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.449 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mtp -97.15 29.13 3.26 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.29 150.13 31.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.212 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -160.13 167.23 28.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -107.51 103.13 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -142.05 146.77 35.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.91 125.64 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.316 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -153.31 156.75 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 t -109.72 145.05 31.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.357 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.09 161.61 85.0 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.49 0.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.99 113.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.37 -126.05 5.0 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 56' ' ' MET . 56.9 mt -73.96 139.18 76.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.88 172.3 12.21 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.631 1.554 . . . . 0.0 112.688 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.38 -1.9 32.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.783 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.22 6.12 23.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.642 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 40' ' ' LEU . 42.3 m-20 -127.26 31.96 5.14 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.105 0.479 . . . . 0.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 33.5 mt -73.37 -46.39 7.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.206 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.1 Cg_endo -75.88 -24.29 11.62 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 121.065 1.177 . . . . 0.0 112.464 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.28 -18.79 48.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.992 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.778 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.4 mp -97.02 29.15 3.21 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -86.04 131.23 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.061 0.458 . . . . 0.0 110.304 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.708 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 22.9 t 61.43 36.06 17.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.673 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.599 ' HE1' HG12 ' A' ' 60' ' ' VAL . 13.0 mtp -91.96 125.77 36.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -79.86 134.66 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.536 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.01 -177.51 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -110.28 -32.26 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.661 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 -177.06 4.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.43 129.01 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.453 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.19 100.77 42.07 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.152 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.87 -178.04 4.26 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.577 1.518 . . . . 0.0 112.682 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.7 mp -66.35 148.04 52.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.6 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.74 52.58 24.21 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -135.19 118.18 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 m -61.52 100.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.552 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.31 113.67 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.6 ' O ' HD11 ' A' ' 32' ' ' ILE . 19.1 mtt -96.14 165.21 16.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.76 -26.29 4.73 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.74 1.626 . . . . 0.0 112.616 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.79 -23.09 55.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.986 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -97.44 28.53 3.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.918 0.39 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HE1' ' A' ' 43' ' ' MET . 34.5 t -141.33 101.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.094 0.473 . . . . 0.0 110.133 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -64.08 124.46 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.453 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.58 7.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.778 ' CE1' HD11 ' A' ' 40' ' ' LEU . 27.5 t80 -72.68 140.44 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.113 0.482 . . . . 0.0 110.433 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -162.0 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.43 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.445 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -75.58 158.17 32.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.54 106.11 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.406 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -98.46 175.69 5.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.37 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.84 147.98 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.25 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.7 t -145.61 149.9 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 102.3 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.299 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.28 -26.33 66.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.583 ' OE1' HG12 ' A' ' 20' ' ' VAL . 17.3 pt20 -149.58 -178.0 6.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' PRO . 31.5 tp -70.4 101.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.601 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.819 HG23 ' CE ' ' A' ' 21' ' ' MET . 38.2 mt -96.06 123.8 54.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.01 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.2 159.93 15.31 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.623 1.549 . . . . 0.0 112.796 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 46' ' ' ASN . 13.8 tt -71.03 151.67 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.06 37.46 21.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.646 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -132.8 134.75 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.472 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -62.02 151.06 36.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 43' ' ' MET . 82.7 mt -90.17 166.63 13.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.1 p -150.13 170.13 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.3 mp -62.08 -32.97 73.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' OE1' ' A' ' 9' ' ' GLN . 21.6 t -70.03 -30.35 43.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 11' ' ' ILE . 29.0 mtp -97.44 28.66 3.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HE3' HG23 ' A' ' 37' ' ' ILE . 29.6 mtm -150.27 125.78 10.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -142.89 161.97 36.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -96.63 143.42 27.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.432 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -177.96 143.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 122.52 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 m -154.45 157.16 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.65 144.91 34.18 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.363 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.41 150.83 81.39 Favored 'Cis proline' 0 N--CA 1.481 0.754 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.462 0.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.7 m -59.45 104.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.44 -121.28 3.69 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -75.62 139.55 70.83 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -82.19 161.24 17.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.612 1.541 . . . . 0.0 112.92 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.63 -16.98 64.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -13.18 61.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.489 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 40' ' ' LEU . 51.0 m-20 -113.75 25.09 11.51 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.609 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 34' ' ' ALA . 39.6 mt -63.45 -47.58 83.29 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.642 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.1 Cg_endo -76.6 -16.31 16.86 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.105 1.203 . . . . 0.0 113.008 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -80.77 -27.27 36.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.773 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.601 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -97.41 38.78 1.24 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.147 0.498 . . . . 0.0 110.721 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.68 141.76 13.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.231 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.502 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.2 m 60.84 32.65 20.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.499 ' HB2' HD12 ' A' ' 17' ' ' LEU . 94.7 mmm -92.25 143.45 26.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -101.2 138.77 37.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.477 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.74 144.77 14.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.346 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.2 p-10 -79.96 -28.24 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.716 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -122.72 168.17 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.103 0.477 . . . . 0.0 110.461 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.97 51.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.03 91.77 23.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.38 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.6 Cg_endo -80.64 -175.13 2.53 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.68 1.587 . . . . 0.0 112.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -61.65 149.39 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.47 61.6 6.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -140.62 111.93 7.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 104.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.54 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.5 109.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.498 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.556 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mtt -93.92 165.02 18.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.72 -20.23 8.01 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 121.828 1.685 . . . . 0.0 113.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.81 -42.77 49.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.992 0.425 . . . . 0.0 110.722 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.418 ' HG3' HG23 ' A' ' 60' ' ' VAL . 3.9 ptp -64.87 -28.16 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.992 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HG3' ' A' ' 59' ' ' MET . 43.5 t -88.63 97.42 6.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.094 0.473 . . . . 0.0 110.247 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -66.05 127.66 33.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.364 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.06 -31.09 8.48 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.601 ' CE1' HD11 ' A' ' 40' ' ' LEU . 43.3 t80 -66.88 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.36 51.79 5.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.568 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.587 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -87.98 -32.4 18.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.451 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.94 108.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.437 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -101.57 -173.06 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -100.27 93.42 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 25' ' ' GLU . 38.7 t -90.1 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.267 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.05 132.5 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.304 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.37 29.49 7.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -177.61 165.55 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.114 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.84 96.13 4.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.2 mt -90.43 112.47 53.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.085 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.91 156.81 20.66 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.562 1.508 . . . . 0.0 112.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.71 154.58 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 m120 60.46 32.83 20.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 156.72 43.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 151.98 21.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.695 ' CD2' HG21 ' A' ' 11' ' ' ILE . 65.5 mt -90.1 168.57 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.457 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -150.12 164.65 35.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.67 -32.06 72.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.448 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -66.29 -31.56 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.288 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.7 mtm -99.43 31.77 3.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.5 mtm -150.12 137.22 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -160.03 162.24 34.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 m -84.71 129.94 34.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.423 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.8 tt0 -162.44 128.94 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.462 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.71 115.18 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.89 162.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -119.55 141.52 31.07 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.263 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 54' ' ' THR . 39.3 Cg_endo -79.99 156.35 87.86 Favored 'Cis proline' 0 N--CA 1.482 0.821 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.523 0.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.4 p -61.11 112.28 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.38 -125.66 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 40' ' ' LEU . 53.8 mt -74.39 139.86 75.44 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.19 165.99 16.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.622 1.548 . . . . 0.0 112.817 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -12.21 60.01 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.613 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.99 -9.75 56.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.774 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.2 m-20 -118.18 27.63 8.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.403 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD11 ' HB1' ' A' ' 34' ' ' ALA . 36.7 mt -65.81 -47.63 64.76 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.555 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.6 Cg_endo -77.96 -18.15 13.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.161 1.241 . . . . 0.0 112.532 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -79.24 -26.27 42.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.67 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -97.44 37.63 1.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.098 0.475 . . . . 0.0 110.893 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 31.7 t -89.05 135.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.162 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m 61.28 37.64 17.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 97.2 mmm -90.37 147.67 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.31 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.67 125.18 47.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.517 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -91.84 -177.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.376 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -108.74 -43.04 4.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.612 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -118.02 -177.49 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.55 121.87 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.507 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 53' ' ' THR . 22.4 t -111.91 91.97 16.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.12 -173.2 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.666 1.577 . . . . 0.0 112.778 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -67.12 137.71 56.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.529 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 31.95 37.25 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.441 HG21 HG13 ' A' ' 49' ' ' VAL . 24.9 m -111.65 112.51 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.052 0.454 . . . . 0.0 110.311 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.5 m -62.04 105.39 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.81 141.58 57.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.267 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 24.4 mmm -127.12 157.03 73.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.74 -20.79 7.57 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 121.803 1.669 . . . . 0.0 113.129 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -79.27 -44.41 21.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 ptm -68.08 -31.38 70.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 27.4 t -79.86 111.28 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -71.75 121.39 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.377 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.66 7.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.67 ' CD2' HD21 ' A' ' 40' ' ' LEU . 48.5 t80 -85.09 110.69 19.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.01 0.433 . . . . 0.0 110.417 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.96 -69.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.384 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.396 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.29 31.28 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.41 125.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.566 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.23 -177.42 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.91 149.63 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.6 t -145.96 153.68 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.136 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 11' ' ' ILE . . . -79.79 121.38 25.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.368 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -99.84 30.54 3.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.99 161.62 0.95 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.988 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -69.79 97.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.433 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 17' ' ' LEU . 10.7 mt -89.7 111.93 48.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.043 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.29 153.49 16.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.603 1.535 . . . . 0.0 112.598 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 tt -61.47 154.15 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.359 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 60.87 33.07 20.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -132.38 146.29 51.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.422 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 155.32 29.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.499 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 11' ' ' ILE . 88.1 mt -90.19 167.44 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.45 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.06 -33.26 74.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' MET . 17.7 m -69.7 -27.88 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.771 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG3' HG23 ' A' ' 20' ' ' VAL . 75.9 mtm -99.02 30.77 3.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.416 ' HE3' ' O ' ' A' ' 37' ' ' ILE . 31.0 mtm -150.15 143.84 25.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -160.21 164.4 32.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -97.46 133.32 42.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -169.14 146.24 3.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.87 130.8 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -155.45 175.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -133.52 144.91 54.18 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.11 169.35 69.92 Favored 'Cis proline' 0 N--CA 1.482 0.843 0 C-N-CA 124.086 -1.214 . . . . 0.0 112.587 -0.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 30' ' ' VAL . 10.9 p -61.58 110.94 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -111.01 -133.63 6.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.469 HD11 ' C ' ' A' ' 56' ' ' MET . 68.8 mt -65.75 139.74 97.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.98 168.28 17.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.576 1.517 . . . . 0.0 112.674 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.36 -2.77 36.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.694 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -90.82 19.82 5.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.624 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -140.39 30.1 1.96 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.608 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 25.4 mt -69.09 -46.97 30.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.111 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.38 -21.3 13.47 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 121.129 1.219 . . . . 0.0 112.657 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -77.05 -26.74 53.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.632 HD21 ' CD1' ' A' ' 63' ' ' TYR . 5.3 mt -97.87 34.44 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.0 t -90.02 141.62 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m 60.8 34.75 19.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.8 mmm -97.03 129.56 44.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.32 136.42 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.407 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.95 163.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.402 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -112.76 32.23 5.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.414 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -178.84 161.13 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.429 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.36 126.6 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.91 94.97 47.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.17 179.85 5.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.07 142.04 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.549 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.25 56.4 6.3 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 m -134.7 118.03 16.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.36 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -62.07 100.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.88 110.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.469 ' C ' HD11 ' A' ' 32' ' ' ILE . 24.0 mtt -95.37 163.08 22.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.455 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.71 -26.85 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.869 1.713 . . . . 0.0 112.685 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.16 -33.15 67.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.431 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.33 -36.6 68.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.432 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 56' ' ' MET . 24.9 t -79.89 110.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -71.88 122.64 21.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.444 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.49 -31.61 7.46 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 63.7 t80 -78.95 157.08 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -160.13 124.37 3.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.448 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.4 pt20 -61.11 166.99 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.514 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.79 160.63 20.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.424 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -126.31 -177.48 3.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.37 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.16 87.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.354 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -89.52 147.8 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.309 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -72.84 129.97 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.452 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -107.9 31.08 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.74 158.09 0.77 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.05 98.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.56 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.1 mt -89.48 112.91 54.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.942 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.8 151.95 19.2 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.386 1.39 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.51 155.06 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.01 32.89 19.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.472 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -134.19 151.52 51.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.99 151.35 24.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' CD2' HG21 ' A' ' 11' ' ' ILE . 23.6 mt -84.89 170.81 12.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.393 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -150.33 166.71 29.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.38 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.03 -32.39 72.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.356 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.43 -30.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.458 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.4 mtm -99.1 31.29 3.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.629 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' HE2' ' A' ' 22' ' ' MET . 26.5 mtm -150.03 151.43 33.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.05 -177.2 6.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -120.77 100.63 7.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.91 144.33 37.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 2' ' ' GLN . 21.7 t -74.84 129.03 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.05 154.02 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -114.18 139.53 23.86 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.6 Cg_endo -80.36 142.14 59.53 Favored 'Cis proline' 0 N--CA 1.483 0.855 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.475 0.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 30' ' ' VAL . 14.0 m -60.64 91.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.874 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.67 -111.94 0.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 56' ' ' MET . 58.4 mt -78.67 139.05 58.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -79.69 173.04 13.45 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.544 1.496 . . . . 0.0 112.525 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.07 14.18 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.559 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 14.89 12.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.405 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -145.57 29.79 1.12 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.4 mt -60.94 -47.33 95.85 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -75.76 -16.95 18.3 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.142 1.228 . . . . 0.0 112.914 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -82.56 -25.66 33.12 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 63' ' ' TYR . 3.3 mp -97.76 34.37 1.89 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.026 0.441 . . . . 0.0 110.731 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -83.59 134.22 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.309 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.523 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.7 t 60.86 35.8 19.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' LEU . 74.8 mmm -84.51 129.25 34.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.459 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -81.44 129.82 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.428 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.23 172.86 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.404 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -106.55 -33.82 7.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.391 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.36 -177.63 3.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.32 141.44 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.504 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.27 91.08 23.69 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.3 Cg_endo -80.44 -171.54 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.678 1.585 . . . . 0.0 112.671 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -67.0 143.32 56.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.438 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.83 49.75 27.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -132.85 114.42 14.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.321 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.6 m -61.86 104.57 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.73 111.22 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.591 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mmt -97.2 163.84 19.05 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.79 -24.62 4.82 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 121.628 1.552 . . . . 0.0 112.941 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.77 -25.73 59.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.0 mtm -98.23 30.21 3.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 56' ' ' MET . 48.2 t -140.2 106.31 2.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.017 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.79 121.62 14.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -31.37 8.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.472 ' CE1' HD11 ' A' ' 40' ' ' LEU . 37.0 t80 -90.22 139.27 30.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 91.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.562 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.47 118.15 27.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.44 167.15 4.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.357 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m -131.17 -174.0 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.08 89.54 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.481 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.12 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.233 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -77.86 137.0 38.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.373 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -112.4 29.52 7.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.633 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.3 157.06 1.29 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.975 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 10' ' ' LEU . 32.8 tp -70.59 97.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.583 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -89.56 125.4 61.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.1 151.16 13.93 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.653 1.568 . . . . 0.0 112.518 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.13 152.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 59.79 36.66 22.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 16' ' ' ALA . 25.7 m -133.31 159.56 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.439 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -89.15 150.47 22.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.464 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.583 ' CD2' HG21 ' A' ' 11' ' ' ILE . 16.6 mt -90.2 175.1 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 p -144.6 -170.94 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.096 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.32 -38.7 26.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.775 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.52 -25.87 37.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.8 mtm -99.19 31.07 3.19 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 37' ' ' ILE . 13.8 mtm -150.18 125.81 10.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -143.76 -178.95 6.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.399 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -114.76 126.58 55.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.406 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.5 136.41 10.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.33 112.36 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.06 149.06 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -108.51 145.16 30.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.38 164.26 80.05 Favored 'Cis proline' 0 N--CA 1.481 0.759 0 C-N-CA 124.106 -1.206 . . . . 0.0 112.532 0.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.7 p -61.56 118.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.33 -130.85 5.3 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.431 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -72.84 139.37 80.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.85 161.9 18.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.632 1.555 . . . . 0.0 112.843 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.48 -23.96 66.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -59.84 -18.89 47.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.541 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 40' ' ' LEU . 7.3 m-20 -109.91 40.09 1.99 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 111.438 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 55.0 mt -85.69 -46.63 0.6 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -78.07 -15.01 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.179 1.253 . . . . 0.0 113.078 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -86.17 -26.61 25.05 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.641 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 63' ' ' TYR . 11.1 mp -93.45 47.87 1.27 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.265 0.555 . . . . 0.0 110.588 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 38' ' ' PRO . 28.6 t -90.15 134.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.251 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.717 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 51.4 m 61.24 32.88 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.45 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.8 mmm -86.02 140.36 30.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.316 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -96.88 144.39 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.522 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 49' ' ' VAL . 25.7 m -110.41 175.55 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -90.52 -38.28 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -177.33 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.27 132.38 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.512 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 45' ' ' VAL . 22.1 t -116.67 91.99 36.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.0 Cg_endo -80.75 -171.23 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.748 1.632 . . . . 0.0 112.613 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.1 mp -71.06 148.65 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.28 32.23 72.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.5 m -116.7 114.92 24.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 110.271 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 m -61.97 100.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.405 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.29 113.43 2.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.442 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 60' ' ' VAL . 7.3 mtt -98.81 159.5 30.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.98 -27.71 2.36 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 121.918 1.745 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.09 -33.44 75.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.43 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.0 mtm -77.55 -33.51 54.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.382 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 56' ' ' MET . 29.5 t -79.85 102.71 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.46 125.82 27.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.71 -31.54 7.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.789 ' CE1' HD11 ' A' ' 40' ' ' LEU . 35.9 t80 -82.54 149.97 27.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.285 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.89 132.36 13.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.347 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -116.95 155.24 29.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.366 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.2 135.12 46.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.24 -172.41 2.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.9 151.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.278 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.14 150.17 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.28 120.88 25.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.368 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -99.7 31.54 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.59 166.16 1.74 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.058 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' HD11 ' A' ' 51' ' ' LEU . 21.0 tp -72.26 102.74 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.262 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.494 HG12 ' HE3' ' A' ' 21' ' ' MET . 46.6 mt -103.58 103.37 35.71 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.79 163.79 20.78 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.563 1.509 . . . . 0.0 112.553 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -61.2 153.82 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.414 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 60.35 37.1 20.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.536 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 m -129.29 132.66 47.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 142.6 50.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 43' ' ' MET . 35.9 mt -82.74 163.71 21.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -150.22 175.79 11.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.304 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.61 -34.14 77.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.336 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.95 -29.69 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.553 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.494 ' HE3' HG12 ' A' ' 11' ' ' ILE . 28.7 mtp -95.16 22.73 6.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.213 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mtm -150.5 143.04 24.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.112 0.482 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -160.04 177.53 10.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 m -111.41 137.19 49.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -171.72 139.06 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.83 123.54 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.301 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.56 173.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -128.33 145.34 55.35 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.365 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.74 -179.97 25.9 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.494 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.87 102.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.91 -131.47 7.37 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.564 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -73.23 139.56 79.08 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -82.79 169.49 13.34 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.606 1.537 . . . . 0.0 112.902 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.18 -24.89 65.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.47 -19.28 46.54 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.38 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 40' ' ' LEU . 39.5 m-20 -106.71 35.75 2.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.087 0.47 . . . . 0.0 111.45 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 34' ' ' ALA . 46.9 mt -81.06 -46.7 1.15 Allowed Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.562 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -77.43 -24.44 9.15 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.175 1.25 . . . . 0.0 112.529 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -78.41 -20.38 51.24 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.885 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.758 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.7 mp -97.19 30.31 2.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.972 0.415 . . . . 0.0 110.793 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.5 t -88.39 135.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.135 0.493 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.79 33.7 17.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.438 ' HE1' ' HB2' ' A' ' 63' ' ' TYR . 17.2 mtp -97.88 119.63 36.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.279 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -79.91 138.71 37.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.459 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.38 -179.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -110.13 -25.21 10.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -128.65 171.59 12.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.11 0.481 . . . . 0.0 110.544 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.45 144.36 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.9 92.49 12.67 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -78.91 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 121.632 1.555 . . . . 0.0 112.686 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.6 mp -61.04 153.55 25.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.675 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.76 53.1 46.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -135.32 117.63 15.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.096 0.474 . . . . 0.0 110.354 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -63.01 104.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.475 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.538 HD23 HD23 ' A' ' 40' ' ' LEU . 7.9 tp -60.83 114.41 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.451 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.564 ' C ' HD11 ' A' ' 32' ' ' ILE . 30.4 mtt -99.92 163.8 17.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.9 -24.79 5.64 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 121.738 1.625 . . . . 0.0 112.757 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.44 -32.31 64.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.453 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.9 mtm -71.67 -38.59 70.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.436 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.8 t -80.23 107.2 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.02 124.81 23.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.64 -29.8 10.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 -87.27 128.08 35.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -161.21 100.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.403 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.46 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 86.25 -50.47 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.163 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . 62.23 113.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.186 0.517 . . . . 0.0 110.425 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -93.6 -171.13 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.47 149.07 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.1 t -146.59 150.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.7 122.14 20.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.244 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.77 -17.79 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -149.27 174.5 12.34 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 0.0 110.576 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 100.64 1.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.733 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.68 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.7 mt -89.98 116.94 67.58 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.937 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.68 147.88 15.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.436 1.424 . . . . 0.0 112.635 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.4 tt -61.1 155.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 61.01 33.25 19.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -133.84 152.62 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.61 138.07 32.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' CD2' HG21 ' A' ' 11' ' ' ILE . 18.7 mt -74.6 172.82 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.419 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -150.19 164.22 36.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.339 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.3 mp -62.5 -31.57 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.484 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.44 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.7 mtm -99.56 35.85 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 0.0 110.544 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.6 mtm -149.99 149.34 30.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.594 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -157.17 166.78 32.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.348 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.6 t -102.5 92.33 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.508 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -126.81 140.02 52.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.6 t -80.19 131.18 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -152.84 -177.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -136.75 139.31 28.67 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.292 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -77.92 148.85 86.46 Favored 'Cis proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.119 -1.2 . . . . 0.0 112.436 0.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.92 91.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.621 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.41 -124.93 0.71 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 56' ' ' MET . 64.7 mt -70.78 139.0 85.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.53 179.45 6.34 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.513 1.475 . . . . 0.0 112.617 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -89.92 13.45 14.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.56 -25.35 20.25 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.994 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 40' ' ' LEU . 11.8 m-20 -98.24 31.02 2.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 34' ' ' ALA . 75.3 mt -66.99 -47.4 52.93 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.51 -24.01 10.89 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 121.036 1.157 . . . . 0.0 112.572 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -26.78 53.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.698 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.759 HD21 ' CD2' ' A' ' 63' ' ' TYR . 6.3 mt -98.21 33.6 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.3 t -88.89 136.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.724 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 64.6 m 60.93 36.08 18.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 mmm -92.45 133.08 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -82.61 131.76 35.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.3 152.47 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.326 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -79.81 -21.86 43.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -145.05 -179.94 6.95 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.55 154.57 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.88 93.86 4.44 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.383 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.49 -176.79 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.683 1.588 . . . . 0.0 112.484 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.69 152.67 30.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.26 57.89 13.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -138.91 113.51 9.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.215 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -61.05 107.53 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.598 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.91 109.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.574 ' C ' HD11 ' A' ' 32' ' ' ILE . 17.0 mtt -97.99 160.8 27.53 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.289 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.45 -23.88 5.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.834 1.689 . . . . 0.0 112.978 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -71.19 -43.28 67.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.0 ptp -67.08 -29.07 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.04 104.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.161 0.505 . . . . 0.0 110.167 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -66.66 121.91 16.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.27 -31.53 7.57 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.759 ' CD2' HD21 ' A' ' 40' ' ' LEU . 50.1 t80 -90.17 89.31 7.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.19 113.66 27.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.458 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.415 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 60.69 98.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.39 156.12 39.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.495 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.61 -171.96 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.425 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.39 85.73 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.92 152.28 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.323 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.88 126.61 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.78 31.97 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -178.55 164.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 10' ' ' LEU . 30.2 tp -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.408 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 17' ' ' LEU . 45.6 mt -102.61 104.35 37.85 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.11 174.79 10.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.551 1.501 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.1 154.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.419 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 60.31 33.79 20.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -128.27 130.91 48.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.455 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 146.79 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' MET . 26.7 mt -87.43 164.96 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.473 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 p -150.27 -171.74 3.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.195 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.94 -45.62 57.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG23 ' HG3' ' A' ' 21' ' ' MET . 29.2 m -64.57 -24.3 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.006 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.463 ' HG3' HG23 ' A' ' 20' ' ' VAL . 27.0 mtp -95.8 25.33 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.4 mtm -150.41 152.23 34.02 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 110.312 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -159.98 176.72 11.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.57 116.75 28.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' OE1' HG13 ' A' ' 27' ' ' VAL . 4.0 tm-20 -152.03 139.07 19.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.11 113.41 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.429 HG13 ' OE1' ' A' ' 25' ' ' GLU . 27.4 m -140.11 178.97 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.431 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -131.44 145.47 57.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.286 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.13 168.11 70.74 Favored 'Cis proline' 0 N--CA 1.481 0.772 0 C-N-CA 124.142 -1.191 . . . . 0.0 112.561 -0.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 95.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.372 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -122.1 3.46 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.88 139.51 46.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.01 165.82 14.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 121.664 1.576 . . . . 0.0 112.78 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -68.99 -14.3 62.96 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -72.12 -7.99 52.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.704 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -116.34 28.94 8.26 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.166 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 49.8 mt -69.75 -46.99 24.84 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.79 -16.21 16.5 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.127 1.218 . . . . 0.0 112.9 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -82.58 -25.3 33.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.715 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.4 mt -96.38 40.02 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -90.12 132.57 34.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.247 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 m 60.69 57.24 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.582 ' HB2' HD12 ' A' ' 17' ' ' LEU . 68.4 mmm -119.88 133.07 55.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.429 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.85 133.18 33.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.505 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.1 -177.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -105.53 -35.65 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -133.03 -177.21 4.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.373 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.53 115.36 11.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.481 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -111.43 93.18 18.27 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.336 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.61 -176.26 3.09 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 121.75 1.633 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 51' ' ' LEU . 2.4 mp -62.17 147.92 46.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.4 44.63 64.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.481 HG21 HG13 ' A' ' 49' ' ' VAL . 26.1 m -127.87 116.72 20.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.147 0.498 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.4 m -62.26 101.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.87 111.73 2.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.2 mtt -91.01 158.82 41.13 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.324 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.4 -26.38 4.09 Favored 'Trans proline' 0 N--CA 1.474 0.373 0 C-N-CA 121.793 1.662 . . . . 0.0 112.737 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.79 -31.94 59.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.501 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.4 mtp -68.38 -38.36 81.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.71 109.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.384 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.19 120.29 12.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.29 -31.85 7.1 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.615 ' CD2' HD21 ' A' ' 40' ' ' LEU . 46.3 t80 -80.31 98.85 7.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 110.362 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.47 -63.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.448 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 60.65 158.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.11 131.18 23.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.408 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -94.09 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 91.99 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.77 153.04 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.301 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 128.65 35.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.416 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.77 31.86 4.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.6 163.34 1.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 10' ' ' LEU . 33.5 tp -73.08 96.57 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.7 mt -90.08 111.77 48.63 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.01 153.9 16.98 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.524 1.483 . . . . 0.0 112.755 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 46' ' ' ASN . 14.2 tt -61.39 154.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.417 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 60.2 33.63 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.556 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 16' ' ' ALA . 10.6 m -130.61 159.66 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' N ' HG22 ' A' ' 15' ' ' THR . . . -89.84 151.53 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 72.9 mt -90.0 165.77 13.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.439 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.2 p -148.28 165.45 30.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.381 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.7 -31.62 71.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.17 -31.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.314 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.0 mtm -99.26 31.07 3.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.593 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.5 mtm -150.05 140.49 22.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.435 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -160.1 -177.36 6.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.15 124.14 51.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.377 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.65 145.51 22.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.07 121.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.348 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.67 159.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -120.3 145.77 41.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.88 166.19 72.13 Favored 'Cis proline' 0 N--CA 1.481 0.736 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.651 -0.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.19 99.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.35 -123.57 3.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.545 HD11 ' C ' ' A' ' 56' ' ' MET . 57.2 mt -76.35 139.55 68.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.25 164.37 17.13 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.71 1.607 . . . . 0.0 112.797 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.41 -21.17 65.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.223 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -64.03 -15.55 59.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.513 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' O ' HD12 ' A' ' 40' ' ' LEU . 2.1 m-20 -110.27 28.1 8.96 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.494 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 mt -71.09 -46.94 14.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.0 -19.32 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.204 1.269 . . . . 0.0 112.844 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -80.91 -24.72 38.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 2.1 mt -96.58 37.65 1.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.102 0.477 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.94 138.57 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.242 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 60.87 35.94 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.627 ' HG3' HD23 ' A' ' 40' ' ' LEU . 86.9 mmm -92.01 143.64 26.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.457 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -103.88 138.25 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.95 175.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.4 p-10 -102.54 -31.38 10.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.561 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -121.83 -179.44 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.72 155.72 33.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.451 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -150.61 90.75 4.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -79.63 -175.29 2.65 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 121.705 1.603 . . . . 0.0 112.657 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -61.73 151.73 33.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.57 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 51.59 48.36 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.451 HG21 HG13 ' A' ' 49' ' ' VAL . 24.7 m -133.62 122.04 22.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.126 0.489 . . . . 0.0 110.427 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -66.64 102.59 0.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.452 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.54 114.05 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.545 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.6 mtt -98.44 161.22 25.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.378 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.6 -26.18 4.04 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.47 -32.86 60.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.361 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.52 -32.77 71.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.425 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -86.84 107.58 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.269 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -66.77 123.07 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.79 -30.95 8.44 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 56.7 t80 -77.45 121.18 23.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.134 0.492 . . . . 0.0 110.338 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.68 -64.36 1.3 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.428 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.453 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -145.05 -178.04 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.445 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.23 118.68 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.428 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -108.67 -175.07 2.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.398 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.68 149.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -150.14 149.6 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.95 127.58 32.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.345 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -105.62 30.68 5.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 160.31 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.121 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -69.48 98.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.43 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.47 112.24 50.43 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 160.94 18.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 121.568 1.512 . . . . 0.0 112.575 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -65.98 154.96 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.31 33.16 20.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 m -130.84 147.96 52.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -81.58 155.76 25.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.432 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.79 169.45 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.368 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.18 163.38 38.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.23 -32.83 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.44 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.65 -31.24 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.428 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.6 mtm -99.29 31.61 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.9 mtm -150.11 138.69 20.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -159.71 163.53 34.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.425 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -90.3 132.34 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.414 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -167.36 136.75 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.89 112.18 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -141.84 153.09 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 t -114.3 144.5 31.82 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.28 152.56 84.01 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.092 -1.212 . . . . 0.0 112.495 0.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.07 113.12 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.452 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.81 -113.05 3.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 40' ' ' LEU . 57.2 mt -83.19 139.5 42.18 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.42 165.74 18.38 Favored 'Trans proline' 0 N--CA 1.476 0.462 0 C-N-CA 121.612 1.541 . . . . 0.0 112.946 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.34 -13.54 62.09 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.4 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.02 -10.21 57.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.609 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 m-20 -115.63 28.65 8.51 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.285 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 HD11 ' HB1' ' A' ' 34' ' ' ALA . 49.5 mt -71.12 -46.79 14.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.825 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 Cg_endo -77.35 -22.67 10.77 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.153 1.235 . . . . 0.0 112.71 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -79.03 -24.52 43.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 63' ' ' TYR . 20.1 mt -97.22 35.86 1.54 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.6 t -90.12 137.42 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.5 p 56.51 45.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.802 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.648 ' SD ' HD23 ' A' ' 40' ' ' LEU . 14.9 mtp -104.14 142.26 34.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.89 136.55 32.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.33 176.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.431 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -93.87 -36.38 12.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -134.7 -177.07 4.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.564 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.79 121.17 21.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.44 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.94 101.79 31.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.151 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.34 176.82 9.26 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 121.51 1.473 . . . . 0.0 112.691 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.0 mp -61.23 151.06 32.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.565 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.07 54.9 29.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -135.82 116.71 14.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 m -61.99 108.86 1.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.5 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -61.3 113.06 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.472 ' C ' HD11 ' A' ' 32' ' ' ILE . 6.7 mmt -94.29 156.39 38.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.346 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -79.9 -24.74 5.68 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.853 1.702 . . . . 0.0 112.778 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -74.64 -31.37 61.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.3 mtm -71.91 -37.78 70.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.73 102.08 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.357 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -66.93 128.72 37.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.61 -29.43 11.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.751 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.1 t80 -61.98 -67.24 0.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.341 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.14 48.8 12.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.386 0.612 . . . . 0.0 110.799 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.544 179.899 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.4 m120 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 60.71 104.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.553 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.48 158.24 28.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.309 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.59 -171.99 2.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -112.22 86.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.566 HG21 HG11 ' A' ' 27' ' ' VAL . 60.0 t -89.88 151.38 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -66.97 154.91 39.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -115.22 -17.52 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.46 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' HA ' HD21 ' A' ' 51' ' ' LEU . 6.7 pt20 -149.42 -179.92 7.45 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.069 0.461 . . . . 0.0 110.494 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' HD11 ' A' ' 51' ' ' LEU . 31.0 tp -71.08 101.36 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.783 HG23 ' CE ' ' A' ' 21' ' ' MET . 37.4 mt -96.95 109.98 51.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.38 154.24 21.38 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.524 1.483 . . . . 0.0 112.782 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.1 tt -61.49 155.45 4.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 60.28 40.99 17.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 m -139.22 138.45 36.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.64 150.53 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.401 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 ' HB2' ' A' ' 43' ' ' MET . 50.5 mt -90.24 164.72 14.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 p -150.08 175.24 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.443 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.28 -33.06 73.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.372 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.57 -28.35 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.783 ' CE ' HG23 ' A' ' 11' ' ' ILE . 32.4 mtp -97.65 29.09 3.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.8 mtm -150.27 140.32 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -148.14 177.52 9.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.398 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.78 108.24 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.458 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -146.62 144.58 29.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.34 120.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.345 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 6' ' ' VAL . 27.6 m -144.51 165.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.399 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 t -122.7 145.45 45.24 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.33 174.98 43.82 Favored 'Cis proline' 0 N--CA 1.481 0.767 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.446 -0.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.22 108.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.49 -120.99 4.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.654 HD13 ' CD2' ' A' ' 40' ' ' LEU . 55.5 mt -85.58 139.71 35.74 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -83.08 166.33 14.61 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.63 1.553 . . . . 0.0 112.68 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -70.47 -23.2 62.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.73 -13.9 60.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.475 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 40' ' ' LEU . 73.1 m-20 -110.76 24.37 13.03 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.603 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 43.6 mt -66.09 -46.88 63.27 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.706 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -76.7 -15.61 17.01 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 121.122 1.215 . . . . 0.0 112.82 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.41 -25.75 33.41 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.71 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD2' HD13 ' A' ' 32' ' ' ILE . 5.1 mp -97.26 36.24 1.49 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.787 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.2 t -86.06 139.72 16.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m 60.99 34.42 19.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.56 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.791 ' HB2' HD12 ' A' ' 17' ' ' LEU . 21.8 mmm -84.15 148.62 26.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.399 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -112.77 124.78 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -95.0 -178.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.299 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -129.98 33.22 4.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -177.53 163.55 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.475 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.93 49.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.397 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.017 HG12 HG21 ' A' ' 53' ' ' THR . 12.5 t -149.75 98.27 3.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.054 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 10' ' ' LEU . 40.6 Cg_endo -81.61 -165.45 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.903 1.735 . . . . 0.0 112.923 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.5 mp -73.68 154.13 39.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.16 58.58 13.3 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.017 HG21 HG12 ' A' ' 49' ' ' VAL . 9.8 t -132.48 136.18 46.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -75.61 104.65 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.113 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.39 108.14 6.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -95.29 164.75 18.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.904 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 39.9 Cg_endo -80.36 -35.7 0.59 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 121.586 1.524 . . . . 0.0 112.657 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.35 -42.36 99.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.399 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtm -63.51 -30.45 71.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.61 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 56' ' ' MET . 31.7 t -88.39 127.79 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -81.42 122.32 27.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.028 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.5 -28.59 7.4 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 57' ' ' PRO . 9.0 t80 -57.31 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.09 0.471 . . . . 0.0 110.536 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.38 100.45 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.46 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.412 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 121.07 0.462 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -134.22 -179.77 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.447 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.49 147.71 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.305 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.71 148.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.175 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.54 149.83 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -111.48 -23.1 10.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.32 178.44 8.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.974 0.416 . . . . 0.0 110.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 10' ' ' LEU . 31.9 tp -68.53 97.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.779 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.709 HG23 ' CE ' ' A' ' 21' ' ' MET . 43.5 mt -89.79 118.48 69.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.78 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.39 147.68 16.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.522 1.481 . . . . 0.0 112.631 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.0 tt -61.14 154.94 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.395 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 60.81 34.35 19.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -127.17 154.64 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.07 140.83 32.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.367 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 43' ' ' MET . 47.9 mt -82.53 167.13 18.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.473 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -143.92 -174.02 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -75.62 -31.9 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.36 -44.31 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.709 ' CE ' HG23 ' A' ' 11' ' ' ILE . 11.6 mtp -65.0 -29.11 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.728 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.46 149.08 23.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.345 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.06 179.35 8.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.84 135.81 51.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.381 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -178.0 141.92 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.7 121.85 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.247 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 167.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.457 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -125.73 138.97 33.01 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.315 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.59 137.17 42.01 Favored 'Cis proline' 0 N--CA 1.482 0.822 0 C-N-CA 124.075 -1.219 . . . . 0.0 112.481 0.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.5 m -59.26 106.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -112.62 2.78 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' C ' ' A' ' 56' ' ' MET . 63.9 mt -70.91 139.46 85.59 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.41 172.69 13.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.525 1.483 . . . . 0.0 112.729 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.52 -0.13 32.03 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.784 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.99 19.79 5.38 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 40' ' ' LEU . 70.1 m-20 -140.14 29.95 2.01 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.429 . . . . 0.0 110.751 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 20.7 mt -70.32 -46.85 20.31 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.147 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -76.66 -4.2 14.7 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.075 1.183 . . . . 0.0 113.263 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -96.87 -25.82 15.31 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -97.53 35.31 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.04 142.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 60.67 32.61 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.497 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.606 ' HB2' HD12 ' A' ' 17' ' ' LEU . 49.6 mmm -94.4 136.66 34.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -100.24 119.08 37.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -79.9 166.59 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.427 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -110.32 32.11 5.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.519 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.61 ' HA ' HD12 ' A' ' 13' ' ' ILE . 9.4 ptm180 -178.37 159.65 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.21 130.19 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -123.23 95.19 46.0 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.316 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.04 -174.96 2.47 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 121.675 1.583 . . . . 0.0 112.625 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 51' ' ' LEU . 2.4 mp -61.66 146.94 47.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.549 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.7 0.77 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 m -145.0 114.4 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' PRO . 3.3 m -61.76 104.1 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.495 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -60.97 113.17 2.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.565 ' C ' HD11 ' A' ' 32' ' ' ILE . 10.2 mtt -96.9 163.1 20.85 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.68 -26.34 3.18 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 121.861 1.707 . . . . 0.0 112.703 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.14 -32.81 61.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.468 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtm -71.66 -36.77 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 56' ' ' MET . 28.6 t -80.02 108.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -66.95 119.18 11.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.49 -31.91 7.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 52.3 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.158 0.504 . . . . 0.0 110.376 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.139 0.495 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -144.56 -174.4 4.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.72 89.0 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.76 152.87 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.294 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.33 128.02 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -103.62 30.53 4.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.611 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -178.02 160.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.74 96.69 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.41 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 ' CD2' ' A' ' 17' ' ' LEU . 19.6 mt -90.74 111.62 48.88 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.97 159.27 18.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.632 1.555 . . . . 0.0 112.607 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.08 154.28 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 60.63 33.29 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -133.07 144.06 49.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -76.43 152.12 36.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 43' ' ' MET . 19.4 mt -90.09 168.25 12.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.364 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -148.66 169.38 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -65.3 -33.19 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.73 -30.08 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.708 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.0 mtm -100.13 31.18 3.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.443 ' HE3' HG23 ' A' ' 37' ' ' ILE . 27.8 mtm -150.13 144.5 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.457 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -160.05 175.87 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.427 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 t -104.24 128.61 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.419 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.92 145.5 8.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.96 127.92 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.333 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 m -154.16 162.8 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -123.91 140.06 33.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.08 140.12 52.29 Favored 'Cis proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.155 -1.185 . . . . 0.0 112.452 0.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.59 107.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.818 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.38 -106.65 1.81 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.546 HD11 ' C ' ' A' ' 56' ' ' MET . 55.9 mt -82.07 139.46 45.91 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.32 165.78 18.57 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.523 1.482 . . . . 0.0 112.702 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -76.3 -3.76 38.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.68 1.7 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.718 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' HD12 ' A' ' 40' ' ' LEU . 42.7 m-20 -128.31 27.74 5.56 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.6 mt -62.2 -47.41 90.15 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.214 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.614 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.5 Cg_endo -75.78 -20.19 15.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.09 1.193 . . . . 0.0 112.674 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -77.1 -28.01 54.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -97.9 35.57 1.69 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.755 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' PRO . 24.3 t -90.29 142.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.327 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.441 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 5.2 m 60.67 32.44 20.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.6 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.61 ' HB2' HD12 ' A' ' 17' ' ' LEU . 38.2 mmm -95.59 139.94 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.473 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -89.25 140.88 29.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.491 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.75 148.01 7.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.303 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -79.81 -21.69 43.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.6 -178.36 5.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.16 24.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.57 92.53 24.24 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.292 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.3 179.44 6.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.742 1.628 . . . . 0.0 112.66 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.9 mp -62.06 151.61 34.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.599 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.96 40.26 93.41 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 m -129.53 118.97 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -62.31 109.74 1.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.44 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.15 114.91 5.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.389 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.546 ' C ' HD11 ' A' ' 32' ' ' ILE . 19.9 mtt -95.91 158.88 33.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.9 -26.89 3.35 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 121.827 1.685 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.91 -32.97 70.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.1 mtp -73.81 -33.73 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 56' ' ' MET . 26.3 t -80.03 104.83 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -65.22 121.09 13.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.48 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.16 -31.2 7.87 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 40' ' ' LEU . 56.1 t80 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.061 0.458 . . . . 0.0 110.367 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.049 0.452 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -129.7 -174.73 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.362 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -107.92 144.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 7' ' ' ALA . 24.9 t -144.93 155.81 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -82.52 122.95 28.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -102.47 32.51 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.41 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.472 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -178.96 164.92 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.169 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' HD11 ' A' ' 51' ' ' LEU . 19.1 tp -71.94 104.44 3.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG23 ' CE ' ' A' ' 21' ' ' MET . 52.3 mt -103.17 104.15 38.83 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.07 164.59 19.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.58 1.52 . . . . 0.0 112.678 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.45 147.93 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.84 51.75 4.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.432 0.634 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -144.97 124.06 12.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.413 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.64 148.44 46.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.423 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 43' ' ' MET . 21.0 mt -88.94 166.67 13.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.513 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.646 ' OG1' HG12 ' A' ' 20' ' ' VAL . 30.7 p -150.25 -172.14 4.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.179 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.63 -31.43 63.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 p -75.3 -26.59 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG3' HG13 ' A' ' 20' ' ' VAL . 33.1 mtp -96.98 27.32 4.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.968 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.491 ' HE3' HG23 ' A' ' 37' ' ' ILE . 25.8 mtm -150.41 148.98 29.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.079 0.466 . . . . 0.0 110.426 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -160.02 178.18 9.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.406 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 t -117.65 126.54 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -159.74 145.73 15.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.09 110.5 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.312 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.59 164.41 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -115.9 145.29 34.44 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.5 169.84 63.82 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 C-N-CA 124.097 -1.21 . . . . 0.0 112.592 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.1 p -61.76 112.16 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.81 -129.6 6.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.643 HD11 ' C ' ' A' ' 56' ' ' MET . 52.3 mt -78.59 139.64 58.98 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.08 163.22 17.88 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.58 1.52 . . . . 0.0 112.882 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.03 -14.58 63.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.401 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.96 -10.92 59.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.695 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.28 26.76 9.68 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.37 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 HD11 ' HB1' ' A' ' 34' ' ' ALA . 47.0 mt -66.74 -47.09 56.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.811 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.5 -22.52 12.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.13 1.22 . . . . 0.0 112.639 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -76.78 -25.02 52.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.5 mt -97.72 31.6 2.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.8 t -88.94 141.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.195 0.522 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.4 m 60.97 34.87 19.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.73 ' HB2' HD12 ' A' ' 17' ' ' LEU . 88.1 mmm -94.86 151.72 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.441 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -109.46 132.37 54.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.5 160.49 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -80.23 -33.96 37.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -131.63 -177.88 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.528 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 133.46 36.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.64 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 53' ' ' THR . 23.6 t -120.7 112.06 34.12 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.71 -176.13 3.02 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.533 1.489 . . . . 0.0 112.672 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.4 mp -69.28 155.17 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.499 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 33.76 88.1 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 49' ' ' VAL . 25.8 m -112.41 118.77 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.057 0.456 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -61.82 104.74 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.28 115.27 3.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.362 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.643 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.7 mtt -96.67 160.74 28.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.542 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.98 -26.98 3.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.917 1.744 . . . . 0.0 112.727 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.35 -33.14 61.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtm -68.21 -38.45 81.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.454 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 40' ' ' LEU . 23.3 t -79.98 108.32 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.359 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -65.14 121.17 14.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.05 -31.39 7.74 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.642 ' CD2' HD21 ' A' ' 40' ' ' LEU . 44.1 t80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -90.74 -173.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.17 92.3 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.398 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.76 151.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.77 126.07 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -102.67 31.42 4.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.66 168.26 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.2 tp -72.49 102.63 3.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.484 HG12 ' HE3' ' A' ' 21' ' ' MET . 47.4 mt -105.76 101.24 31.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.316 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.45 162.1 22.28 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.579 1.52 . . . . 0.0 112.58 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.15 155.6 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.536 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.27 45.16 9.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.47 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 m -147.22 126.77 13.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -65.31 147.11 54.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.394 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 43' ' ' MET . 18.2 mt -81.69 168.96 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.41 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -150.32 -179.84 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.382 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mt -68.79 -37.84 79.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.34 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 21' ' ' MET . 23.4 m -71.19 -26.48 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.484 ' HE3' HG12 ' A' ' 11' ' ' ILE . 29.0 mtp -96.55 27.97 3.59 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.523 ' HE3' HG23 ' A' ' 37' ' ' ILE . 28.9 mtm -150.25 144.31 25.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.05 0.452 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -156.07 166.25 34.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.08 117.71 34.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -148.88 151.27 34.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.61 121.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.12 155.16 6.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.414 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -118.34 144.29 34.8 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.289 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.83 156.3 88.47 Favored 'Cis proline' 0 N--CA 1.481 0.77 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.463 0.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -60.97 112.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.505 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.75 -121.1 4.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 56' ' ' MET . 57.5 mt -75.5 139.61 71.35 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.16 159.11 17.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.689 1.592 . . . . 0.0 112.926 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -18.33 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.03 -13.86 60.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.541 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.9 m-20 -113.72 25.67 11.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.567 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 34' ' ' ALA . 40.8 mt -64.37 -47.46 77.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.703 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -76.72 -13.48 17.93 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.174 1.25 . . . . 0.0 113.011 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.64 -27.69 28.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.904 0.383 . . . . 0.0 110.647 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.609 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -96.37 41.87 1.1 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.166 0.507 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 38' ' ' PRO . 23.2 t -90.1 135.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.395 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.594 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.8 t 60.3 37.5 20.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.611 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.615 ' HB2' HD12 ' A' ' 17' ' ' LEU . 95.8 mmm -91.5 140.24 29.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.268 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.22 143.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -110.47 160.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.386 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -113.43 31.93 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -178.59 172.43 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.6 142.33 37.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 92.06 7.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.4 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.33 -171.84 1.36 Allowed 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 121.743 1.629 . . . . 0.0 112.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.6 mp -63.03 147.75 49.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.68 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.15 61.26 6.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -139.54 118.36 12.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 110.384 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -61.71 104.21 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.481 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.52 110.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.439 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.406 ' C ' HD11 ' A' ' 32' ' ' ILE . 3.2 mtt -97.84 158.68 32.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.067 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.24 -18.51 11.07 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.734 1.623 . . . . 0.0 113.1 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -74.29 -40.26 62.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.954 0.407 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 60' ' ' VAL . 10.2 ptp -68.77 -30.4 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.457 HG23 ' HG3' ' A' ' 59' ' ' MET . 41.1 t -85.47 101.09 9.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.188 0.518 . . . . 0.0 110.11 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -64.47 126.96 29.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.27 -30.19 9.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.609 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 121.032 0.444 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 121.116 0.484 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -145.2 -177.15 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.479 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PRO . 20.5 t -98.56 92.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.98 145.7 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.221 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -68.12 120.73 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.448 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -102.32 30.93 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.35 158.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.939 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.7 tp -69.82 97.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.411 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.3 mt -89.74 117.8 68.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.8 153.48 17.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.544 1.496 . . . . 0.0 112.635 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.58 149.98 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.449 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.56 37.02 19.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.558 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -136.18 140.6 43.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -70.9 153.0 43.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.443 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 67.0 mt -88.47 172.66 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.28 165.4 33.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.343 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.1 -32.96 73.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.342 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 -30.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.374 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 mtm -98.84 32.32 2.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.422 ' HE3' HG23 ' A' ' 37' ' ' ILE . 26.6 mtm -149.22 144.26 26.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.307 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.07 158.02 32.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.406 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -94.19 104.31 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.508 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -141.04 142.68 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.42 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.56 129.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.422 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -155.52 161.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -119.57 144.18 36.28 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.2 160.47 85.76 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.524 0.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.35 96.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.48 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.19 -126.86 4.66 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.587 HD11 ' C ' ' A' ' 56' ' ' MET . 54.0 mt -73.66 139.19 77.34 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 5' ' ' VAL . 39.7 Cg_endo -81.11 -179.88 5.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.574 1.516 . . . . 0.0 112.471 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.55 17.12 7.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.565 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -90.4 -29.54 17.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.012 0.434 . . . . 0.0 110.599 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -99.09 31.81 2.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.958 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.74 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.9 mt -64.17 -47.55 78.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.607 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.04 -22.12 13.35 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.052 1.168 . . . . 0.0 112.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -77.59 -25.35 49.87 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.655 HD21 ' CG ' ' A' ' 63' ' ' TYR . 4.2 mt -98.06 31.14 2.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 38' ' ' PRO . 29.3 t -86.47 137.06 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.572 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 46.4 t 61.09 43.1 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.483 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 84.8 mmm -100.09 134.64 42.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.433 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.82 123.04 32.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.85 158.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.386 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -82.29 -31.84 29.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -132.36 -177.36 4.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.37 144.49 48.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.75 90.49 16.53 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.373 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 39.9 Cg_endo -80.01 -178.21 4.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.714 1.609 . . . . 0.0 112.642 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.27 144.66 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.68 56.63 8.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -143.95 119.7 10.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 m -63.47 124.13 20.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 tp -81.15 119.59 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.301 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.587 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.3 mtt -96.49 155.56 37.77 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.95 -27.1 3.19 Favored 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 121.788 1.659 . . . . 0.0 112.699 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.27 -32.61 64.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.381 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -73.36 -35.0 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.447 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' MET . 22.1 t -79.81 112.63 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -71.48 120.67 17.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.392 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.65 7.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 40' ' ' LEU . 53.1 t80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.097 0.475 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -101.33 -173.4 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.71 147.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -142.3 150.65 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.55 114.6 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.327 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.14 -27.21 65.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.62 -178.23 6.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.4 tp -71.11 102.63 2.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.721 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.835 HG23 ' CE ' ' A' ' 21' ' ' MET . 25.4 mt -89.95 127.41 53.92 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.77 150.89 14.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.632 1.555 . . . . 0.0 112.753 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.6 tt -67.61 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.16 35.14 21.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 m -129.8 148.29 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -77.19 136.53 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.46 170.34 15.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -150.27 168.41 24.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.0 -33.28 74.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.7 -28.59 34.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.435 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.835 ' CE ' HG23 ' A' ' 11' ' ' ILE . 26.3 mtp -94.74 24.23 4.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.302 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 mtm -150.14 132.57 15.63 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 121.051 0.453 . . . . 0.0 110.218 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -143.8 172.45 12.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 t -105.53 126.02 51.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.269 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -161.43 146.22 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.65 125.66 38.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.83 168.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.475 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t -124.54 146.09 51.3 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.44 169.24 66.39 Favored 'Cis proline' 0 N--CA 1.482 0.818 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.665 0.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.73 99.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.54 -127.14 4.87 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.517 HD11 ' C ' ' A' ' 56' ' ' MET . 55.1 mt -78.14 139.37 60.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.35 163.84 17.06 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.673 1.582 . . . . 0.0 112.894 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.54 -14.71 63.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.368 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -68.83 -10.89 59.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.656 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -118.52 30.61 7.11 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.36 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.575 HD11 ' HB1' ' A' ' 34' ' ' ALA . 43.5 mt -69.04 -47.36 29.85 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.795 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.2 Cg_endo -76.05 -24.37 11.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 120.992 1.128 . . . . 0.0 112.551 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -25.52 61.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.743 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' A' ' 43' ' ' MET . 1.6 mt -96.64 27.85 3.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.2 t -86.91 136.1 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.09 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 42.5 t 61.04 32.69 19.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.733 ' SD ' HD23 ' A' ' 40' ' ' LEU . 15.2 mtp -94.33 134.48 36.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.244 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -86.18 145.31 27.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.545 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.66 -178.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.342 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.07 -22.39 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.2 ptp180 -137.52 -178.47 5.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.83 161.22 30.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.6 t -148.19 93.72 4.37 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.245 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -80.13 -176.01 3.0 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.683 1.589 . . . . 0.0 112.606 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 51' ' ' LEU . 6.2 mp -65.01 154.26 38.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.577 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.3 46.02 95.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.9 m -128.61 109.74 11.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 0.0 110.175 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -60.34 109.38 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.576 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.39 115.69 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.517 ' C ' HD11 ' A' ' 32' ' ' ILE . 5.7 mtt -96.34 158.57 33.66 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.39 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.63 -26.39 3.88 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 121.826 1.684 . . . . 0.0 112.755 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.49 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 mtm -70.4 -38.56 74.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.492 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HE1' ' A' ' 43' ' ' MET . 23.2 t -80.31 110.32 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -70.15 123.43 21.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.372 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.01 -31.35 7.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.137 0.494 . . . . 0.0 110.292 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.154 0.502 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 m -134.02 -172.19 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.45 89.4 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.364 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.82 151.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.0 128.45 35.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.476 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -103.28 30.16 5.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.559 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.25 161.21 1.42 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.453 ' N ' HD11 ' A' ' 51' ' ' LEU . 35.5 tp -71.75 94.83 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.61 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.4 mt -89.92 111.98 49.53 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.137 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.26 157.17 19.8 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.457 1.438 . . . . 0.0 112.575 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.08 154.83 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 61.25 33.23 19.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.484 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -130.51 153.17 49.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -86.87 148.16 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 ' CD2' HG21 ' A' ' 11' ' ' ILE . 14.7 mt -89.91 170.27 10.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -148.18 173.26 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.456 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.21 -32.4 73.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.48 -29.94 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.705 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.0 mtm -100.29 32.16 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.105 0.479 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.5 mtm -150.05 114.17 5.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.75 -178.04 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -109.63 113.36 26.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -137.82 142.31 40.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.46 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.98 82.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -114.53 146.12 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.41 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 t -111.25 141.97 25.44 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.306 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.86 132.05 23.7 Favored 'Cis proline' 0 N--CA 1.482 0.828 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.441 0.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.26 111.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.09 -94.19 1.09 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.475 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -90.01 139.73 27.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 167.05 16.29 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.677 1.585 . . . . 0.0 112.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.38 -26.4 66.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.837 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.16 -18.1 56.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' HD12 ' A' ' 40' ' ' LEU . 4.1 m-20 -110.4 35.73 3.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.407 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.8 mt -79.77 -46.84 1.49 Allowed Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.616 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 Cg_endo -77.13 -11.15 17.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.127 1.218 . . . . 0.0 113.084 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -85.68 -27.44 25.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.521 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' HG3' ' A' ' 43' ' ' MET . 3.7 mt -94.16 46.64 1.17 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' PRO . 32.8 t -90.16 133.89 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.309 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.513 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.2 m 60.79 38.33 18.14 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.652 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.651 ' HG3' HD23 ' A' ' 40' ' ' LEU . 76.2 mmm -95.31 137.55 34.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.12 144.55 25.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.12 163.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.4 -33.6 20.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -126.95 -177.74 4.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.486 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.59 122.1 24.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.88 90.67 28.21 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.46 -172.86 1.64 Allowed 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 121.741 1.627 . . . . 0.0 112.662 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -66.0 152.83 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.71 39.02 90.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -130.79 118.06 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.7 m -61.9 108.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD23 HD12 ' A' ' 32' ' ' ILE . 12.8 tp -61.73 114.95 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.604 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.3 mtt -93.22 150.03 38.43 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.345 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.19 -26.58 3.34 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.819 1.679 . . . . 0.0 112.635 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.46 -32.89 64.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mtm -74.27 -32.09 62.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 56' ' ' MET . 29.0 t -79.8 102.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.259 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -68.86 124.61 24.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.74 7.28 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.8 t80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -92.02 -171.51 2.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.391 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.72 90.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 7' ' ' ALA . 25.4 t -90.56 154.79 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -80.38 131.61 35.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.384 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -107.99 31.91 5.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.65 158.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.08 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -70.28 97.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.501 HG21 ' CD2' ' A' ' 17' ' ' LEU . 14.9 mt -89.75 112.14 50.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.079 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.35 157.49 19.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.507 1.471 . . . . 0.0 112.683 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.05 153.79 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.394 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 60.65 32.52 20.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -133.04 137.08 46.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.442 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -74.34 156.14 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' CD2' HG21 ' A' ' 11' ' ' ILE . 21.5 mt -90.07 169.9 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.0 p -150.1 174.62 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.41 -36.14 81.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.02 -30.1 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.443 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 mtp -96.78 26.79 4.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.1 mtm -150.36 141.68 23.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.343 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.69 -178.11 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -115.56 129.45 56.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -158.63 139.45 12.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.361 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.76 121.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -152.83 161.34 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.444 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.18 145.61 35.36 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.42 175.69 41.15 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 C-N-CA 124.12 -1.2 . . . . 0.0 112.563 0.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -65.55 117.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.57 -134.28 5.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.507 HD11 ' C ' ' A' ' 56' ' ' MET . 57.7 mt -72.92 139.33 79.9 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.65 164.18 16.26 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.663 1.575 . . . . 0.0 112.868 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.46 -25.04 66.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.946 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -58.98 -19.75 46.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.478 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HD13 ' A' ' 40' ' ' LEU . 65.6 m-20 -107.65 38.72 2.08 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.192 0.52 . . . . 0.0 111.483 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.3 mt -84.06 -46.94 0.74 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.576 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.4 Cg_endo -78.35 -19.08 12.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.229 1.286 . . . . 0.0 112.853 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -83.73 -20.66 33.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.957 HD11 ' CE1' ' A' ' 63' ' ' TYR . 9.0 mp -97.31 32.01 2.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.008 0.433 . . . . 0.0 110.935 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.7 t -79.5 140.08 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.037 0.446 . . . . 0.0 110.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.3 p 56.68 41.43 28.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.435 ' HB2' HD12 ' A' ' 17' ' ' LEU . 92.3 mmm -97.43 133.12 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -92.43 144.02 25.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.626 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -110.91 157.89 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.165 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.94 -30.19 39.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -128.04 -177.42 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.534 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.75 35.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.528 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.92 98.06 49.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.94 177.77 7.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.628 1.552 . . . . 0.0 112.714 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.566 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.3 mp -64.32 150.11 46.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.2 32.22 75.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -116.81 117.94 31.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -61.87 104.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.464 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.85 115.53 4.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.507 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.3 mtt -100.35 160.26 27.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.65 -26.85 3.58 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 121.81 1.673 . . . . 0.0 112.615 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.83 -39.13 83.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 41.1 mtm -69.98 -32.18 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' MET . 42.8 t -82.77 95.36 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -66.02 127.37 31.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.7 -31.09 8.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.957 ' CE1' HD11 ' A' ' 40' ' ' LEU . 33.1 t80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.266 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 121.09 0.471 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -149.87 -177.02 5.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.89 146.89 7.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 7' ' ' ALA . 26.1 t -142.89 156.08 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.121 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.436 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -85.1 119.73 25.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -99.9 31.07 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.534 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -179.42 164.45 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.02 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.658 ' N ' HD11 ' A' ' 51' ' ' LEU . 23.2 tp -71.72 101.09 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.479 HG23 ' CE ' ' A' ' 21' ' ' MET . 31.2 mt -96.5 108.93 45.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.73 -178.6 4.29 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.56 1.507 . . . . 0.0 112.589 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.04 154.66 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 60.62 33.98 20.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.526 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -130.42 131.47 45.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.2 157.1 36.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' A' ' 43' ' ' MET . 86.5 mt -90.18 165.55 13.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.3 p -150.08 171.14 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.336 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.26 -34.03 75.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -30.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.453 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' HG23 ' A' ' 11' ' ' ILE . 25.4 mtp -94.52 21.21 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.42 140.14 21.72 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.983 0.42 . . . . 0.0 110.425 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.13 176.37 11.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -103.05 142.81 33.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.372 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -170.88 140.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.467 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.67 96.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.19 172.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -131.46 145.72 58.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.5 167.33 71.16 Favored 'Cis proline' 0 N--CA 1.481 0.782 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.522 0.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.17 92.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.47 -126.61 2.31 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 56' ' ' MET . 44.0 mt -73.88 139.66 76.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.18 163.69 15.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.661 1.574 . . . . 0.0 112.653 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.66 67.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.62 -22.42 45.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 m-20 -109.9 37.98 2.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.149 0.499 . . . . 0.0 111.443 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 58.8 mt -81.31 -46.98 1.11 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.607 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.35 -22.35 11.02 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 121.164 1.243 . . . . 0.0 112.592 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -79.18 -22.56 44.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 36' ' ' ASP . 5.7 mp -96.83 28.78 3.31 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.1 t -84.29 145.21 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.566 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.8 m 60.92 32.87 20.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.651 ' HB2' HD12 ' A' ' 17' ' ' LEU . 72.3 mmm -94.83 134.71 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.423 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.27 141.52 28.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.458 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 m -102.12 170.68 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.47 -31.4 15.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.614 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.74 167.91 21.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.0 120.36 13.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 53' ' ' THR . 22.9 t -105.89 114.29 62.89 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.123 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.2 -176.71 3.26 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 121.534 1.489 . . . . 0.0 112.604 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 10' ' ' LEU . 6.4 mp -70.58 157.16 38.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.416 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.41 31.93 82.41 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 49' ' ' VAL . 13.3 m -113.33 118.71 35.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.065 0.459 . . . . 0.0 110.385 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.9 m -61.81 105.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.27 115.5 3.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.484 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 60' ' ' VAL . 35.4 mtt -101.46 155.65 36.11 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.1 -27.61 2.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.887 1.725 . . . . 0.0 112.629 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -64.84 -37.11 86.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.4 mtm -75.66 -34.8 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.404 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 56' ' ' MET . 26.5 t -79.94 111.2 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.289 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -82.82 129.75 35.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.85 -32.2 6.73 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' CE1' HD11 ' A' ' 40' ' ' LEU . 1.7 t80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.14 0.495 . . . . 0.0 110.346 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -108.0 175.91 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.24 143.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.228 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.78 147.91 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.94 106.25 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.63 -28.69 67.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.8 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.505 ' HA ' HD21 ' A' ' 51' ' ' LEU . 4.2 pt20 -149.79 -177.97 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.114 0.483 . . . . 0.0 110.364 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.3 tp -70.81 103.56 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.627 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.2 mt -89.32 132.49 37.29 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.912 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.9 152.73 14.65 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.656 1.571 . . . . 0.0 112.744 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.2 tt -70.69 150.18 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 60.39 32.75 20.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.538 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -130.34 141.39 50.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.88 140.62 55.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HG21 ' A' ' 11' ' ' ILE . 74.0 mt -78.22 169.81 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -150.15 167.51 26.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.397 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.3 -32.47 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.316 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -65.24 -30.6 50.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.634 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.432 ' CE ' HG23 ' A' ' 11' ' ' ILE . 14.3 mtm -103.65 27.86 7.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 mtp -145.89 132.21 19.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.369 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.12 -179.57 7.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.1 136.61 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -169.13 143.9 3.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.62 110.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.327 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.77 167.45 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.49 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.94 143.56 49.19 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.327 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.15 163.44 82.31 Favored 'Cis proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.55 0.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.6 p -61.72 120.89 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.87 -130.64 4.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.46 HD11 ' C ' ' A' ' 56' ' ' MET . 67.5 mt -67.5 139.78 94.45 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.71 160.65 19.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.64 1.56 . . . . 0.0 112.921 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -18.47 64.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -66.37 -13.45 60.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.6 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 40' ' ' LEU . 61.9 m-20 -113.58 23.31 13.26 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.532 HD11 ' HB1' ' A' ' 34' ' ' ALA . 38.4 mt -62.25 -47.42 89.89 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.703 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.62 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.5 -19.09 15.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 121.14 1.227 . . . . 0.0 112.848 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -77.97 -27.72 49.24 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -98.11 35.03 1.81 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' PRO . 30.1 t -88.01 139.73 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.272 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 1.6 t 60.9 32.62 20.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.542 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 mtp -95.6 135.76 36.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.33 145.29 24.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.502 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.54 174.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -92.46 -30.98 15.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HA ' HD12 ' A' ' 13' ' ' ILE . 7.3 ptp180 -134.05 -177.54 4.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.339 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.41 149.34 46.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.207 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.8 90.51 36.03 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.51 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 10' ' ' LEU . 38.8 Cg_endo -78.63 176.4 9.93 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 121.829 1.686 . . . . 0.0 112.611 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -62.59 137.75 58.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.749 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.59 -31.99 7.5 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 108.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.138 0.494 . . . . 0.0 110.519 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -63.01 118.61 8.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.43 113.47 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -99.73 158.42 32.15 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.34 -25.9 4.45 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 121.824 1.683 . . . . 0.0 112.714 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.06 -32.5 61.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.3 mtm -73.98 -36.02 64.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.56 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 56' ' ' MET . 25.6 t -79.84 104.54 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.281 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.37 127.42 32.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.441 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.16 -30.78 8.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CE1' HD11 ' A' ' 40' ' ' LEU . 41.5 t80 . . . . . 0 C--N 1.331 -0.219 0 CA-C-O 121.05 0.452 . . . . 0.0 110.287 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.11 0.481 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.04 -171.74 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.352 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -119.33 87.03 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.376 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.7 153.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.376 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.28 122.22 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.56 30.76 3.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.87 167.73 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.1 tp -72.62 102.62 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 27.1 mt -95.99 109.1 44.93 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.21 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.83 166.7 17.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.595 1.53 . . . . 0.0 112.643 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -73.29 154.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.37 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.38 32.28 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 m -132.38 146.59 52.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.405 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -82.07 148.75 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 11' ' ' ILE . 68.6 mt -80.5 169.83 17.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -150.19 170.31 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.11 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.87 -28.22 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.449 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mtp -97.15 29.13 3.26 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.29 150.13 31.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.212 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -160.13 167.23 28.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -107.51 103.13 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -142.05 146.77 35.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.91 125.64 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.316 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -153.31 156.75 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 t -109.72 145.05 31.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.357 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.09 161.61 85.0 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.49 0.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.99 113.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.37 -126.05 5.0 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 56' ' ' MET . 56.9 mt -73.96 139.18 76.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.88 172.3 12.21 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.631 1.554 . . . . 0.0 112.688 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.38 -1.9 32.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.783 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.22 6.12 23.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.642 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 40' ' ' LEU . 42.3 m-20 -127.26 31.96 5.14 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.105 0.479 . . . . 0.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 33.5 mt -73.37 -46.39 7.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.206 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.1 Cg_endo -75.88 -24.29 11.62 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 121.065 1.177 . . . . 0.0 112.464 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.28 -18.79 48.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.992 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.778 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.4 mp -97.02 29.15 3.21 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -86.04 131.23 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.061 0.458 . . . . 0.0 110.304 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.708 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 22.9 t 61.43 36.06 17.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.673 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.599 ' HE1' HG12 ' A' ' 60' ' ' VAL . 13.0 mtp -91.96 125.77 36.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -79.86 134.66 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.536 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.01 -177.51 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -110.28 -32.26 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.661 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 -177.06 4.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.43 129.01 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.453 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.19 100.77 42.07 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.152 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.87 -178.04 4.26 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.577 1.518 . . . . 0.0 112.682 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.7 mp -66.35 148.04 52.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.6 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.74 52.58 24.21 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -135.19 118.18 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 m -61.52 100.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.552 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.31 113.67 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.6 ' O ' HD11 ' A' ' 32' ' ' ILE . 19.1 mtt -96.14 165.21 16.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.76 -26.29 4.73 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.74 1.626 . . . . 0.0 112.616 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.79 -23.09 55.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.986 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -97.44 28.53 3.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.918 0.39 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HE1' ' A' ' 43' ' ' MET . 34.5 t -141.33 101.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.094 0.473 . . . . 0.0 110.133 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -64.08 124.46 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.453 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.58 7.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.778 ' CE1' HD11 ' A' ' 40' ' ' LEU . 27.5 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.113 0.482 . . . . 0.0 110.433 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 121.103 0.477 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -98.46 175.69 5.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.37 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.84 147.98 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.25 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.7 t -145.61 149.9 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 102.3 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.299 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.28 -26.33 66.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.583 ' OE1' HG12 ' A' ' 20' ' ' VAL . 17.3 pt20 -149.58 -178.0 6.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' PRO . 31.5 tp -70.4 101.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.601 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.819 HG23 ' CE ' ' A' ' 21' ' ' MET . 38.2 mt -96.06 123.8 54.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.01 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.2 159.93 15.31 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.623 1.549 . . . . 0.0 112.796 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 46' ' ' ASN . 13.8 tt -71.03 151.67 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.06 37.46 21.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.646 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -132.8 134.75 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.472 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -62.02 151.06 36.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 43' ' ' MET . 82.7 mt -90.17 166.63 13.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.1 p -150.13 170.13 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.3 mp -62.08 -32.97 73.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' OE1' ' A' ' 9' ' ' GLN . 21.6 t -70.03 -30.35 43.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 11' ' ' ILE . 29.0 mtp -97.44 28.66 3.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HE3' HG23 ' A' ' 37' ' ' ILE . 29.6 mtm -150.27 125.78 10.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -142.89 161.97 36.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -96.63 143.42 27.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.432 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -177.96 143.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 122.52 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 m -154.45 157.16 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.65 144.91 34.18 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.363 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.41 150.83 81.39 Favored 'Cis proline' 0 N--CA 1.481 0.754 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.462 0.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.7 m -59.45 104.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.44 -121.28 3.69 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -75.62 139.55 70.83 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -82.19 161.24 17.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.612 1.541 . . . . 0.0 112.92 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.63 -16.98 64.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -13.18 61.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.489 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 40' ' ' LEU . 51.0 m-20 -113.75 25.09 11.51 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.609 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 34' ' ' ALA . 39.6 mt -63.45 -47.58 83.29 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.642 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.1 Cg_endo -76.6 -16.31 16.86 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.105 1.203 . . . . 0.0 113.008 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -80.77 -27.27 36.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.773 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.601 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -97.41 38.78 1.24 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.147 0.498 . . . . 0.0 110.721 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.68 141.76 13.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.231 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.502 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.2 m 60.84 32.65 20.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.499 ' HB2' HD12 ' A' ' 17' ' ' LEU . 94.7 mmm -92.25 143.45 26.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -101.2 138.77 37.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.477 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.74 144.77 14.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.346 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.2 p-10 -79.96 -28.24 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.716 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -122.72 168.17 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.103 0.477 . . . . 0.0 110.461 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.97 51.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.03 91.77 23.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.38 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.6 Cg_endo -80.64 -175.13 2.53 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.68 1.587 . . . . 0.0 112.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -61.65 149.39 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.47 61.6 6.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -140.62 111.93 7.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 104.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.54 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.5 109.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.498 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.556 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mtt -93.92 165.02 18.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.72 -20.23 8.01 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 121.828 1.685 . . . . 0.0 113.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.81 -42.77 49.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.992 0.425 . . . . 0.0 110.722 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.418 ' HG3' HG23 ' A' ' 60' ' ' VAL . 3.9 ptp -64.87 -28.16 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.992 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HG3' ' A' ' 59' ' ' MET . 43.5 t -88.63 97.42 6.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.094 0.473 . . . . 0.0 110.247 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -66.05 127.66 33.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.364 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.06 -31.09 8.48 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.601 ' CE1' HD11 ' A' ' 40' ' ' LEU . 43.3 t80 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.246 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -101.57 -173.06 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -100.27 93.42 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 25' ' ' GLU . 38.7 t -90.1 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.267 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.05 132.5 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.304 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.37 29.49 7.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -177.61 165.55 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.114 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.84 96.13 4.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.2 mt -90.43 112.47 53.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.085 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.91 156.81 20.66 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.562 1.508 . . . . 0.0 112.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.71 154.58 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 m120 60.46 32.83 20.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 156.72 43.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 151.98 21.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.695 ' CD2' HG21 ' A' ' 11' ' ' ILE . 65.5 mt -90.1 168.57 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.457 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -150.12 164.65 35.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.67 -32.06 72.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.448 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -66.29 -31.56 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.288 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.7 mtm -99.43 31.77 3.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.5 mtm -150.12 137.22 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -160.03 162.24 34.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 m -84.71 129.94 34.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.423 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.8 tt0 -162.44 128.94 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.462 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.71 115.18 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.89 162.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -119.55 141.52 31.07 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.263 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 54' ' ' THR . 39.3 Cg_endo -79.99 156.35 87.86 Favored 'Cis proline' 0 N--CA 1.482 0.821 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.523 0.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.4 p -61.11 112.28 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.38 -125.66 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 40' ' ' LEU . 53.8 mt -74.39 139.86 75.44 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.19 165.99 16.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.622 1.548 . . . . 0.0 112.817 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -12.21 60.01 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.613 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.99 -9.75 56.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.774 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.2 m-20 -118.18 27.63 8.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.403 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD11 ' HB1' ' A' ' 34' ' ' ALA . 36.7 mt -65.81 -47.63 64.76 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.555 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.6 Cg_endo -77.96 -18.15 13.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.161 1.241 . . . . 0.0 112.532 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -79.24 -26.27 42.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.67 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -97.44 37.63 1.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.098 0.475 . . . . 0.0 110.893 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 31.7 t -89.05 135.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.162 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m 61.28 37.64 17.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 97.2 mmm -90.37 147.67 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.31 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.67 125.18 47.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.517 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -91.84 -177.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.376 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -108.74 -43.04 4.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.612 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -118.02 -177.49 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.55 121.87 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.507 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 53' ' ' THR . 22.4 t -111.91 91.97 16.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.12 -173.2 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.666 1.577 . . . . 0.0 112.778 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -67.12 137.71 56.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.529 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 31.95 37.25 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.441 HG21 HG13 ' A' ' 49' ' ' VAL . 24.9 m -111.65 112.51 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.052 0.454 . . . . 0.0 110.311 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.5 m -62.04 105.39 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.81 141.58 57.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.267 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 24.4 mmm -127.12 157.03 73.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.74 -20.79 7.57 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 121.803 1.669 . . . . 0.0 113.129 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -79.27 -44.41 21.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 ptm -68.08 -31.38 70.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 27.4 t -79.86 111.28 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -71.75 121.39 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.377 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.66 7.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.67 ' CD2' HD21 ' A' ' 40' ' ' LEU . 48.5 t80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 121.01 0.433 . . . . 0.0 110.417 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 121.213 0.53 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.23 -177.42 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.91 149.63 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.6 t -145.96 153.68 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.136 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 11' ' ' ILE . . . -79.79 121.38 25.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.368 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -99.84 30.54 3.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.99 161.62 0.95 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.988 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -69.79 97.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.433 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 17' ' ' LEU . 10.7 mt -89.7 111.93 48.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.043 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.29 153.49 16.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.603 1.535 . . . . 0.0 112.598 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 tt -61.47 154.15 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.359 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 60.87 33.07 20.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -132.38 146.29 51.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.422 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 155.32 29.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.499 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 11' ' ' ILE . 88.1 mt -90.19 167.44 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.45 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.06 -33.26 74.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' MET . 17.7 m -69.7 -27.88 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.771 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG3' HG23 ' A' ' 20' ' ' VAL . 75.9 mtm -99.02 30.77 3.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.416 ' HE3' ' O ' ' A' ' 37' ' ' ILE . 31.0 mtm -150.15 143.84 25.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -160.21 164.4 32.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -97.46 133.32 42.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -169.14 146.24 3.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.87 130.8 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -155.45 175.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -133.52 144.91 54.18 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.11 169.35 69.92 Favored 'Cis proline' 0 N--CA 1.482 0.843 0 C-N-CA 124.086 -1.214 . . . . 0.0 112.587 -0.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 30' ' ' VAL . 10.9 p -61.58 110.94 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -111.01 -133.63 6.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.469 HD11 ' C ' ' A' ' 56' ' ' MET . 68.8 mt -65.75 139.74 97.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.98 168.28 17.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.576 1.517 . . . . 0.0 112.674 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.36 -2.77 36.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.694 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -90.82 19.82 5.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.624 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -140.39 30.1 1.96 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.608 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 25.4 mt -69.09 -46.97 30.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.111 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.38 -21.3 13.47 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 121.129 1.219 . . . . 0.0 112.657 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -77.05 -26.74 53.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.632 HD21 ' CD1' ' A' ' 63' ' ' TYR . 5.3 mt -97.87 34.44 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.0 t -90.02 141.62 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m 60.8 34.75 19.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.8 mmm -97.03 129.56 44.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.32 136.42 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.407 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.95 163.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.402 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -112.76 32.23 5.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.414 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -178.84 161.13 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.429 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.36 126.6 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.91 94.97 47.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.17 179.85 5.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.07 142.04 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.549 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.25 56.4 6.3 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 m -134.7 118.03 16.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.36 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -62.07 100.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.88 110.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.469 ' C ' HD11 ' A' ' 32' ' ' ILE . 24.0 mtt -95.37 163.08 22.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.455 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.71 -26.85 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.869 1.713 . . . . 0.0 112.685 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.16 -33.15 67.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.431 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.33 -36.6 68.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.432 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 56' ' ' MET . 24.9 t -79.89 110.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -71.88 122.64 21.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.444 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.49 -31.61 7.46 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 63.7 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.054 0.454 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -126.31 -177.48 3.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.37 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.16 87.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.354 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -89.52 147.8 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.309 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -72.84 129.97 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.452 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -107.9 31.08 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.74 158.09 0.77 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.05 98.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.56 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.1 mt -89.48 112.91 54.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.942 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.8 151.95 19.2 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.386 1.39 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.51 155.06 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.01 32.89 19.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.472 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -134.19 151.52 51.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.99 151.35 24.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.608 ' CD2' HG21 ' A' ' 11' ' ' ILE . 23.6 mt -84.89 170.81 12.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.393 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -150.33 166.71 29.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.38 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.03 -32.39 72.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.356 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.43 -30.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.458 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.4 mtm -99.1 31.29 3.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.629 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' HE2' ' A' ' 22' ' ' MET . 26.5 mtm -150.03 151.43 33.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.05 -177.2 6.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -120.77 100.63 7.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.91 144.33 37.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.84 129.03 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.324 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.05 154.02 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -114.18 139.53 23.86 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.6 Cg_endo -80.36 142.14 59.53 Favored 'Cis proline' 0 N--CA 1.483 0.855 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.475 0.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 30' ' ' VAL . 14.0 m -60.64 91.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.874 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.67 -111.94 0.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 56' ' ' MET . 58.4 mt -78.67 139.05 58.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -79.69 173.04 13.45 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.544 1.496 . . . . 0.0 112.525 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.07 14.18 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.559 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 14.89 12.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.405 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -145.57 29.79 1.12 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.4 mt -60.94 -47.33 95.85 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -75.76 -16.95 18.3 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.142 1.228 . . . . 0.0 112.914 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -82.56 -25.66 33.12 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 63' ' ' TYR . 3.3 mp -97.76 34.37 1.89 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.026 0.441 . . . . 0.0 110.731 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -83.59 134.22 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.309 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.523 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.7 t 60.86 35.8 19.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' LEU . 74.8 mmm -84.51 129.25 34.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.459 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -81.44 129.82 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.428 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.23 172.86 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.404 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -106.55 -33.82 7.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.391 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.36 -177.63 3.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.32 141.44 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.504 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.27 91.08 23.69 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.3 Cg_endo -80.44 -171.54 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.678 1.585 . . . . 0.0 112.671 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -67.0 143.32 56.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.438 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.83 49.75 27.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -132.85 114.42 14.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.321 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.6 m -61.86 104.57 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.73 111.22 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.591 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mmt -97.2 163.84 19.05 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.79 -24.62 4.82 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 121.628 1.552 . . . . 0.0 112.941 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.77 -25.73 59.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.0 mtm -98.23 30.21 3.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 56' ' ' MET . 48.2 t -140.2 106.31 2.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.017 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.79 121.62 14.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -31.37 8.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.472 ' CE1' HD11 ' A' ' 40' ' ' LEU . 37.0 t80 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.497 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m -131.17 -174.0 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.08 89.54 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.481 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.12 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.233 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -77.86 137.0 38.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.373 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -112.4 29.52 7.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.633 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.3 157.06 1.29 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.975 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 10' ' ' LEU . 32.8 tp -70.59 97.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.583 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -89.56 125.4 61.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.1 151.16 13.93 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.653 1.568 . . . . 0.0 112.518 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.13 152.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 59.79 36.66 22.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 16' ' ' ALA . 25.7 m -133.31 159.56 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.439 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -89.15 150.47 22.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.464 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.583 ' CD2' HG21 ' A' ' 11' ' ' ILE . 16.6 mt -90.2 175.1 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 p -144.6 -170.94 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.096 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.32 -38.7 26.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.775 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.52 -25.87 37.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.8 mtm -99.19 31.07 3.19 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 37' ' ' ILE . 13.8 mtm -150.18 125.81 10.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -143.76 -178.95 6.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.399 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -114.76 126.58 55.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.406 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.5 136.41 10.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.33 112.36 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.06 149.06 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -108.51 145.16 30.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.38 164.26 80.05 Favored 'Cis proline' 0 N--CA 1.481 0.759 0 C-N-CA 124.106 -1.206 . . . . 0.0 112.532 0.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.7 p -61.56 118.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.33 -130.85 5.3 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.431 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -72.84 139.37 80.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.85 161.9 18.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.632 1.555 . . . . 0.0 112.843 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.48 -23.96 66.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -59.84 -18.89 47.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.541 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 40' ' ' LEU . 7.3 m-20 -109.91 40.09 1.99 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 111.438 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 55.0 mt -85.69 -46.63 0.6 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -78.07 -15.01 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.179 1.253 . . . . 0.0 113.078 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -86.17 -26.61 25.05 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.641 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 63' ' ' TYR . 11.1 mp -93.45 47.87 1.27 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.265 0.555 . . . . 0.0 110.588 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 38' ' ' PRO . 28.6 t -90.15 134.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.251 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.717 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 51.4 m 61.24 32.88 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.45 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.8 mmm -86.02 140.36 30.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.316 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -96.88 144.39 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.522 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 49' ' ' VAL . 25.7 m -110.41 175.55 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -90.52 -38.28 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -177.33 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.27 132.38 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.512 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 45' ' ' VAL . 22.1 t -116.67 91.99 36.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.0 Cg_endo -80.75 -171.23 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.748 1.632 . . . . 0.0 112.613 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.1 mp -71.06 148.65 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.28 32.23 72.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.5 m -116.7 114.92 24.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 110.271 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 m -61.97 100.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.405 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.29 113.43 2.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.442 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 60' ' ' VAL . 7.3 mtt -98.81 159.5 30.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.98 -27.71 2.36 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 121.918 1.745 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.09 -33.44 75.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.43 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.0 mtm -77.55 -33.51 54.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.382 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 56' ' ' MET . 29.5 t -79.85 102.71 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.46 125.82 27.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.71 -31.54 7.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.789 ' CE1' HD11 ' A' ' 40' ' ' LEU . 35.9 t80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.285 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 121.105 0.479 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.24 -172.41 2.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.9 151.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.278 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.14 150.17 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.28 120.88 25.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.368 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -99.7 31.54 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.59 166.16 1.74 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.058 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' HD11 ' A' ' 51' ' ' LEU . 21.0 tp -72.26 102.74 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.262 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.494 HG12 ' HE3' ' A' ' 21' ' ' MET . 46.6 mt -103.58 103.37 35.71 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.79 163.79 20.78 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.563 1.509 . . . . 0.0 112.553 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -61.2 153.82 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.414 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 60.35 37.1 20.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.536 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 m -129.29 132.66 47.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 142.6 50.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 43' ' ' MET . 35.9 mt -82.74 163.71 21.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -150.22 175.79 11.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.304 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.61 -34.14 77.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.336 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.95 -29.69 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.553 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.494 ' HE3' HG12 ' A' ' 11' ' ' ILE . 28.7 mtp -95.16 22.73 6.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.213 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mtm -150.5 143.04 24.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.112 0.482 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -160.04 177.53 10.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 m -111.41 137.19 49.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -171.72 139.06 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.83 123.54 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.301 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.56 173.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -128.33 145.34 55.35 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.365 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.74 -179.97 25.9 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.494 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.87 102.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.91 -131.47 7.37 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.564 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -73.23 139.56 79.08 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -82.79 169.49 13.34 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.606 1.537 . . . . 0.0 112.902 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.18 -24.89 65.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.47 -19.28 46.54 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.38 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 40' ' ' LEU . 39.5 m-20 -106.71 35.75 2.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.087 0.47 . . . . 0.0 111.45 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 34' ' ' ALA . 46.9 mt -81.06 -46.7 1.15 Allowed Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.562 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -77.43 -24.44 9.15 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.175 1.25 . . . . 0.0 112.529 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -78.41 -20.38 51.24 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.885 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.758 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.7 mp -97.19 30.31 2.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.972 0.415 . . . . 0.0 110.793 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.5 t -88.39 135.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.135 0.493 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.79 33.7 17.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.438 ' HE1' ' HB2' ' A' ' 63' ' ' TYR . 17.2 mtp -97.88 119.63 36.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.279 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -79.91 138.71 37.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.459 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.38 -179.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -110.13 -25.21 10.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -128.65 171.59 12.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.11 0.481 . . . . 0.0 110.544 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.45 144.36 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.9 92.49 12.67 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -78.91 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 121.632 1.555 . . . . 0.0 112.686 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.6 mp -61.04 153.55 25.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.675 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.76 53.1 46.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -135.32 117.63 15.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.096 0.474 . . . . 0.0 110.354 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -63.01 104.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.475 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.538 HD23 HD23 ' A' ' 40' ' ' LEU . 7.9 tp -60.83 114.41 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.451 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.564 ' C ' HD11 ' A' ' 32' ' ' ILE . 30.4 mtt -99.92 163.8 17.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.9 -24.79 5.64 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 121.738 1.625 . . . . 0.0 112.757 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.44 -32.31 64.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.453 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.9 mtm -71.67 -38.59 70.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.436 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.8 t -80.23 107.2 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.02 124.81 23.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.64 -29.8 10.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 110.335 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 121.186 0.517 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -93.6 -171.13 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.47 149.07 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.1 t -146.59 150.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.7 122.14 20.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.244 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.77 -17.79 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -149.27 174.5 12.34 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 0.0 110.576 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 100.64 1.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.733 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.68 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.7 mt -89.98 116.94 67.58 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.937 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.68 147.88 15.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.436 1.424 . . . . 0.0 112.635 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.4 tt -61.1 155.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 61.01 33.25 19.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -133.84 152.62 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.61 138.07 32.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' CD2' HG21 ' A' ' 11' ' ' ILE . 18.7 mt -74.6 172.82 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.419 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -150.19 164.22 36.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.339 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.3 mp -62.5 -31.57 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.484 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.44 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.7 mtm -99.56 35.85 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 0.0 110.544 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.6 mtm -149.99 149.34 30.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.594 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -157.17 166.78 32.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.348 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.6 t -102.5 92.33 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.508 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -126.81 140.02 52.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.6 t -80.19 131.18 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -152.84 -177.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -136.75 139.31 28.67 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.292 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -77.92 148.85 86.46 Favored 'Cis proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.119 -1.2 . . . . 0.0 112.436 0.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.92 91.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.621 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.41 -124.93 0.71 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 56' ' ' MET . 64.7 mt -70.78 139.0 85.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.53 179.45 6.34 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.513 1.475 . . . . 0.0 112.617 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -89.92 13.45 14.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.56 -25.35 20.25 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.994 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 40' ' ' LEU . 11.8 m-20 -98.24 31.02 2.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 34' ' ' ALA . 75.3 mt -66.99 -47.4 52.93 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.51 -24.01 10.89 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 121.036 1.157 . . . . 0.0 112.572 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -26.78 53.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.698 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.759 HD21 ' CD2' ' A' ' 63' ' ' TYR . 6.3 mt -98.21 33.6 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.3 t -88.89 136.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.724 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 64.6 m 60.93 36.08 18.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 mmm -92.45 133.08 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -82.61 131.76 35.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.3 152.47 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.326 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -79.81 -21.86 43.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -145.05 -179.94 6.95 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.55 154.57 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.88 93.86 4.44 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.383 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.49 -176.79 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.683 1.588 . . . . 0.0 112.484 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.69 152.67 30.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.26 57.89 13.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -138.91 113.51 9.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.215 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -61.05 107.53 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.598 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.91 109.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.574 ' C ' HD11 ' A' ' 32' ' ' ILE . 17.0 mtt -97.99 160.8 27.53 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.289 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.45 -23.88 5.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.834 1.689 . . . . 0.0 112.978 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -71.19 -43.28 67.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.0 ptp -67.08 -29.07 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.04 104.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.161 0.505 . . . . 0.0 110.167 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -66.66 121.91 16.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.27 -31.53 7.57 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.759 ' CD2' HD21 ' A' ' 40' ' ' LEU . 50.1 t80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.297 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.043 0.449 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.61 -171.96 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.425 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.39 85.73 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.92 152.28 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.323 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.88 126.61 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.78 31.97 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -178.55 164.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 10' ' ' LEU . 30.2 tp -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.408 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 17' ' ' LEU . 45.6 mt -102.61 104.35 37.85 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.11 174.79 10.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.551 1.501 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.1 154.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.419 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 60.31 33.79 20.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -128.27 130.91 48.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.455 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 146.79 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' MET . 26.7 mt -87.43 164.96 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.473 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 p -150.27 -171.74 3.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.195 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.94 -45.62 57.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG23 ' HG3' ' A' ' 21' ' ' MET . 29.2 m -64.57 -24.3 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.006 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.463 ' HG3' HG23 ' A' ' 20' ' ' VAL . 27.0 mtp -95.8 25.33 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.4 mtm -150.41 152.23 34.02 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 110.312 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -159.98 176.72 11.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.57 116.75 28.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' OE1' HG13 ' A' ' 27' ' ' VAL . 4.0 tm-20 -152.03 139.07 19.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.11 113.41 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.429 HG13 ' OE1' ' A' ' 25' ' ' GLU . 27.4 m -140.11 178.97 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.431 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -131.44 145.47 57.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.286 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.13 168.11 70.74 Favored 'Cis proline' 0 N--CA 1.481 0.772 0 C-N-CA 124.142 -1.191 . . . . 0.0 112.561 -0.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 95.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.372 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -122.1 3.46 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.88 139.51 46.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.01 165.82 14.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 121.664 1.576 . . . . 0.0 112.78 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -68.99 -14.3 62.96 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -72.12 -7.99 52.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.704 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -116.34 28.94 8.26 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.166 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 49.8 mt -69.75 -46.99 24.84 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.79 -16.21 16.5 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.127 1.218 . . . . 0.0 112.9 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -82.58 -25.3 33.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.715 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.4 mt -96.38 40.02 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -90.12 132.57 34.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.247 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 m 60.69 57.24 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.582 ' HB2' HD12 ' A' ' 17' ' ' LEU . 68.4 mmm -119.88 133.07 55.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.429 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.85 133.18 33.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.505 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.1 -177.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -105.53 -35.65 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -133.03 -177.21 4.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.373 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.53 115.36 11.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.481 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -111.43 93.18 18.27 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.336 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.61 -176.26 3.09 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 121.75 1.633 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 51' ' ' LEU . 2.4 mp -62.17 147.92 46.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.4 44.63 64.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.481 HG21 HG13 ' A' ' 49' ' ' VAL . 26.1 m -127.87 116.72 20.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.147 0.498 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.4 m -62.26 101.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.87 111.73 2.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.2 mtt -91.01 158.82 41.13 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.324 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.4 -26.38 4.09 Favored 'Trans proline' 0 N--CA 1.474 0.373 0 C-N-CA 121.793 1.662 . . . . 0.0 112.737 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.79 -31.94 59.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.501 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.4 mtp -68.38 -38.36 81.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.71 109.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.384 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.19 120.29 12.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.29 -31.85 7.1 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.615 ' CD2' HD21 ' A' ' 40' ' ' LEU . 46.3 t80 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 110.362 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.084 0.469 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -94.09 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 91.99 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.77 153.04 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.301 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 128.65 35.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.416 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.77 31.86 4.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.6 163.34 1.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 10' ' ' LEU . 33.5 tp -73.08 96.57 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.7 mt -90.08 111.77 48.63 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.01 153.9 16.98 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.524 1.483 . . . . 0.0 112.755 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 46' ' ' ASN . 14.2 tt -61.39 154.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.417 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 60.2 33.63 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.556 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 16' ' ' ALA . 10.6 m -130.61 159.66 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' N ' HG22 ' A' ' 15' ' ' THR . . . -89.84 151.53 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 72.9 mt -90.0 165.77 13.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.439 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.2 p -148.28 165.45 30.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.381 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.7 -31.62 71.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.17 -31.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.314 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.0 mtm -99.26 31.07 3.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.593 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.5 mtm -150.05 140.49 22.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.435 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -160.1 -177.36 6.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.15 124.14 51.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.377 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.65 145.51 22.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.07 121.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.348 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.67 159.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -120.3 145.77 41.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.88 166.19 72.13 Favored 'Cis proline' 0 N--CA 1.481 0.736 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.651 -0.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.19 99.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.35 -123.57 3.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.545 HD11 ' C ' ' A' ' 56' ' ' MET . 57.2 mt -76.35 139.55 68.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.25 164.37 17.13 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.71 1.607 . . . . 0.0 112.797 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.41 -21.17 65.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.223 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -64.03 -15.55 59.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.513 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' O ' HD12 ' A' ' 40' ' ' LEU . 2.1 m-20 -110.27 28.1 8.96 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.494 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 mt -71.09 -46.94 14.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.0 -19.32 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.204 1.269 . . . . 0.0 112.844 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -80.91 -24.72 38.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 2.1 mt -96.58 37.65 1.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.102 0.477 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.94 138.57 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.242 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 60.87 35.94 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.627 ' HG3' HD23 ' A' ' 40' ' ' LEU . 86.9 mmm -92.01 143.64 26.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.457 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -103.88 138.25 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.95 175.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.442 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.4 p-10 -102.54 -31.38 10.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.561 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -121.83 -179.44 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.72 155.72 33.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.451 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -150.61 90.75 4.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -79.63 -175.29 2.65 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 121.705 1.603 . . . . 0.0 112.657 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -61.73 151.73 33.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.57 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 51.59 48.36 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.451 HG21 HG13 ' A' ' 49' ' ' VAL . 24.7 m -133.62 122.04 22.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.126 0.489 . . . . 0.0 110.427 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -66.64 102.59 0.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.452 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.54 114.05 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.545 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.6 mtt -98.44 161.22 25.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.378 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.6 -26.18 4.04 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.47 -32.86 60.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.361 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.52 -32.77 71.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.425 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -86.84 107.58 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.269 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -66.77 123.07 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.79 -30.95 8.44 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 56.7 t80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 121.134 0.492 . . . . 0.0 110.338 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.171 0.51 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -108.67 -175.07 2.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.398 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.68 149.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -150.14 149.6 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.95 127.58 32.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.345 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -105.62 30.68 5.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 160.31 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.121 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -69.48 98.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.43 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.47 112.24 50.43 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 160.94 18.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 121.568 1.512 . . . . 0.0 112.575 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -65.98 154.96 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.31 33.16 20.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 m -130.84 147.96 52.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -81.58 155.76 25.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.432 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.79 169.45 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.368 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.18 163.38 38.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.23 -32.83 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.44 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.65 -31.24 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.428 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.6 mtm -99.29 31.61 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.9 mtm -150.11 138.69 20.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -159.71 163.53 34.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.425 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -90.3 132.34 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.414 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -167.36 136.75 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.89 112.18 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -141.84 153.09 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 t -114.3 144.5 31.82 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.28 152.56 84.01 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.092 -1.212 . . . . 0.0 112.495 0.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.07 113.12 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.452 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.81 -113.05 3.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 40' ' ' LEU . 57.2 mt -83.19 139.5 42.18 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.42 165.74 18.38 Favored 'Trans proline' 0 N--CA 1.476 0.462 0 C-N-CA 121.612 1.541 . . . . 0.0 112.946 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.34 -13.54 62.09 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.4 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.02 -10.21 57.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.609 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 m-20 -115.63 28.65 8.51 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.285 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 HD11 ' HB1' ' A' ' 34' ' ' ALA . 49.5 mt -71.12 -46.79 14.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.825 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 Cg_endo -77.35 -22.67 10.77 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.153 1.235 . . . . 0.0 112.71 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -79.03 -24.52 43.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 63' ' ' TYR . 20.1 mt -97.22 35.86 1.54 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.6 t -90.12 137.42 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.5 p 56.51 45.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.802 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.648 ' SD ' HD23 ' A' ' 40' ' ' LEU . 14.9 mtp -104.14 142.26 34.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.89 136.55 32.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.33 176.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.431 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -93.87 -36.38 12.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -134.7 -177.07 4.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.564 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.79 121.17 21.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.44 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.94 101.79 31.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.151 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.34 176.82 9.26 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 121.51 1.473 . . . . 0.0 112.691 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.0 mp -61.23 151.06 32.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.565 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.07 54.9 29.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -135.82 116.71 14.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 m -61.99 108.86 1.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.5 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -61.3 113.06 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.472 ' C ' HD11 ' A' ' 32' ' ' ILE . 6.7 mmt -94.29 156.39 38.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.346 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -79.9 -24.74 5.68 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.853 1.702 . . . . 0.0 112.778 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -74.64 -31.37 61.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.3 mtm -71.91 -37.78 70.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.73 102.08 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.357 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -66.93 128.72 37.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.61 -29.43 11.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.751 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.1 t80 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.341 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.068 0 CA-C-O 121.078 0.466 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.59 -171.99 2.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -112.22 86.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.566 HG21 HG11 ' A' ' 27' ' ' VAL . 60.0 t -89.88 151.38 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -66.97 154.91 39.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -115.22 -17.52 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.46 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.451 ' HA ' HD21 ' A' ' 51' ' ' LEU . 6.7 pt20 -149.42 -179.92 7.45 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.069 0.461 . . . . 0.0 110.494 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' HD11 ' A' ' 51' ' ' LEU . 31.0 tp -71.08 101.36 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.783 HG23 ' CE ' ' A' ' 21' ' ' MET . 37.4 mt -96.95 109.98 51.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.38 154.24 21.38 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.524 1.483 . . . . 0.0 112.782 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.1 tt -61.49 155.45 4.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 60.28 40.99 17.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 m -139.22 138.45 36.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.64 150.53 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.401 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 ' HB2' ' A' ' 43' ' ' MET . 50.5 mt -90.24 164.72 14.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 p -150.08 175.24 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.443 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.28 -33.06 73.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.372 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.57 -28.35 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.783 ' CE ' HG23 ' A' ' 11' ' ' ILE . 32.4 mtp -97.65 29.09 3.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.8 mtm -150.27 140.32 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -148.14 177.52 9.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.398 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.78 108.24 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.458 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -146.62 144.58 29.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.34 120.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.345 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 6' ' ' VAL . 27.6 m -144.51 165.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.399 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 t -122.7 145.45 45.24 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.33 174.98 43.82 Favored 'Cis proline' 0 N--CA 1.481 0.767 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.446 -0.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.22 108.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.49 -120.99 4.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.654 HD13 ' CD2' ' A' ' 40' ' ' LEU . 55.5 mt -85.58 139.71 35.74 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -83.08 166.33 14.61 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.63 1.553 . . . . 0.0 112.68 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -70.47 -23.2 62.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.73 -13.9 60.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.475 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 40' ' ' LEU . 73.1 m-20 -110.76 24.37 13.03 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.603 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 43.6 mt -66.09 -46.88 63.27 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.706 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -76.7 -15.61 17.01 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 121.122 1.215 . . . . 0.0 112.82 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.41 -25.75 33.41 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.71 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD2' HD13 ' A' ' 32' ' ' ILE . 5.1 mp -97.26 36.24 1.49 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.787 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.2 t -86.06 139.72 16.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m 60.99 34.42 19.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.56 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.791 ' HB2' HD12 ' A' ' 17' ' ' LEU . 21.8 mmm -84.15 148.62 26.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.399 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -112.77 124.78 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -95.0 -178.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.299 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -129.98 33.22 4.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -177.53 163.55 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.475 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.93 49.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.397 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.017 HG12 HG21 ' A' ' 53' ' ' THR . 12.5 t -149.75 98.27 3.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.054 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 10' ' ' LEU . 40.6 Cg_endo -81.61 -165.45 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.903 1.735 . . . . 0.0 112.923 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.5 mp -73.68 154.13 39.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.16 58.58 13.3 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.017 HG21 HG12 ' A' ' 49' ' ' VAL . 9.8 t -132.48 136.18 46.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -75.61 104.65 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.113 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.39 108.14 6.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -95.29 164.75 18.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.904 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 39.9 Cg_endo -80.36 -35.7 0.59 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 121.586 1.524 . . . . 0.0 112.657 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.35 -42.36 99.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.399 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtm -63.51 -30.45 71.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.61 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 56' ' ' MET . 31.7 t -88.39 127.79 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -81.42 122.32 27.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.028 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.5 -28.59 7.4 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 57' ' ' PRO . 9.0 t80 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 121.09 0.471 . . . . 0.0 110.536 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -74.55 126.83 31.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.426 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.27 152.56 18.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -134.22 -179.77 5.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.447 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.49 147.71 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.305 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.71 148.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.175 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.54 149.83 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -111.48 -23.1 10.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.32 178.44 8.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.974 0.416 . . . . 0.0 110.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 10' ' ' LEU . 31.9 tp -68.53 97.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.779 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.709 HG23 ' CE ' ' A' ' 21' ' ' MET . 43.5 mt -89.79 118.48 69.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.78 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.39 147.68 16.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.522 1.481 . . . . 0.0 112.631 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.0 tt -61.14 154.94 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.395 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 60.81 34.35 19.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.508 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -127.17 154.64 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.07 140.83 32.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.367 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 43' ' ' MET . 47.9 mt -82.53 167.13 18.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.473 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -143.92 -174.02 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -75.62 -31.9 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.36 -44.31 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.709 ' CE ' HG23 ' A' ' 11' ' ' ILE . 11.6 mtp -65.0 -29.11 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.728 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.46 149.08 23.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.345 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.06 179.35 8.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.84 135.81 51.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.381 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -178.0 141.92 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.7 121.85 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.247 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 167.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.457 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -125.73 138.97 33.01 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.315 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.59 137.17 42.01 Favored 'Cis proline' 0 N--CA 1.482 0.822 0 C-N-CA 124.075 -1.219 . . . . 0.0 112.481 0.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.5 m -59.26 106.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -112.62 2.78 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.565 HD11 ' C ' ' A' ' 56' ' ' MET . 63.9 mt -70.91 139.46 85.59 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.41 172.69 13.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.525 1.483 . . . . 0.0 112.729 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.52 -0.13 32.03 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.784 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.99 19.79 5.38 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 40' ' ' LEU . 70.1 m-20 -140.14 29.95 2.01 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.429 . . . . 0.0 110.751 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 20.7 mt -70.32 -46.85 20.31 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.147 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 39.4 Cg_endo -76.66 -4.2 14.7 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.075 1.183 . . . . 0.0 113.263 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -96.87 -25.82 15.31 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -97.53 35.31 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.04 142.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 60.67 32.61 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.497 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.606 ' HB2' HD12 ' A' ' 17' ' ' LEU . 49.6 mmm -94.4 136.66 34.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -100.24 119.08 37.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -79.9 166.59 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.427 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -110.32 32.11 5.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.519 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.61 ' HA ' HD12 ' A' ' 13' ' ' ILE . 9.4 ptm180 -178.37 159.65 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.21 130.19 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -123.23 95.19 46.0 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.316 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.04 -174.96 2.47 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 121.675 1.583 . . . . 0.0 112.625 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 51' ' ' LEU . 2.4 mp -61.66 146.94 47.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.549 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.7 0.77 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 m -145.0 114.4 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' PRO . 3.3 m -61.76 104.1 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.495 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -60.97 113.17 2.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.44 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.565 ' C ' HD11 ' A' ' 32' ' ' ILE . 10.2 mtt -96.9 163.1 20.85 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.68 -26.34 3.18 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 121.861 1.707 . . . . 0.0 112.703 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.14 -32.81 61.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.468 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtm -71.66 -36.77 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 56' ' ' MET . 28.6 t -80.02 108.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -66.95 119.18 11.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.49 -31.91 7.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 52.3 t80 -80.64 103.17 10.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.158 0.504 . . . . 0.0 110.376 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.6 173.71 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.442 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -131.26 130.87 43.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.59 177.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.439 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -144.56 -174.4 4.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.72 89.0 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.76 152.87 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.294 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.33 128.02 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -103.62 30.53 4.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.611 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -178.02 160.94 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.74 96.69 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.41 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 ' CD2' ' A' ' 17' ' ' LEU . 19.6 mt -90.74 111.62 48.88 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.97 159.27 18.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.632 1.555 . . . . 0.0 112.607 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.08 154.28 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 60.63 33.29 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -133.07 144.06 49.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -76.43 152.12 36.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 43' ' ' MET . 19.4 mt -90.09 168.25 12.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.364 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -148.66 169.38 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -65.3 -33.19 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.73 -30.08 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.708 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.0 mtm -100.13 31.18 3.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.443 ' HE3' HG23 ' A' ' 37' ' ' ILE . 27.8 mtm -150.13 144.5 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.457 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -160.05 175.87 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.427 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 t -104.24 128.61 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.419 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.92 145.5 8.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.96 127.92 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.333 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 m -154.16 162.8 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.389 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 t -123.91 140.06 33.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.08 140.12 52.29 Favored 'Cis proline' 0 N--CA 1.482 0.808 0 C-N-CA 124.155 -1.185 . . . . 0.0 112.452 0.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.59 107.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.818 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.38 -106.65 1.81 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.546 HD11 ' C ' ' A' ' 56' ' ' MET . 55.9 mt -82.07 139.46 45.91 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.32 165.78 18.57 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.523 1.482 . . . . 0.0 112.702 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -76.3 -3.76 38.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.68 1.7 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.718 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' HD12 ' A' ' 40' ' ' LEU . 42.7 m-20 -128.31 27.74 5.56 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.6 mt -62.2 -47.41 90.15 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.214 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.614 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.5 Cg_endo -75.78 -20.19 15.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.09 1.193 . . . . 0.0 112.674 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -77.1 -28.01 54.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -97.9 35.57 1.69 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.755 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' PRO . 24.3 t -90.29 142.04 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.327 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.441 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 5.2 m 60.67 32.44 20.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.6 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.61 ' HB2' HD12 ' A' ' 17' ' ' LEU . 38.2 mmm -95.59 139.94 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.473 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -89.25 140.88 29.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.491 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.75 148.01 7.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.303 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -79.81 -21.69 43.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.6 -178.36 5.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.16 24.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.57 92.53 24.24 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.292 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.3 179.44 6.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.742 1.628 . . . . 0.0 112.66 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.9 mp -62.06 151.61 34.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.599 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.96 40.26 93.41 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 m -129.53 118.97 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -62.31 109.74 1.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.44 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.15 114.91 5.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.389 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.546 ' C ' HD11 ' A' ' 32' ' ' ILE . 19.9 mtt -95.91 158.88 33.49 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.9 -26.89 3.35 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 121.827 1.685 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.91 -32.97 70.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.1 mtp -73.81 -33.73 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 56' ' ' MET . 26.3 t -80.03 104.83 8.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -65.22 121.09 13.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.48 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.16 -31.2 7.87 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 40' ' ' LEU . 56.1 t80 -88.58 149.77 23.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.061 0.458 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -166.38 103.81 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.396 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' NE2' HG21 ' A' ' 30' ' ' VAL . 25.1 pt20 -136.08 133.28 37.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.4 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.06 160.01 29.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -129.7 -174.73 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.362 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -107.92 144.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 7' ' ' ALA . 24.9 t -144.93 155.81 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -82.52 122.95 28.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -102.47 32.51 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.41 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.472 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -178.96 164.92 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.169 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' HD11 ' A' ' 51' ' ' LEU . 19.1 tp -71.94 104.44 3.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG23 ' CE ' ' A' ' 21' ' ' MET . 52.3 mt -103.17 104.15 38.83 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.07 164.59 19.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.58 1.52 . . . . 0.0 112.678 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.45 147.93 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.84 51.75 4.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.432 0.634 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -144.97 124.06 12.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.413 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.64 148.44 46.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.423 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 43' ' ' MET . 21.0 mt -88.94 166.67 13.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.513 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.646 ' OG1' HG12 ' A' ' 20' ' ' VAL . 30.7 p -150.25 -172.14 4.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.179 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.63 -31.43 63.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' OG1' ' A' ' 18' ' ' THR . 9.7 p -75.3 -26.59 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG3' HG13 ' A' ' 20' ' ' VAL . 33.1 mtp -96.98 27.32 4.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.968 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.491 ' HE3' HG23 ' A' ' 37' ' ' ILE . 25.8 mtm -150.41 148.98 29.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.079 0.466 . . . . 0.0 110.426 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -160.02 178.18 9.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.406 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 t -117.65 126.54 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -159.74 145.73 15.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.09 110.5 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.312 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.59 164.41 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -115.9 145.29 34.44 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.5 169.84 63.82 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 C-N-CA 124.097 -1.21 . . . . 0.0 112.592 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.1 p -61.76 112.16 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.81 -129.6 6.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.643 HD11 ' C ' ' A' ' 56' ' ' MET . 52.3 mt -78.59 139.64 58.98 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.08 163.22 17.88 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.58 1.52 . . . . 0.0 112.882 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.03 -14.58 63.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.401 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.96 -10.92 59.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.695 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.28 26.76 9.68 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.37 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 HD11 ' HB1' ' A' ' 34' ' ' ALA . 47.0 mt -66.74 -47.09 56.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.811 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.5 -22.52 12.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.13 1.22 . . . . 0.0 112.639 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -76.78 -25.02 52.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.5 mt -97.72 31.6 2.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.8 t -88.94 141.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.195 0.522 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.4 m 60.97 34.87 19.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.73 ' HB2' HD12 ' A' ' 17' ' ' LEU . 88.1 mmm -94.86 151.72 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.441 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -109.46 132.37 54.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.5 160.49 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -80.23 -33.96 37.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -131.63 -177.88 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.528 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 133.46 36.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.64 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 53' ' ' THR . 23.6 t -120.7 112.06 34.12 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.71 -176.13 3.02 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.533 1.489 . . . . 0.0 112.672 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.4 mp -69.28 155.17 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.499 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 33.76 88.1 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 49' ' ' VAL . 25.8 m -112.41 118.77 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.057 0.456 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -61.82 104.74 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.28 115.27 3.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.362 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.643 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.7 mtt -96.67 160.74 28.71 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.542 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.98 -26.98 3.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.917 1.744 . . . . 0.0 112.727 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.35 -33.14 61.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtm -68.21 -38.45 81.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.454 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 40' ' ' LEU . 23.3 t -79.98 108.32 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.359 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -65.14 121.17 14.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.405 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.05 -31.39 7.74 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.642 ' CD2' HD21 ' A' ' 40' ' ' LEU . 44.1 t80 -79.46 128.22 33.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.362 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.7 150.57 40.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.463 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.443 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.7 p30 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -81.01 -11.08 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.41 110.71 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.392 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -90.74 -173.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.17 92.3 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.398 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.76 151.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.77 126.07 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -102.67 31.42 4.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.66 168.26 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.2 tp -72.49 102.63 3.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG12 ' HE3' ' A' ' 21' ' ' MET . 47.4 mt -105.76 101.24 31.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.316 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.45 162.1 22.28 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.579 1.52 . . . . 0.0 112.58 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.4 tt -61.15 155.6 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.536 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.27 45.16 9.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.47 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 m -147.22 126.77 13.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -65.31 147.11 54.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.394 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 43' ' ' MET . 18.2 mt -81.69 168.96 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.41 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -150.32 -179.84 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.382 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mt -68.79 -37.84 79.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.34 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 21' ' ' MET . 23.4 m -71.19 -26.48 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.484 ' HE3' HG12 ' A' ' 11' ' ' ILE . 29.0 mtp -96.55 27.97 3.59 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.523 ' HE3' HG23 ' A' ' 37' ' ' ILE . 28.9 mtm -150.25 144.31 25.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.05 0.452 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -156.07 166.25 34.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.08 117.71 34.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -148.88 151.27 34.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.61 121.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.12 155.16 6.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.414 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -118.34 144.29 34.8 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.289 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.83 156.3 88.47 Favored 'Cis proline' 0 N--CA 1.481 0.77 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.463 0.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -60.97 112.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.505 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.75 -121.1 4.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 56' ' ' MET . 57.5 mt -75.5 139.61 71.35 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.16 159.11 17.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.689 1.592 . . . . 0.0 112.926 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -18.33 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.03 -13.86 60.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.541 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.9 m-20 -113.72 25.67 11.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.567 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 34' ' ' ALA . 40.8 mt -64.37 -47.46 77.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.703 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -76.72 -13.48 17.93 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 121.174 1.25 . . . . 0.0 113.011 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.64 -27.69 28.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.904 0.383 . . . . 0.0 110.647 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.609 HD11 ' CE1' ' A' ' 63' ' ' TYR . 1.8 mp -96.37 41.87 1.1 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.166 0.507 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 38' ' ' PRO . 23.2 t -90.1 135.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.395 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.594 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.8 t 60.3 37.5 20.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.611 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.615 ' HB2' HD12 ' A' ' 17' ' ' LEU . 95.8 mmm -91.5 140.24 29.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.268 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.22 143.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -110.47 160.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.386 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -113.43 31.93 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -178.59 172.43 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.6 142.33 37.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 92.06 7.55 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.4 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.33 -171.84 1.36 Allowed 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 121.743 1.629 . . . . 0.0 112.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.6 mp -63.03 147.75 49.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.68 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.15 61.26 6.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -139.54 118.36 12.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 110.384 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -61.71 104.21 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.481 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.52 110.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.439 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.406 ' C ' HD11 ' A' ' 32' ' ' ILE . 3.2 mtt -97.84 158.68 32.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.067 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.24 -18.51 11.07 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.734 1.623 . . . . 0.0 113.1 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -74.29 -40.26 62.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.954 0.407 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 60' ' ' VAL . 10.2 ptp -68.77 -30.4 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.457 HG23 ' HG3' ' A' ' 59' ' ' MET . 41.1 t -85.47 101.09 9.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.188 0.518 . . . . 0.0 110.11 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -64.47 126.96 29.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.27 -30.19 9.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.609 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 -89.58 114.38 25.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.032 0.444 . . . . 0.0 110.434 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -61.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.414 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.5 m120 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.11 105.27 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.6 -178.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -145.2 -177.15 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.479 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PRO . 20.5 t -98.56 92.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.98 145.7 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.221 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -68.12 120.73 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.448 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -102.32 30.93 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.35 158.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.939 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.7 tp -69.82 97.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.411 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.3 mt -89.74 117.8 68.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.032 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.8 153.48 17.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.544 1.496 . . . . 0.0 112.635 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -61.58 149.98 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.449 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.56 37.02 19.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.558 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -136.18 140.6 43.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -70.9 153.0 43.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.443 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 67.0 mt -88.47 172.66 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.28 165.4 33.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.343 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.1 -32.96 73.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.342 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 -30.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.374 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 mtm -98.84 32.32 2.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.422 ' HE3' HG23 ' A' ' 37' ' ' ILE . 26.6 mtm -149.22 144.26 26.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.307 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.07 158.02 32.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.406 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -94.19 104.31 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.508 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -141.04 142.68 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.42 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.56 129.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.422 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -155.52 161.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -119.57 144.18 36.28 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.2 160.47 85.76 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.524 0.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.35 96.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.48 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.19 -126.86 4.66 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.587 HD11 ' C ' ' A' ' 56' ' ' MET . 54.0 mt -73.66 139.19 77.34 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 5' ' ' VAL . 39.7 Cg_endo -81.11 -179.88 5.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.574 1.516 . . . . 0.0 112.471 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.55 17.12 7.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.565 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -90.4 -29.54 17.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.012 0.434 . . . . 0.0 110.599 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -99.09 31.81 2.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.958 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.74 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.9 mt -64.17 -47.55 78.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.607 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.04 -22.12 13.35 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.052 1.168 . . . . 0.0 112.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -77.59 -25.35 49.87 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.655 HD21 ' CG ' ' A' ' 63' ' ' TYR . 4.2 mt -98.06 31.14 2.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 38' ' ' PRO . 29.3 t -86.47 137.06 21.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.572 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 46.4 t 61.09 43.1 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.483 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 84.8 mmm -100.09 134.64 42.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.433 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.82 123.04 32.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.85 158.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.386 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -82.29 -31.84 29.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -132.36 -177.36 4.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.37 144.49 48.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.75 90.49 16.53 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.373 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 39.9 Cg_endo -80.01 -178.21 4.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.714 1.609 . . . . 0.0 112.642 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.27 144.66 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.68 56.63 8.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -143.95 119.7 10.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 m -63.47 124.13 20.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 tp -81.15 119.59 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.301 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.587 ' C ' HD11 ' A' ' 32' ' ' ILE . 21.3 mtt -96.49 155.56 37.77 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.95 -27.1 3.19 Favored 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 121.788 1.659 . . . . 0.0 112.699 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.27 -32.61 64.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.381 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -73.36 -35.0 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.447 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' MET . 22.1 t -79.81 112.63 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -71.48 120.67 17.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.392 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.65 7.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 40' ' ' LEU . 53.1 t80 -83.01 135.75 34.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.17 87.62 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.411 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.525 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' OE1' HG11 ' A' ' 30' ' ' VAL . 2.0 tt0 -102.49 132.82 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.03 113.37 25.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.402 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -101.33 -173.4 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.71 147.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -142.3 150.65 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.55 114.6 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.327 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -69.14 -27.21 65.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.91 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.62 -178.23 6.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.153 0.501 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.4 tp -71.11 102.63 2.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.721 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.835 HG23 ' CE ' ' A' ' 21' ' ' MET . 25.4 mt -89.95 127.41 53.92 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.77 150.89 14.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.632 1.555 . . . . 0.0 112.753 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.6 tt -67.61 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.16 35.14 21.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 m -129.8 148.29 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -77.19 136.53 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.46 170.34 15.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -150.27 168.41 24.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.0 -33.28 74.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.7 -28.59 34.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.435 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.835 ' CE ' HG23 ' A' ' 11' ' ' ILE . 26.3 mtp -94.74 24.23 4.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.302 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 mtm -150.14 132.57 15.63 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 121.051 0.453 . . . . 0.0 110.218 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -143.8 172.45 12.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 t -105.53 126.02 51.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.269 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -161.43 146.22 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.65 125.66 38.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.83 168.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.475 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t -124.54 146.09 51.3 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.44 169.24 66.39 Favored 'Cis proline' 0 N--CA 1.482 0.818 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.665 0.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG11 ' OE1' ' A' ' 2' ' ' GLN . 21.0 t -61.73 99.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.414 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.54 -127.14 4.87 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.517 HD11 ' C ' ' A' ' 56' ' ' MET . 55.1 mt -78.14 139.37 60.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.35 163.84 17.06 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.673 1.582 . . . . 0.0 112.894 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.54 -14.71 63.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.368 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -68.83 -10.89 59.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.656 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -118.52 30.61 7.11 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.36 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.575 HD11 ' HB1' ' A' ' 34' ' ' ALA . 43.5 mt -69.04 -47.36 29.85 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.795 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.2 Cg_endo -76.05 -24.37 11.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 120.992 1.128 . . . . 0.0 112.551 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -25.52 61.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.743 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' A' ' 43' ' ' MET . 1.6 mt -96.64 27.85 3.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.2 t -86.91 136.1 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.09 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 42.5 t 61.04 32.69 19.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.437 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.733 ' SD ' HD23 ' A' ' 40' ' ' LEU . 15.2 mtp -94.33 134.48 36.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.244 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -86.18 145.31 27.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.545 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.66 -178.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.342 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -109.07 -22.39 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.2 ptp180 -137.52 -178.47 5.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.83 161.22 30.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.6 t -148.19 93.72 4.37 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.245 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -80.13 -176.01 3.0 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.683 1.589 . . . . 0.0 112.606 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.496 ' H ' HD12 ' A' ' 51' ' ' LEU . 6.2 mp -65.01 154.26 38.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.577 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.3 46.02 95.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.9 m -128.61 109.74 11.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.482 . . . . 0.0 110.175 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -60.34 109.38 0.98 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.576 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.39 115.69 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.517 ' C ' HD11 ' A' ' 32' ' ' ILE . 5.7 mtt -96.34 158.57 33.66 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.39 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.63 -26.39 3.88 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 121.826 1.684 . . . . 0.0 112.755 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.49 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 mtm -70.4 -38.56 74.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.492 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HE1' ' A' ' 43' ' ' MET . 23.2 t -80.31 110.32 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -70.15 123.43 21.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.372 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.01 -31.35 7.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -76.08 145.23 40.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.137 0.494 . . . . 0.0 110.292 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -170.93 110.62 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.481 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.385 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 60.74 82.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.5 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.51 169.78 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.453 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 m -134.02 -172.19 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.45 89.4 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.364 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.82 151.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.0 128.45 35.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.476 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -103.28 30.16 5.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.559 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.25 161.21 1.42 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' N ' HD11 ' A' ' 51' ' ' LEU . 35.5 tp -71.75 94.83 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.61 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.4 mt -89.92 111.98 49.53 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.137 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.26 157.17 19.8 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.457 1.438 . . . . 0.0 112.575 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.08 154.83 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 61.25 33.23 19.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.484 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -130.51 153.17 49.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -86.87 148.16 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 ' CD2' HG21 ' A' ' 11' ' ' ILE . 14.7 mt -89.91 170.27 10.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -148.18 173.26 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.456 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.21 -32.4 73.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.48 -29.94 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.705 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.0 mtm -100.29 32.16 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.105 0.479 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.5 mtm -150.05 114.17 5.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.75 -178.04 4.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -109.63 113.36 26.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -137.82 142.31 40.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.46 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.98 82.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -114.53 146.12 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.41 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 t -111.25 141.97 25.44 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.306 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.2 Cg_endo -79.86 132.05 23.7 Favored 'Cis proline' 0 N--CA 1.482 0.828 0 C-N-CA 124.062 -1.224 . . . . 0.0 112.441 0.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.3 m -59.26 111.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.862 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.09 -94.19 1.09 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.475 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -90.01 139.73 27.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 167.05 16.29 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.677 1.585 . . . . 0.0 112.944 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.38 -26.4 66.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.837 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.16 -18.1 56.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' HD12 ' A' ' 40' ' ' LEU . 4.1 m-20 -110.4 35.73 3.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.407 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.8 mt -79.77 -46.84 1.49 Allowed Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.616 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 Cg_endo -77.13 -11.15 17.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.127 1.218 . . . . 0.0 113.084 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -85.68 -27.44 25.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.521 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' HG3' ' A' ' 43' ' ' MET . 3.7 mt -94.16 46.64 1.17 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' PRO . 32.8 t -90.16 133.89 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.309 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.513 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.2 m 60.79 38.33 18.14 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.652 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.651 ' HG3' HD23 ' A' ' 40' ' ' LEU . 76.2 mmm -95.31 137.55 34.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.12 144.55 25.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.12 163.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.4 -33.6 20.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -126.95 -177.74 4.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.486 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.59 122.1 24.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.88 90.67 28.21 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.46 -172.86 1.64 Allowed 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 121.741 1.627 . . . . 0.0 112.662 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -66.0 152.83 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.71 39.02 90.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -130.79 118.06 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.7 m -61.9 108.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD23 HD12 ' A' ' 32' ' ' ILE . 12.8 tp -61.73 114.95 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.604 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.3 mtt -93.22 150.03 38.43 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.345 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.19 -26.58 3.34 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.819 1.679 . . . . 0.0 112.635 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.46 -32.89 64.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mtm -74.27 -32.09 62.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 56' ' ' MET . 29.0 t -79.8 102.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.259 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -68.86 124.61 24.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.85 -31.74 7.28 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.8 t80 -62.89 -67.28 0.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.341 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.07 49.05 12.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.839 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.639 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -79.37 109.31 13.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.406 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.86 125.7 29.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.432 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -92.02 -171.51 2.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.391 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.72 90.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 7' ' ' ALA . 25.4 t -90.56 154.79 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -80.38 131.61 35.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.384 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -107.99 31.91 5.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.48 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.65 158.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.08 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -70.28 97.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.34 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG21 ' CD2' ' A' ' 17' ' ' LEU . 14.9 mt -89.75 112.14 50.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.079 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.35 157.49 19.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.507 1.471 . . . . 0.0 112.683 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.05 153.79 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.394 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 60.65 32.52 20.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -133.04 137.08 46.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.442 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -74.34 156.14 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' CD2' HG21 ' A' ' 11' ' ' ILE . 21.5 mt -90.07 169.9 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.0 p -150.1 174.62 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.41 -36.14 81.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.02 -30.1 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.443 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 mtp -96.78 26.79 4.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.1 mtm -150.36 141.68 23.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.343 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.69 -178.11 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -115.56 129.45 56.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -158.63 139.45 12.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.361 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.76 121.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -152.83 161.34 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.444 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.18 145.61 35.36 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.42 175.69 41.15 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 C-N-CA 124.12 -1.2 . . . . 0.0 112.563 0.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -65.55 117.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.57 -134.28 5.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.507 HD11 ' C ' ' A' ' 56' ' ' MET . 57.7 mt -72.92 139.33 79.9 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.65 164.18 16.26 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.663 1.575 . . . . 0.0 112.868 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.46 -25.04 66.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.946 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -58.98 -19.75 46.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.478 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HD13 ' A' ' 40' ' ' LEU . 65.6 m-20 -107.65 38.72 2.08 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.192 0.52 . . . . 0.0 111.483 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 34' ' ' ALA . 49.3 mt -84.06 -46.94 0.74 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.576 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.4 Cg_endo -78.35 -19.08 12.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.229 1.286 . . . . 0.0 112.853 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -83.73 -20.66 33.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.957 HD11 ' CE1' ' A' ' 63' ' ' TYR . 9.0 mp -97.31 32.01 2.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.008 0.433 . . . . 0.0 110.935 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' PRO . 36.7 t -79.5 140.08 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.037 0.446 . . . . 0.0 110.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.3 p 56.68 41.43 28.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.435 ' HB2' HD12 ' A' ' 17' ' ' LEU . 92.3 mmm -97.43 133.12 42.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -92.43 144.02 25.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.626 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -110.91 157.89 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.165 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.94 -30.19 39.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -128.04 -177.42 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.534 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.75 35.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.528 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.92 98.06 49.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.94 177.77 7.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.628 1.552 . . . . 0.0 112.714 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -64.32 150.11 46.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.2 32.22 75.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -116.81 117.94 31.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -61.87 104.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.464 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.85 115.53 4.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.507 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.3 mtt -100.35 160.26 27.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.65 -26.85 3.58 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 121.81 1.673 . . . . 0.0 112.615 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.83 -39.13 83.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 41.1 mtm -69.98 -32.18 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' MET . 42.8 t -82.77 95.36 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -66.02 127.37 31.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.7 -31.09 8.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.957 ' CE1' HD11 ' A' ' 40' ' ' LEU . 33.1 t80 -68.53 -70.29 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.266 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.54 85.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.925 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.688 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.472 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -143.08 149.89 38.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.407 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.49 160.55 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.438 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -149.87 -177.02 5.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.89 146.89 7.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 7' ' ' ALA . 26.1 t -142.89 156.08 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.121 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' N ' HG12 ' A' ' 6' ' ' VAL . . . -85.1 119.73 25.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.338 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -99.9 31.07 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.534 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -179.42 164.45 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.02 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.658 ' N ' HD11 ' A' ' 51' ' ' LEU . 23.2 tp -71.72 101.09 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.479 HG23 ' CE ' ' A' ' 21' ' ' MET . 31.2 mt -96.5 108.93 45.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.73 -178.6 4.29 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.56 1.507 . . . . 0.0 112.589 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.04 154.66 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 60.62 33.98 20.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.526 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -130.42 131.47 45.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.2 157.1 36.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' A' ' 43' ' ' MET . 86.5 mt -90.18 165.55 13.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.3 p -150.08 171.14 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.336 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.26 -34.03 75.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -30.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.453 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' HG23 ' A' ' 11' ' ' ILE . 25.4 mtp -94.52 21.21 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mtm -150.42 140.14 21.72 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.983 0.42 . . . . 0.0 110.425 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.13 176.37 11.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -103.05 142.81 33.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.372 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -170.88 140.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.467 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.67 96.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.19 172.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -131.46 145.72 58.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.5 167.33 71.16 Favored 'Cis proline' 0 N--CA 1.481 0.782 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.522 0.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.17 92.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.47 -126.61 2.31 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 56' ' ' MET . 44.0 mt -73.88 139.66 76.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.18 163.69 15.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.661 1.574 . . . . 0.0 112.653 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.66 67.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.62 -22.42 45.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 m-20 -109.9 37.98 2.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.149 0.499 . . . . 0.0 111.443 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 58.8 mt -81.31 -46.98 1.11 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.607 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.35 -22.35 11.02 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 121.164 1.243 . . . . 0.0 112.592 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -79.18 -22.56 44.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 36' ' ' ASP . 5.7 mp -96.83 28.78 3.31 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.1 t -84.29 145.21 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.566 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.8 m 60.92 32.87 20.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.444 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.651 ' HB2' HD12 ' A' ' 17' ' ' LEU . 72.3 mmm -94.83 134.71 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.423 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.27 141.52 28.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.458 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 m -102.12 170.68 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.47 -31.4 15.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.614 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.74 167.91 21.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.0 120.36 13.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 53' ' ' THR . 22.9 t -105.89 114.29 62.89 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.123 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.2 -176.71 3.26 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 121.534 1.489 . . . . 0.0 112.604 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 10' ' ' LEU . 6.4 mp -70.58 157.16 38.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.416 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.41 31.93 82.41 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 49' ' ' VAL . 13.3 m -113.33 118.71 35.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.065 0.459 . . . . 0.0 110.385 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.9 m -61.81 105.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.27 115.5 3.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.484 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 60' ' ' VAL . 35.4 mtt -101.46 155.65 36.11 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.1 -27.61 2.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.887 1.725 . . . . 0.0 112.629 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -64.84 -37.11 86.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.403 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.4 mtm -75.66 -34.8 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.404 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 56' ' ' MET . 26.5 t -79.94 111.2 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.289 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -82.82 129.75 35.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.85 -32.2 6.73 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.732 ' CZ ' ' HB2' ' A' ' 65' ' ' ALA . 1.7 t80 -63.49 115.57 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.14 0.495 . . . . 0.0 110.346 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.18 -52.7 8.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.579 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.732 ' HB2' ' CZ ' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.477 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.45 160.98 41.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.4 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.63 125.56 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.512 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 m -108.0 175.91 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.24 143.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.228 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.78 147.91 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.313 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.94 106.25 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.63 -28.69 67.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.8 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.505 ' HA ' HD21 ' A' ' 51' ' ' LEU . 4.2 pt20 -149.79 -177.97 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.114 0.483 . . . . 0.0 110.364 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 50' ' ' PRO . 30.3 tp -70.81 103.56 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.627 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 17' ' ' LEU . 9.2 mt -89.32 132.49 37.29 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.912 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.9 152.73 14.65 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.656 1.571 . . . . 0.0 112.744 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ARG . 14.2 tt -70.69 150.18 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 60.39 32.75 20.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.538 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -130.34 141.39 50.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -68.88 140.62 55.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HG21 ' A' ' 11' ' ' ILE . 74.0 mt -78.22 169.81 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -150.15 167.51 26.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.397 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.3 -32.47 73.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.316 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -65.24 -30.6 50.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.634 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.432 ' CE ' HG23 ' A' ' 11' ' ' ILE . 14.3 mtm -103.65 27.86 7.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 mtp -145.89 132.21 19.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.369 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.12 -179.57 7.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.1 136.61 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -169.13 143.9 3.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.62 110.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.327 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.77 167.45 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.49 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.94 143.56 49.19 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.327 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.15 163.44 82.31 Favored 'Cis proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.55 0.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.6 p -61.72 120.89 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.87 -130.64 4.7 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.46 HD11 ' C ' ' A' ' 56' ' ' MET . 67.5 mt -67.5 139.78 94.45 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.71 160.65 19.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.64 1.56 . . . . 0.0 112.921 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -18.47 64.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -66.37 -13.45 60.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.6 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 40' ' ' LEU . 61.9 m-20 -113.58 23.31 13.26 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.532 HD11 ' HB1' ' A' ' 34' ' ' ALA . 38.4 mt -62.25 -47.42 89.89 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.703 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.62 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.8 Cg_endo -76.5 -19.09 15.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 121.14 1.227 . . . . 0.0 112.848 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -77.97 -27.72 49.24 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -98.11 35.03 1.81 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' PRO . 30.1 t -88.01 139.73 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.272 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 1.6 t 60.9 32.62 20.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.542 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 mtp -95.6 135.76 36.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.33 145.29 24.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.502 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.54 174.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -92.46 -30.98 15.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HA ' HD12 ' A' ' 13' ' ' ILE . 7.3 ptp180 -134.05 -177.54 4.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.339 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.41 149.34 46.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.207 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.8 90.51 36.03 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.51 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 10' ' ' LEU . 38.8 Cg_endo -78.63 176.4 9.93 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 121.829 1.686 . . . . 0.0 112.611 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -62.59 137.75 58.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.749 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.59 -31.99 7.5 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 108.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.138 0.494 . . . . 0.0 110.519 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -63.01 118.61 8.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.43 113.47 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 60' ' ' VAL . 2.5 mtt -99.73 158.42 32.15 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.34 -25.9 4.45 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 121.824 1.683 . . . . 0.0 112.714 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.06 -32.5 61.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 16.3 mtm -73.98 -36.02 64.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.56 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 56' ' ' MET . 25.6 t -79.84 104.54 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.281 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.37 127.42 32.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.441 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.16 -30.78 8.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.622 ' CE1' HD11 ' A' ' 40' ' ' LEU . 41.5 t80 -64.88 -66.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.05 0.452 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.9 79.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.636 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.605 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 60.55 101.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.543 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.27 176.48 9.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.04 -171.74 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.352 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -119.33 87.03 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.376 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.7 153.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.376 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.28 122.22 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.56 30.76 3.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.87 167.73 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' N ' HD11 ' A' ' 51' ' ' LEU . 26.1 tp -72.62 102.62 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 27.1 mt -95.99 109.1 44.93 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.21 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.83 166.7 17.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.595 1.53 . . . . 0.0 112.643 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -73.29 154.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.37 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 60.38 32.28 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 m -132.38 146.59 52.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.405 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -82.07 148.75 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.401 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 11' ' ' ILE . 68.6 mt -80.5 169.83 17.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -150.19 170.31 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mp -62.11 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.87 -28.22 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.449 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mtp -97.15 29.13 3.26 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.6 mtm -150.29 150.13 31.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.212 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -160.13 167.23 28.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -107.51 103.13 12.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -142.05 146.77 35.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.91 125.64 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.316 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -153.31 156.75 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 t -109.72 145.05 31.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.357 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.09 161.61 85.0 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.49 0.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.99 113.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.37 -126.05 5.0 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 56' ' ' MET . 56.9 mt -73.96 139.18 76.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.88 172.3 12.21 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.631 1.554 . . . . 0.0 112.688 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.38 -1.9 32.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.783 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.22 6.12 23.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.642 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 40' ' ' LEU . 42.3 m-20 -127.26 31.96 5.14 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.105 0.479 . . . . 0.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 33.5 mt -73.37 -46.39 7.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.206 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.1 Cg_endo -75.88 -24.29 11.62 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 121.065 1.177 . . . . 0.0 112.464 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.28 -18.79 48.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.992 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.778 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.4 mp -97.02 29.15 3.21 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -86.04 131.23 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.061 0.458 . . . . 0.0 110.304 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.708 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 22.9 t 61.43 36.06 17.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.673 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.599 ' HE1' HG12 ' A' ' 60' ' ' VAL . 13.0 mtp -91.96 125.77 36.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.282 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -79.86 134.66 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.536 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.01 -177.51 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -110.28 -32.26 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.661 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 -177.06 4.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.43 129.01 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.453 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.19 100.77 42.07 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.152 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.87 -178.04 4.26 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.577 1.518 . . . . 0.0 112.682 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.7 mp -66.35 148.04 52.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.6 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.74 52.58 24.21 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -135.19 118.18 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 m -61.52 100.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.552 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.31 113.67 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.6 ' O ' HD11 ' A' ' 32' ' ' ILE . 19.1 mtt -96.14 165.21 16.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.76 -26.29 4.73 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 121.74 1.626 . . . . 0.0 112.616 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.79 -23.09 55.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.986 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.2 mtm -97.44 28.53 3.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.918 0.39 . . . . 0.0 110.934 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HE1' ' A' ' 43' ' ' MET . 34.5 t -141.33 101.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.094 0.473 . . . . 0.0 110.133 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -64.08 124.46 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.453 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.58 7.41 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.778 ' CE1' HD11 ' A' ' 40' ' ' LEU . 27.5 t80 -72.68 140.44 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.113 0.482 . . . . 0.0 110.433 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -162.0 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.43 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.445 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -75.58 158.17 32.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.54 106.11 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.406 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -98.46 175.69 5.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.37 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.84 147.98 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.25 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.7 t -145.61 149.9 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 102.3 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.299 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.28 -26.33 66.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.583 ' OE1' HG12 ' A' ' 20' ' ' VAL . 17.3 pt20 -149.58 -178.0 6.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 50' ' ' PRO . 31.5 tp -70.4 101.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.601 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.819 HG23 ' CE ' ' A' ' 21' ' ' MET . 38.2 mt -96.06 123.8 54.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.01 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.2 159.93 15.31 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.623 1.549 . . . . 0.0 112.796 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 46' ' ' ASN . 13.8 tt -71.03 151.67 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.06 37.46 21.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.646 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -132.8 134.75 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.472 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -62.02 151.06 36.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 43' ' ' MET . 82.7 mt -90.17 166.63 13.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.1 p -150.13 170.13 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.3 mp -62.08 -32.97 73.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' OE1' ' A' ' 9' ' ' GLN . 21.6 t -70.03 -30.35 43.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 11' ' ' ILE . 29.0 mtp -97.44 28.66 3.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HE3' HG23 ' A' ' 37' ' ' ILE . 29.6 mtm -150.27 125.78 10.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -142.89 161.97 36.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -96.63 143.42 27.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.432 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -177.96 143.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 122.52 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 m -154.45 157.16 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -116.65 144.91 34.18 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.363 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.41 150.83 81.39 Favored 'Cis proline' 0 N--CA 1.481 0.754 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.462 0.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.7 m -59.45 104.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.44 -121.28 3.69 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -75.62 139.55 70.83 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -82.19 161.24 17.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.612 1.541 . . . . 0.0 112.92 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.63 -16.98 64.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -13.18 61.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.489 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 40' ' ' LEU . 51.0 m-20 -113.75 25.09 11.51 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.609 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 34' ' ' ALA . 39.6 mt -63.45 -47.58 83.29 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.642 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.1 Cg_endo -76.6 -16.31 16.86 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.105 1.203 . . . . 0.0 113.008 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -80.77 -27.27 36.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.773 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.601 HD11 ' CE1' ' A' ' 63' ' ' TYR . 2.1 mp -97.41 38.78 1.24 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.147 0.498 . . . . 0.0 110.721 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.68 141.76 13.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.231 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.502 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 2.2 m 60.84 32.65 20.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.514 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.499 ' HB2' HD12 ' A' ' 17' ' ' LEU . 94.7 mmm -92.25 143.45 26.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -101.2 138.77 37.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.477 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.74 144.77 14.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.346 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.2 p-10 -79.96 -28.24 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.716 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -122.72 168.17 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.103 0.477 . . . . 0.0 110.461 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.97 51.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.03 91.77 23.4 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.38 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HA ' HD12 ' A' ' 10' ' ' LEU . 39.6 Cg_endo -80.64 -175.13 2.53 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.68 1.587 . . . . 0.0 112.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.2 mp -61.65 149.39 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.47 61.6 6.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -140.62 111.93 7.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 104.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.54 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.5 109.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.498 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.556 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mtt -93.92 165.02 18.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.72 -20.23 8.01 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 121.828 1.685 . . . . 0.0 113.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.81 -42.77 49.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.992 0.425 . . . . 0.0 110.722 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.418 ' HG3' HG23 ' A' ' 60' ' ' VAL . 3.9 ptp -64.87 -28.16 69.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.992 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HG3' ' A' ' 59' ' ' MET . 43.5 t -88.63 97.42 6.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.094 0.473 . . . . 0.0 110.247 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -66.05 127.66 33.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.364 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.06 -31.09 8.48 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.601 ' CE1' HD11 ' A' ' 40' ' ' LEU . 43.3 t80 -66.88 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.36 51.79 5.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.568 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.587 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -87.98 -32.4 18.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.451 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.94 108.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.437 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -101.57 -173.06 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -100.27 93.42 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 25' ' ' GLU . 38.7 t -90.1 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.267 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.05 132.5 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.304 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.37 29.49 7.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -177.61 165.55 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.114 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.84 96.13 4.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.2 mt -90.43 112.47 53.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.085 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.91 156.81 20.66 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.562 1.508 . . . . 0.0 112.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.71 154.58 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 m120 60.46 32.83 20.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 156.72 43.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 151.98 21.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.695 ' CD2' HG21 ' A' ' 11' ' ' ILE . 65.5 mt -90.1 168.57 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.457 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -150.12 164.65 35.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.67 -32.06 72.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.448 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -66.29 -31.56 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.288 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.7 mtm -99.43 31.77 3.02 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 29.5 mtm -150.12 137.22 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -160.03 162.24 34.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.402 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 m -84.71 129.94 34.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.423 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.8 tt0 -162.44 128.94 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.462 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.71 115.18 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.89 162.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -119.55 141.52 31.07 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.263 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 54' ' ' THR . 39.3 Cg_endo -79.99 156.35 87.86 Favored 'Cis proline' 0 N--CA 1.482 0.821 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.523 0.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.4 p -61.11 112.28 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.38 -125.66 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 40' ' ' LEU . 53.8 mt -74.39 139.86 75.44 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -82.19 165.99 16.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.622 1.548 . . . . 0.0 112.817 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.7 -12.21 60.01 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.613 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.99 -9.75 56.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.774 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.2 m-20 -118.18 27.63 8.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.403 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD11 ' HB1' ' A' ' 34' ' ' ALA . 36.7 mt -65.81 -47.63 64.76 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.555 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.6 Cg_endo -77.96 -18.15 13.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.161 1.241 . . . . 0.0 112.532 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -79.24 -26.27 42.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.67 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -97.44 37.63 1.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.098 0.475 . . . . 0.0 110.893 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 31.7 t -89.05 135.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.162 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m 61.28 37.64 17.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.547 ' HG3' HD23 ' A' ' 40' ' ' LEU . 97.2 mmm -90.37 147.67 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.31 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.67 125.18 47.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.517 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -91.84 -177.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.376 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -108.74 -43.04 4.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.612 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -118.02 -177.49 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.55 121.87 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.507 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 53' ' ' THR . 22.4 t -111.91 91.97 16.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.12 -173.2 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.666 1.577 . . . . 0.0 112.778 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -67.12 137.71 56.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.529 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 31.95 37.25 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.441 HG21 HG13 ' A' ' 49' ' ' VAL . 24.9 m -111.65 112.51 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.052 0.454 . . . . 0.0 110.311 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 29' ' ' PRO . 10.5 m -62.04 105.39 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.81 141.58 57.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.267 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 60' ' ' VAL . 24.4 mmm -127.12 157.03 73.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.74 -20.79 7.57 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 121.803 1.669 . . . . 0.0 113.129 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -79.27 -44.41 21.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 ptm -68.08 -31.38 70.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 56' ' ' MET . 27.4 t -79.86 111.28 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -71.75 121.39 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.377 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.84 -31.66 7.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.67 ' CD2' HD21 ' A' ' 40' ' ' LEU . 48.5 t80 -85.09 110.69 19.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.01 0.433 . . . . 0.0 110.417 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.96 -69.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.384 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.396 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.29 31.28 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.41 125.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.566 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.23 -177.42 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.91 149.63 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.6 t -145.96 153.68 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.136 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 11' ' ' ILE . . . -79.79 121.38 25.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.368 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -99.84 30.54 3.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.99 161.62 0.95 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.988 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 10' ' ' LEU . 31.9 tp -69.79 97.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.433 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 17' ' ' LEU . 10.7 mt -89.7 111.93 48.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.043 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.29 153.49 16.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.603 1.535 . . . . 0.0 112.598 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 tt -61.47 154.15 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.359 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 60.87 33.07 20.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -132.38 146.29 51.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.422 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 155.32 29.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.499 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 11' ' ' ILE . 88.1 mt -90.19 167.44 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.45 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.06 -33.26 74.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' MET . 17.7 m -69.7 -27.88 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.771 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG3' HG23 ' A' ' 20' ' ' VAL . 75.9 mtm -99.02 30.77 3.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.416 ' HE3' ' O ' ' A' ' 37' ' ' ILE . 31.0 mtm -150.15 143.84 25.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -160.21 164.4 32.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -97.46 133.32 42.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -169.14 146.24 3.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.87 130.8 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -155.45 175.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 t -133.52 144.91 54.18 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.11 169.35 69.92 Favored 'Cis proline' 0 N--CA 1.482 0.843 0 C-N-CA 124.086 -1.214 . . . . 0.0 112.587 -0.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 30' ' ' VAL . 10.9 p -61.58 110.94 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -111.01 -133.63 6.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.469 HD11 ' C ' ' A' ' 56' ' ' MET . 68.8 mt -65.75 139.74 97.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -80.98 168.28 17.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.576 1.517 . . . . 0.0 112.674 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.36 -2.77 36.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.694 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -90.82 19.82 5.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.624 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.3 m-20 -140.39 30.1 1.96 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.608 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.448 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 25.4 mt -69.09 -46.97 30.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.111 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.7 Cg_endo -76.38 -21.3 13.47 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 121.129 1.219 . . . . 0.0 112.657 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -77.05 -26.74 53.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.632 HD21 ' CD1' ' A' ' 63' ' ' TYR . 5.3 mt -97.87 34.44 1.89 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.0 t -90.02 141.62 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m 60.8 34.75 19.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.8 mmm -97.03 129.56 44.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.32 136.42 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.407 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.95 163.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.402 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -112.76 32.23 5.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.414 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -178.84 161.13 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.429 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.36 126.6 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.91 94.97 47.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -80.17 179.85 5.84 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.697 1.598 . . . . 0.0 112.636 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.07 142.04 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.549 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.25 56.4 6.3 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 m -134.7 118.03 16.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.452 . . . . 0.0 110.36 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -62.07 100.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.88 110.09 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.469 ' C ' HD11 ' A' ' 32' ' ' ILE . 24.0 mtt -95.37 163.08 22.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.455 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.71 -26.85 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.869 1.713 . . . . 0.0 112.685 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.16 -33.15 67.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.431 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 mtm -72.33 -36.6 68.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.432 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 56' ' ' MET . 24.9 t -79.89 110.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -71.88 122.64 21.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.444 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.49 -31.61 7.46 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD1' HD21 ' A' ' 40' ' ' LEU . 63.7 t80 -78.95 157.08 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -160.13 124.37 3.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.448 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . . . . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.423 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.4 pt20 -61.11 166.99 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.514 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.79 160.63 20.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.424 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -126.31 -177.48 3.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.37 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.16 87.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.354 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -89.52 147.8 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.309 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -72.84 129.97 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.452 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -107.9 31.08 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.74 158.09 0.77 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.05 98.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.56 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.1 mt -89.48 112.91 54.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.942 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.8 151.95 19.2 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.386 1.39 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.51 155.06 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.01 32.89 19.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.472 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -134.19 151.52 51.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.99 151.35 24.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' CD2' HG21 ' A' ' 11' ' ' ILE . 23.6 mt -84.89 170.81 12.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.393 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -150.33 166.71 29.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.38 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.3 mm? -62.03 -32.39 72.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.356 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.43 -30.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.458 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.4 mtm -99.1 31.29 3.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.629 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' HE2' ' A' ' 22' ' ' MET . 26.5 mtm -150.03 151.43 33.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.05 -177.2 6.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -120.77 100.63 7.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.91 144.33 37.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 2' ' ' GLN . 21.7 t -74.84 129.03 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -155.05 154.02 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -114.18 139.53 23.86 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 54' ' ' THR . 39.6 Cg_endo -80.36 142.14 59.53 Favored 'Cis proline' 0 N--CA 1.483 0.855 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.475 0.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 30' ' ' VAL . 14.0 m -60.64 91.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.874 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.67 -111.94 0.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 56' ' ' MET . 58.4 mt -78.67 139.05 58.26 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -79.69 173.04 13.45 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.544 1.496 . . . . 0.0 112.525 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -90.07 14.18 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.559 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.78 14.89 12.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.405 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -145.57 29.79 1.12 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.4 mt -60.94 -47.33 95.85 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -75.76 -16.95 18.3 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.142 1.228 . . . . 0.0 112.914 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -82.56 -25.66 33.12 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 63' ' ' TYR . 3.3 mp -97.76 34.37 1.89 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.026 0.441 . . . . 0.0 110.731 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -83.59 134.22 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.309 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.523 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 3.7 t 60.86 35.8 19.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' LEU . 74.8 mmm -84.51 129.25 34.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.459 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -81.44 129.82 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.428 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.4 m -99.23 172.86 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.404 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -106.55 -33.82 7.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.391 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.36 -177.63 3.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.32 141.44 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.504 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.27 91.08 23.69 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.3 Cg_endo -80.44 -171.54 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.678 1.585 . . . . 0.0 112.671 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -67.0 143.32 56.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.438 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.83 49.75 27.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -132.85 114.42 14.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.321 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 29' ' ' PRO . 2.6 m -61.86 104.57 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.73 111.22 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.591 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.5 mmt -97.2 163.84 19.05 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -80.79 -24.62 4.82 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 121.628 1.552 . . . . 0.0 112.941 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.77 -25.73 59.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.0 mtm -98.23 30.21 3.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 56' ' ' MET . 48.2 t -140.2 106.31 2.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.017 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.79 121.62 14.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -31.37 8.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.472 ' CE1' HD11 ' A' ' 40' ' ' LEU . 37.0 t80 -90.22 139.27 30.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -177.81 91.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.562 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.47 118.15 27.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.44 167.15 4.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.357 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m -131.17 -174.0 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.08 89.54 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.481 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.12 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.233 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -77.86 137.0 38.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.373 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -112.4 29.52 7.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.633 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.3 157.06 1.29 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.975 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 10' ' ' LEU . 32.8 tp -70.59 97.64 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.583 HG21 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -89.56 125.4 61.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.1 151.16 13.93 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.653 1.568 . . . . 0.0 112.518 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.13 152.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 59.79 36.66 22.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 16' ' ' ALA . 25.7 m -133.31 159.56 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.439 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -89.15 150.47 22.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.464 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.583 ' CD2' HG21 ' A' ' 11' ' ' ILE . 16.6 mt -90.2 175.1 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 p -144.6 -170.94 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.096 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.32 -38.7 26.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.775 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.52 -25.87 37.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.8 mtm -99.19 31.07 3.19 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 37' ' ' ILE . 13.8 mtm -150.18 125.81 10.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -143.76 -178.95 6.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.399 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -114.76 126.58 55.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.406 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.5 136.41 10.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.33 112.36 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.06 149.06 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.459 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -108.51 145.16 30.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.38 164.26 80.05 Favored 'Cis proline' 0 N--CA 1.481 0.759 0 C-N-CA 124.106 -1.206 . . . . 0.0 112.532 0.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.7 p -61.56 118.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.33 -130.85 5.3 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.431 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -72.84 139.37 80.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.85 161.9 18.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.632 1.555 . . . . 0.0 112.843 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -66.48 -23.96 66.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -59.84 -18.89 47.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.541 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 40' ' ' LEU . 7.3 m-20 -109.91 40.09 1.99 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 111.438 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 55.0 mt -85.69 -46.63 0.6 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -78.07 -15.01 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.179 1.253 . . . . 0.0 113.078 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -86.17 -26.61 25.05 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.641 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 63' ' ' TYR . 11.1 mp -93.45 47.87 1.27 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.265 0.555 . . . . 0.0 110.588 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 38' ' ' PRO . 28.6 t -90.15 134.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.251 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.717 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 51.4 m 61.24 32.88 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.45 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.8 mmm -86.02 140.36 30.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.316 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -96.88 144.39 26.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.522 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 49' ' ' VAL . 25.7 m -110.41 175.55 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -90.52 -38.28 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.419 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -177.33 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.27 132.38 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.512 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 45' ' ' VAL . 22.1 t -116.67 91.99 36.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 40.0 Cg_endo -80.75 -171.23 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.748 1.632 . . . . 0.0 112.613 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.1 mp -71.06 148.65 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.28 32.23 72.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.5 m -116.7 114.92 24.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 110.271 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.5 m -61.97 100.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.405 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.29 113.43 2.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.442 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.602 ' O ' HG23 ' A' ' 60' ' ' VAL . 7.3 mtt -98.81 159.5 30.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.98 -27.71 2.36 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 121.918 1.745 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.09 -33.44 75.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.43 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 55.0 mtm -77.55 -33.51 54.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.382 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 56' ' ' MET . 29.5 t -79.85 102.71 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.46 125.82 27.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.71 -31.54 7.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.789 ' CE1' HD11 ' A' ' 40' ' ' LEU . 35.9 t80 -82.54 149.97 27.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.285 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.89 132.36 13.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.347 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -116.95 155.24 29.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.366 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.2 135.12 46.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.24 -172.41 2.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.9 151.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.278 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.14 150.17 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.28 120.88 25.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.368 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -99.7 31.54 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.59 166.16 1.74 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.058 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' HD11 ' A' ' 51' ' ' LEU . 21.0 tp -72.26 102.74 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.262 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.494 HG12 ' HE3' ' A' ' 21' ' ' MET . 46.6 mt -103.58 103.37 35.71 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.79 163.79 20.78 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.563 1.509 . . . . 0.0 112.553 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -61.2 153.82 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.414 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 60.35 37.1 20.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.536 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 m -129.29 132.66 47.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 142.6 50.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 43' ' ' MET . 35.9 mt -82.74 163.71 21.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -150.22 175.79 11.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.304 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.61 -34.14 77.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.336 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.95 -29.69 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.553 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.494 ' HE3' HG12 ' A' ' 11' ' ' ILE . 28.7 mtp -95.16 22.73 6.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.213 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 mtm -150.5 143.04 24.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.112 0.482 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -160.04 177.53 10.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 m -111.41 137.19 49.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -171.72 139.06 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.83 123.54 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.301 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.56 173.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -128.33 145.34 55.35 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.365 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.74 -179.97 25.9 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.494 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.87 102.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.91 -131.47 7.37 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.564 HD11 ' C ' ' A' ' 56' ' ' MET . 56.8 mt -73.23 139.56 79.08 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -82.79 169.49 13.34 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.606 1.537 . . . . 0.0 112.902 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.18 -24.89 65.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.47 -19.28 46.54 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.38 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 40' ' ' LEU . 39.5 m-20 -106.71 35.75 2.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.087 0.47 . . . . 0.0 111.45 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 34' ' ' ALA . 46.9 mt -81.06 -46.7 1.15 Allowed Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.562 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -77.43 -24.44 9.15 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.175 1.25 . . . . 0.0 112.529 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -78.41 -20.38 51.24 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.885 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.758 HD11 ' CE1' ' A' ' 63' ' ' TYR . 6.7 mp -97.19 30.31 2.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.972 0.415 . . . . 0.0 110.793 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.5 t -88.39 135.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.135 0.493 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.79 33.7 17.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.438 ' HE1' ' HB2' ' A' ' 63' ' ' TYR . 17.2 mtp -97.88 119.63 36.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.279 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -79.91 138.71 37.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.459 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.38 -179.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.45 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -110.13 -25.21 10.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -128.65 171.59 12.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.11 0.481 . . . . 0.0 110.544 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.45 144.36 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.9 92.49 12.67 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -78.91 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 121.632 1.555 . . . . 0.0 112.686 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.6 mp -61.04 153.55 25.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.675 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.76 53.1 46.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -135.32 117.63 15.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.096 0.474 . . . . 0.0 110.354 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -63.01 104.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.475 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.538 HD23 HD23 ' A' ' 40' ' ' LEU . 7.9 tp -60.83 114.41 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.451 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.564 ' C ' HD11 ' A' ' 32' ' ' ILE . 30.4 mtt -99.92 163.8 17.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.9 -24.79 5.64 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 121.738 1.625 . . . . 0.0 112.757 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.44 -32.31 64.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.453 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 40.9 mtm -71.67 -38.59 70.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.436 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.8 t -80.23 107.2 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.02 124.81 23.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.64 -29.8 10.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.758 ' CE1' HD11 ' A' ' 40' ' ' LEU . 58.0 t80 -87.27 128.08 35.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -161.21 100.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.403 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.46 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 86.25 -50.47 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.163 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . 62.23 113.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.186 0.517 . . . . 0.0 110.425 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -93.6 -171.13 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.47 149.07 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.1 t -146.59 150.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.7 122.14 20.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.244 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.77 -17.79 32.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -149.27 174.5 12.34 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 0.0 110.576 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 100.64 1.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.733 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.68 HG21 ' CD2' ' A' ' 17' ' ' LEU . 16.7 mt -89.98 116.94 67.58 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.937 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.68 147.88 15.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.436 1.424 . . . . 0.0 112.635 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.4 tt -61.1 155.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 61.01 33.25 19.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -133.84 152.62 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -84.61 138.07 32.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' CD2' HG21 ' A' ' 11' ' ' ILE . 18.7 mt -74.6 172.82 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.419 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -150.19 164.22 36.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.339 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.3 mp -62.5 -31.57 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.484 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.44 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.7 mtm -99.56 35.85 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 0.0 110.544 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.6 mtm -149.99 149.34 30.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.594 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -157.17 166.78 32.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.348 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.6 t -102.5 92.33 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.508 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -126.81 140.02 52.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.6 t -80.19 131.18 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -152.84 -177.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -136.75 139.31 28.67 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.292 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -77.92 148.85 86.46 Favored 'Cis proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.119 -1.2 . . . . 0.0 112.436 0.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.92 91.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.621 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.41 -124.93 0.71 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 56' ' ' MET . 64.7 mt -70.78 139.0 85.64 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.53 179.45 6.34 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.513 1.475 . . . . 0.0 112.617 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -89.92 13.45 14.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.56 -25.35 20.25 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.994 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 40' ' ' LEU . 11.8 m-20 -98.24 31.02 2.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 34' ' ' ALA . 75.3 mt -66.99 -47.4 52.93 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.51 -24.01 10.89 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 121.036 1.157 . . . . 0.0 112.572 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -26.78 53.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.698 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.759 HD21 ' CD2' ' A' ' 63' ' ' TYR . 6.3 mt -98.21 33.6 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 38' ' ' PRO . 27.3 t -88.89 136.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.724 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 64.6 m 60.93 36.08 18.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 mmm -92.45 133.08 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -82.61 131.76 35.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.3 152.47 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.326 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -79.81 -21.86 43.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -145.05 -179.94 6.95 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.55 154.57 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.88 93.86 4.44 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.383 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -80.49 -176.79 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.683 1.588 . . . . 0.0 112.484 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.3 mp -61.69 152.67 30.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.26 57.89 13.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -138.91 113.51 9.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.215 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -61.05 107.53 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.598 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.91 109.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.574 ' C ' HD11 ' A' ' 32' ' ' ILE . 17.0 mtt -97.99 160.8 27.53 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.289 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -80.45 -23.88 5.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.834 1.689 . . . . 0.0 112.978 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -71.19 -43.28 67.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.0 ptp -67.08 -29.07 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.04 104.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.161 0.505 . . . . 0.0 110.167 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -66.66 121.91 16.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.27 -31.53 7.57 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.759 ' CD2' HD21 ' A' ' 40' ' ' LEU . 50.1 t80 -90.17 89.31 7.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.19 113.66 27.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.458 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.415 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 60.69 98.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.39 156.12 39.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.495 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.61 -171.96 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.425 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.39 85.73 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.3 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.92 152.28 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.323 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.88 126.61 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.78 31.97 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -178.55 164.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 10' ' ' LEU . 30.2 tp -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.408 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 17' ' ' LEU . 45.6 mt -102.61 104.35 37.85 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.11 174.79 10.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.551 1.501 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.1 154.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.419 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 60.31 33.79 20.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -128.27 130.91 48.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.455 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 146.79 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' MET . 26.7 mt -87.43 164.96 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.473 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 p -150.27 -171.74 3.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.195 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.94 -45.62 57.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG23 ' HG3' ' A' ' 21' ' ' MET . 29.2 m -64.57 -24.3 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.006 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.463 ' HG3' HG23 ' A' ' 20' ' ' VAL . 27.0 mtp -95.8 25.33 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.196 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.4 mtm -150.41 152.23 34.02 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 110.312 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -159.98 176.72 11.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.57 116.75 28.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' OE1' HG13 ' A' ' 27' ' ' VAL . 4.0 tm-20 -152.03 139.07 19.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.406 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.11 113.41 7.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.276 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.429 HG13 ' OE1' ' A' ' 25' ' ' GLU . 27.4 m -140.11 178.97 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.431 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 t -131.44 145.47 57.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.286 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.13 168.11 70.74 Favored 'Cis proline' 0 N--CA 1.481 0.772 0 C-N-CA 124.142 -1.191 . . . . 0.0 112.561 -0.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 95.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.372 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -122.1 3.46 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.88 139.51 46.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.01 165.82 14.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 121.664 1.576 . . . . 0.0 112.78 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -68.99 -14.3 62.96 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -72.12 -7.99 52.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.704 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -116.34 28.94 8.26 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.166 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 49.8 mt -69.75 -46.99 24.84 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 Cg_endo -76.79 -16.21 16.5 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.127 1.218 . . . . 0.0 112.9 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -82.58 -25.3 33.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.715 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD21 ' CD2' ' A' ' 63' ' ' TYR . 3.4 mt -96.38 40.02 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.3 t -90.12 132.57 34.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.247 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 m 60.69 57.24 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.582 ' HB2' HD12 ' A' ' 17' ' ' LEU . 68.4 mmm -119.88 133.07 55.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.429 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.85 133.18 33.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.505 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.1 -177.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -105.53 -35.65 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -133.03 -177.21 4.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.373 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.53 115.36 11.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.481 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -111.43 93.18 18.27 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.336 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -80.61 -176.26 3.09 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 121.75 1.633 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 51' ' ' LEU . 2.4 mp -62.17 147.92 46.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.4 44.63 64.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.481 HG21 HG13 ' A' ' 49' ' ' VAL . 26.1 m -127.87 116.72 20.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.147 0.498 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.4 m -62.26 101.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.87 111.73 2.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.2 mtt -91.01 158.82 41.13 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.324 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.4 -26.38 4.09 Favored 'Trans proline' 0 N--CA 1.474 0.373 0 C-N-CA 121.793 1.662 . . . . 0.0 112.737 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.79 -31.94 59.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.501 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.4 mtp -68.38 -38.36 81.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.71 109.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.384 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.19 120.29 12.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.29 -31.85 7.1 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.615 ' CD2' HD21 ' A' ' 40' ' ' LEU . 46.3 t80 -80.31 98.85 7.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 110.362 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.47 -63.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.448 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 60.65 158.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.11 131.18 23.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.408 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 m -94.09 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 91.99 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.77 153.04 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.301 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 128.65 35.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.416 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.77 31.86 4.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.6 163.34 1.5 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 10' ' ' LEU . 33.5 tp -73.08 96.57 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.648 HG21 ' CD2' ' A' ' 17' ' ' LEU . 17.7 mt -90.08 111.77 48.63 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -82.01 153.9 16.98 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.524 1.483 . . . . 0.0 112.755 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 46' ' ' ASN . 14.2 tt -61.39 154.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.417 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 60.2 33.63 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.556 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 16' ' ' ALA . 10.6 m -130.61 159.66 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' N ' HG22 ' A' ' 15' ' ' THR . . . -89.84 151.53 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.648 ' CD2' HG21 ' A' ' 11' ' ' ILE . 72.9 mt -90.0 165.77 13.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.439 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.2 p -148.28 165.45 30.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.381 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.7 -31.62 71.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.17 -31.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.314 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.0 mtm -99.26 31.07 3.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.593 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.5 mtm -150.05 140.49 22.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.435 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -160.1 -177.36 6.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.15 124.14 51.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.377 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.65 145.51 22.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.07 121.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.348 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.67 159.73 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 t -120.3 145.77 41.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -81.88 166.19 72.13 Favored 'Cis proline' 0 N--CA 1.481 0.736 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.651 -0.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.19 99.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.35 -123.57 3.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.545 HD11 ' C ' ' A' ' 56' ' ' MET . 57.2 mt -76.35 139.55 68.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.25 164.37 17.13 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.71 1.607 . . . . 0.0 112.797 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -67.41 -21.17 65.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.223 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -64.03 -15.55 59.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.513 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' O ' HD12 ' A' ' 40' ' ' LEU . 2.1 m-20 -110.27 28.1 8.96 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.494 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 mt -71.09 -46.94 14.57 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.6 Cg_endo -77.0 -19.32 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.204 1.269 . . . . 0.0 112.844 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -80.91 -24.72 38.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' ' 63' ' ' TYR . 2.1 mt -96.58 37.65 1.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.102 0.477 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.7 t -89.94 138.57 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.242 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m 60.87 35.94 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.476 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.627 ' HG3' HD23 ' A' ' 40' ' ' LEU . 86.9 mmm -92.01 143.64 26.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.457 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -103.88 138.25 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.95 175.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' O ' HD11 ' A' ' 13' ' ' ILE . 1.4 p-10 -102.54 -31.38 10.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.561 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -121.83 -179.44 4.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.72 155.72 33.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.451 HG13 HG21 ' A' ' 53' ' ' THR . 22.0 t -150.61 90.75 4.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -79.63 -175.29 2.65 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 121.705 1.603 . . . . 0.0 112.657 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -61.73 151.73 33.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.57 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 51.59 48.36 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.451 HG21 HG13 ' A' ' 49' ' ' VAL . 24.7 m -133.62 122.04 22.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.126 0.489 . . . . 0.0 110.427 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -66.64 102.59 0.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.452 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.54 114.05 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.545 ' C ' HD11 ' A' ' 32' ' ' ILE . 4.6 mtt -98.44 161.22 25.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.378 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.6 -26.18 4.04 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.47 -32.86 60.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.361 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.52 -32.77 71.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.425 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -86.84 107.58 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.269 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -66.77 123.07 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.79 -30.95 8.44 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.663 ' CD1' HD21 ' A' ' 40' ' ' LEU . 56.7 t80 -77.45 121.18 23.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.134 0.492 . . . . 0.0 110.338 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.68 -64.36 1.3 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.428 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.453 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -145.05 -178.04 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.445 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.23 118.68 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.428 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -108.67 -175.07 2.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.398 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.68 149.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -150.14 149.6 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.95 127.58 32.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.345 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -105.62 30.68 5.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 160.31 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.121 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 tp -69.48 98.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.43 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.47 112.24 50.43 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.09 160.94 18.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 121.568 1.512 . . . . 0.0 112.575 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -65.98 154.96 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.31 33.16 20.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 m -130.84 147.96 52.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 42' ' ' SER . . . -81.58 155.76 25.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.432 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.79 169.45 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.368 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.18 163.38 38.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.23 -32.83 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.44 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.65 -31.24 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.428 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.6 mtm -99.29 31.61 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.9 mtm -150.11 138.69 20.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -159.71 163.53 34.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.425 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 m -90.3 132.34 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.414 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -167.36 136.75 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.89 112.18 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.0 m -141.84 153.09 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 t -114.3 144.5 31.82 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -80.28 152.56 84.01 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.092 -1.212 . . . . 0.0 112.495 0.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 30' ' ' VAL . 11.5 p -61.07 113.12 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.452 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.81 -113.05 3.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 40' ' ' LEU . 57.2 mt -83.19 139.5 42.18 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -81.42 165.74 18.38 Favored 'Trans proline' 0 N--CA 1.476 0.462 0 C-N-CA 121.612 1.541 . . . . 0.0 112.946 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . -67.34 -13.54 62.09 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.4 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.02 -10.21 57.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.609 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 m-20 -115.63 28.65 8.51 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.285 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 HD11 ' HB1' ' A' ' 34' ' ' ALA . 49.5 mt -71.12 -46.79 14.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.825 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 Cg_endo -77.35 -22.67 10.77 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.153 1.235 . . . . 0.0 112.71 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -79.03 -24.52 43.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 63' ' ' TYR . 20.1 mt -97.22 35.86 1.54 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' PRO . 26.6 t -90.12 137.42 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.215 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 20.5 p 56.51 45.6 22.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.802 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.648 ' SD ' HD23 ' A' ' 40' ' ' LEU . 14.9 mtp -104.14 142.26 34.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.89 136.55 32.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.33 176.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.431 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -93.87 -36.38 12.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -134.7 -177.07 4.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.564 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.79 121.17 21.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.44 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.94 101.79 31.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.151 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.34 176.82 9.26 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 121.51 1.473 . . . . 0.0 112.691 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 51' ' ' LEU . 5.0 mp -61.23 151.06 32.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.565 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.07 54.9 29.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -135.82 116.71 14.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.073 0.463 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 m -61.99 108.86 1.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.5 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -61.3 113.06 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.472 ' C ' HD11 ' A' ' 32' ' ' ILE . 6.7 mmt -94.29 156.39 38.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.346 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -79.9 -24.74 5.68 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.853 1.702 . . . . 0.0 112.778 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -74.64 -31.37 61.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.3 mtm -71.91 -37.78 70.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.601 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.73 102.08 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.357 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -66.93 128.72 37.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.61 -29.43 11.86 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.751 ' CD1' HD21 ' A' ' 40' ' ' LEU . 39.1 t80 -61.98 -67.24 0.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.341 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.14 48.8 12.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.386 0.612 . . . . 0.0 110.799 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.544 179.899 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.4 m120 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 60.71 104.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.553 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.48 158.24 28.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.309 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.59 -171.99 2.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 32' ' ' ILE . 21.7 t -112.22 86.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.566 HG21 HG11 ' A' ' 27' ' ' VAL . 60.0 t -89.88 151.38 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -66.97 154.91 39.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -115.22 -17.52 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.46 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' HA ' HD21 ' A' ' 51' ' ' LEU . 6.7 pt20 -149.42 -179.92 7.45 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.069 0.461 . . . . 0.0 110.494 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' HD11 ' A' ' 51' ' ' LEU . 31.0 tp -71.08 101.36 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.522 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.783 HG23 ' CE ' ' A' ' 21' ' ' MET . 37.4 mt -96.95 109.98 51.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.38 154.24 21.38 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.524 1.483 . . . . 0.0 112.782 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' ARG . 15.1 tt -61.49 155.45 4.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 60.28 40.99 17.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 m -139.22 138.45 36.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.418 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.64 150.53 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.401 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 ' HB2' ' A' ' 43' ' ' MET . 50.5 mt -90.24 164.72 14.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 p -150.08 175.24 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.443 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.28 -33.06 73.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.372 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.57 -28.35 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.5 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.783 ' CE ' HG23 ' A' ' 11' ' ' ILE . 32.4 mtp -97.65 29.09 3.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 33.8 mtm -150.27 140.32 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -148.14 177.52 9.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.398 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.78 108.24 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.458 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -146.62 144.58 29.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.34 120.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.345 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 6' ' ' VAL . 27.6 m -144.51 165.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.399 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 t -122.7 145.45 45.24 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -81.33 174.98 43.82 Favored 'Cis proline' 0 N--CA 1.481 0.767 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.446 -0.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.22 108.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.49 -120.99 4.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.654 HD13 ' CD2' ' A' ' 40' ' ' LEU . 55.5 mt -85.58 139.71 35.74 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -83.08 166.33 14.61 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.63 1.553 . . . . 0.0 112.68 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -70.47 -23.2 62.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.73 -13.9 60.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.475 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 40' ' ' LEU . 73.1 m-20 -110.76 24.37 13.03 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.603 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 43.6 mt -66.09 -46.88 63.27 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.706 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.4 Cg_endo -76.7 -15.61 17.01 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 121.122 1.215 . . . . 0.0 112.82 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.41 -25.75 33.41 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.71 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD2' HD13 ' A' ' 32' ' ' ILE . 5.1 mp -97.26 36.24 1.49 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.787 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 38' ' ' PRO . 25.2 t -86.06 139.72 16.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m 60.99 34.42 19.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.56 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.791 ' HB2' HD12 ' A' ' 17' ' ' LEU . 21.8 mmm -84.15 148.62 26.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.399 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -112.77 124.78 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -95.0 -178.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.299 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -129.98 33.22 4.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -177.53 163.55 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.475 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.93 49.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.397 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.017 HG12 HG21 ' A' ' 53' ' ' THR . 12.5 t -149.75 98.27 3.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.054 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 10' ' ' LEU . 40.6 Cg_endo -81.61 -165.45 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.903 1.735 . . . . 0.0 112.923 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.5 mp -73.68 154.13 39.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.16 58.58 13.3 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.017 HG21 HG12 ' A' ' 49' ' ' VAL . 9.8 t -132.48 136.18 46.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.17 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -75.61 104.65 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.113 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.39 108.14 6.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -95.29 164.75 18.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.904 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 39.9 Cg_endo -80.36 -35.7 0.59 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 121.586 1.524 . . . . 0.0 112.657 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.35 -42.36 99.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.399 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtm -63.51 -30.45 71.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.61 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 56' ' ' MET . 31.7 t -88.39 127.79 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -81.42 122.32 27.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.028 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.5 -28.59 7.4 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 57' ' ' PRO . 9.0 t80 -57.31 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.09 0.471 . . . . 0.0 110.536 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.38 100.45 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.46 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.412 -179.942 . . . . . . . . 0 0 . 1 stop_ save_